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ABSTRACT 
The effects of 3,3',4,4'-tetrachlorobiphenyl (TCB) were examined in the marine 
fish scup (Stenotomus chrysops), focusing on the interactions between TCB and the 
CYP 1 A 1 enzyme system. A low TCB dose (0.1 mg/kg) elicited strong and sustained 
induction of hepatic CYP1A1 mRNA, protein content, and catalytic activity. A high TCB 
dose (5.0 mg/kg) elicited similar, strong induction of hepatic CYP1A1 mRNA, but not of 
CYP1A1 protein content or catalytic activity. This post-transcriptional "suppression" at the 
high TCB dose was specific for CYP1A1, and was not seen with other hepatic enzymes. 
In vitro studies indicate that hepatic microsomal CYP1A1 is inactivated in the presence of 
TCB plus cofactor, likely due to the production of reactive oxygen species during TCB 
occupation of the active site. CYP1A1 inactivation by TCB in vitro may explain the TCB-
elicited suppression of CYPlAl protein content in vivo. 
Both TCB doses elicited strong CYP1A1 induction in vascular endothelium of all 
organs, which was sustained for several weeks. Induction in intestinal epithelia was 
stronger at the high TCB dose, but induction in epithelia of liver, kidney, and gill were 
stronger at the low TCB dose. Both TCB doses caused proliferation of endoplasmic 
reticulum in liver, renal tubule necrosis, depletion of hematopoietic tissue in kidney, 
hyperplasia of gill epithelia, and increased number of ni.elanomacrophage aggregates in 
spleen. The high dose induced tail fin erosion, affecting both epithelial and calcified bone 
tissue. Tissue alterations were more severe at the high TCB dose, and repair of lesions 
occurred by day 16 at the low dose. The high dose caused mortality of many individuals. 
The two TCB congeners 3,3',4,4'-TCB and 2,2',5,5'-TCB were each converted to 
aqueous-soluble metabolites by hepatic microsomes from scup, beluga whale, and pilot 
whale. Induction response, correlation analysis, and inhibition studies indicate that 
3,3',4,4'-TCB is metabolized by scup CYP1A1, and 2,2',5,5'-TCB by the putative scup 
CYP2B. Correlation analysis and inhibition studies suggest that 3,3',4,4'-TCB is 
metabolized by cetacean CYP1A. Both cetacean species expressed microsomal proteins 
that are immunochemically related to mammalian CYP2B forms. Cytochrome P450 
systems from both cetacean species are partially characterized here. 
Thesis Supervisor: John J. Stegeman, Senior Scientist, WHOI 
3 
4 
ACKNOWLEDGMENTS 
First, I would like to thank my thesis supervisor, John Stegeman, for his advice in 
·helping to shape my research projects, for reminding me to be critical of my own work, for 
teaching me to choose my words carefully, and for his positive feedback and excellent 
editorial skills. I thank my committee member Mark Hahn, for offering valuable insights 
into the data, and a constant flow of reprints. I thank Judy McDowell, my thesis 
supervisor during my first two years here and then a committee member, for her support, 
her positive attitude, and her helpful comments on the chapters. I would also like to thank 
my other committee members: Steve Tannenbaum (M.I.T.) for traveling to Woods Hole to 
attend committee meetings, and for offering valuable input into the research as it 
progressed; David Kupfer (Worcester Foundation for Experimental Biology) for long talks 
about my results and other topics during NUTMEG meetings; Jay Gooch (Proctor and 
Gamble), whose early work on TCB/CYPlAl interactions in John Stegeman's lab 
provided a starting point for much of my thesis research; and John Farrington (committee 
member emeritus), for his participation in the proposal defense. I would also like to thank 
John Teal, who offered his time to chair both the proposal defense and the thesis defense. 
I also owe a profound thanks to those people in the laboratory who provided the 
day-to-day advice that made this work possible. I especially thank Michael Moore and 
Bruce Woodin, who have been infinitely generous with their time and expertise. Both 
helped to collect and prepare some of the scup tissue samples used in the thesis research, 
Michael has answered countless questions about histology, and Bruce has always been 
there to answer questions about laboratory techniques. Roxanna Smolowitz (M.B.L.) has 
provided expert advice on histopathology, for which I am very grateful. Several people 
advised me on rnRNA techniques, including Grace Bruning (M.B.L.), Bonnie Woodward, 
Sibel Karchner, and Margie Oleksiak. 
I would like to thank those people with whom I collaborated on laboratory projects. 
Andy Solow (WHOI, Marine Policy Center) developed a statistical analysis for the data 
from treated scup. Damian Shea (North Carolina State University) analyzed PCB residues 
and PCB metabolites in the treated scup samples. Lyle Lockhart (Department of Fisheries 
and Oceans, Winnipeg) collaborated on a study of P450 in beluga whales, and provided 
PCB residue analyses of these samples. Jennifer Joy has collaborated with me on an 
analysis of pilot whale liver biochemistry, and on an experiment of TCB distribution in 
scup. I also thank Neal Cornell (M.B.L.) and Hillary Morrison, who supplied nucleotide 
probes used in the research. And I am grateful to those who generously provided tissue 
samples for use in the thesis research: Mark Melancon (U.S. Fish and Wildlife Service, 
5 
Laurel, MD) donated rat liver microsomes, Greg Early (New England Aquarium) and 
Michael Moore provided access to pilot whale liver samples, and Lyle Lockhart and Lothar 
Dahlke (Department of Fisheries and Oceans, Winnipeg) provided beluga whale liver 
samples. 
I would like to acknowledge every member of the Stegeman lab with whom I have 
worked over the years. These people have made the work more enjoyable, and have 
provided distractions from work whenever they were needed. I especially acknowledge 
Margie Oleksiak, Jennifer Joy, Connie Hart, Malin Celander, Rachel Cox, Sibel Karchner, 
Roxanna Smolowitz, Bonnie Woodward, Michael Moore, Bruce Woodin, Mark Hahn, and 
John Stegeman. 
I also owe thanks to my friends and family, for their support, and for helping me to 
remember that there is more to life than writing one's thesis. I especially thank my 
graduate student cohorts Susie McGroddy, Cheri Recchia, Alan Kuo, and Michele Durand, 
and my family, Myra White, Lawrence White, Dan White, Ken White, Barbara White, 
Suzanne Sack, Audrey Stahl, and of course Michael Cassell , for his tireless support, and 
Chunky. 
This research was funded in part by the Massachusetts Institute of Technology I 
Woods Hole Oceanographic Institution Joint Doctoral Program; by NIH grant 
P30ES021 09; by EPA grant R817988; and by grant NA-90-AA-D-SG480 from the Coastal 
Ocean Program of the National Oceanic and Atmospheric Administration to the Woods 
Hole Oceanographic Institution Sea Grant Program. 
6 
TABLE OF CONTENTS 
Abstract 
Acknowledgments 
List of Tables 
List of Figures 
Abbreviations 
CHAPTER ONE: Introduction 
Introduction 
Cytochrome P450 Structure and Function 
Cytochrome P450 Regulation 
Cytochrome P450 in Marine Vertebrates 
Polychlorinated Biphenyls: Distribution, Toxicity, Metabolism 
Interaction Between Polychlorinated Biphenyls and Cytochromes P450 
Goals of Dissertation Research 
CHAPTER TWO: 3,3',4,4'-Tetrachlorobiphenyl Elicits Induction, 
Inhibition, and Inactivation of Cytochrome P4501Al in Teleost Liver 
in vivo and in vitro 
Abstract 
Introduction 
Materials and Methods 
Results 
Discussion 
Page 
3 
5 
10 
11 
13 
15 
29 
CHAPTER THREE: Temporal Pattern of Induction of Cytochrome P4501Al 69 
in Multiple Organs and Cell Types of the Marine Fish Scup Treated with Low 
and High Doses of 3,3',4,4'-Tetrachlorobiphenyl 
Abstract 
Introduction 
Materials and Methods 
7 
Results 
Discussion 
CHAPTER FOUR: Histopathological Analysis of 3,3',4,4'-
Tetrachlorobiphenyl Toxicity in Multiple Organs of the Marine Fish Scup: 
a Time-Course and Dose-Response Study 
Abstract 
Introduction 
Materials and Methods 
Results 
Discussion 
103 
CHAPTER FIVE: In vitro Metabolism of Polychlorinated Biphenyl (PCB) 131 
Congeners by the Marine Fish Scup (Stenotomus chrysops): Relationship to 
Cytochrome P450 Expression 
Abstract 
Introduction 
Materials and Methods 
Results 
Discussion 
CHAPTER SIX: In vitro Metabolism of Polychlorinated Biphenyl (PCB) 165 
Congeners by Beluga Whale (Delphinapterus leucas) and Pilot Whale 
(Globicephala melaena): Relationship to Cytochrome P450 Expression 
Abstract 
Introduction 
Materials and Methods 
Results 
Discussion 
CHAPTER SEVEN: Catalytic and Immunochemical Characterization of 191 
Hepatic Microsomal Cytochromes P450 in Beluga Whale (Delphinapterus leucas). 
Reprint from Toxicology and Applied Pharmacology 126. 
Abstract 
Introduction 
Materials and Methods 
8 
Results 
Discussion 
CHAPTER EIGHT: Summary and Conclusions 
Teleost studies 
Cetacean studies 
BIBLIOGRAPHY 
9 
205 
212 
LIST OFT ABLES Page 
Chapter 1: 
Table 1: Selected Cytochrome P450 Gene Products 20 
Chapter 2: 
Table 1: Induction of Total Hepatic Cytochrome P450 due to CYPIAl 41 
Table 2: Metabolites of 3,3',4,4'-TCB Covalently Bound to Microsomal Protein 51 
Table 3: Cytochrome P450 Content and EROD Activity in Microsomal 
Incubations at 30 Minutes 
Chapter 3: 
Table 1: CYPlAl Induction in Renal Tubules ofTCB-Treated Scup 
Table 2: CYPlAl Induction in Multiple Cell Types on Day 5 
Chapter4: 
Table 1: Number of Melanomacrophage Aggregates in Spleen of TCB-Treated 
53 
81 
96 
and Control Fish 116 
Table 2: Plasma Chemistry in Vehicle-Treated and TCB-Treated Fish 124 
Table 3: TCB Concentration in Pooled Tissue Samples ofTCB-Treated Scup 125 
Chapter 5: 
Table 1: Microsomal Enzyme Contents and Activities in Depurated, Feral, 
and Treated Scup 150 
Table 2: Rate of Metabolism of 14c-TCB Congeners in Hepatic Microsomes 
from Feral Scup: Addition of a "Competing" TCB Congener 156 
Chapter 6: 
Table 1: Microsomal Monooxygenase Components and Activities in Pilot and 
Beluga Liver Samples 174 
Table 2: TCB Metabolism Rates and P450 Parameters in Selected Samples 175 
Chapter 7: 
Table 1: Microsomal Electron Transport Components in Beluga Whale Liver 195 
Table 2: Microsomal Monooxygenase Activities in Beluga Whale Liver 195 
Table 3: Profile of Benzo[a]pyrene Metabolites Produced by Liver Microsomes 
of Beluga Whale 199 
Table 4: Comparison of Liver Microsomal Monooxygenase Components and 
Activities in Different Species of Adult Cetacean 200 
10 
LIST OF FIGURES 
Chapter 2: 
Fig 1: Hepatic microsomal content of cytochrome P450 and cytochrome b5 
Fig 2: Hepatic microsomal content of CYPIAl, P450B, and P450A 
Fig 3: Hepatic microsomal EROD activity and PROD activity 
Fig 4: Hepatic microsomal NADPH reductase activity and UGT activity 
Fig 5: Northern blot of hepatic CYP1Al mRNA in pooled scup samples 
Fig 6: Hepatic CYP1Al mRNA content 
Fig 7: GC/MS analysis of TCB content in pooled liver samples 
Fig 8: Spectrophotometric analysis of cytochrome P450 in microsomes 
Fig 9: Enzyme inactivation by TCB in vitro 
Fig 10: CYPlAl inactivation in the presence of azide in vitro 
Chapter 3: 
Fig 1: Immunodetectable CYP I A 1 content in kidney, gill, and liver 
Fig 2: Rate of EROD activity in kidney, gill, and liver microsomes 
Fig 3: IHC analysis of CYPlAl induction in liver and kidney 
Fig 4: Time-course of CYPIAI induction in epithelial cells 
Fig 5: Time-course of CYPIA1 induction in endothelial cells 
Fig 6: IHC analysis of CYP 1 A 1 induction in gill 
Fig 7: IHC analysis of CYP1Al induction in intestine and spleen 
Fig 8: IHC analysis of CYP1A1 induction in heart and gonad 
Chapter 4: 
Fig I : Cumulative mortality in treated fish 
Fig 2: Condition index and hepatosomatic index in treated fish 
Fig 3: Histopathology in treated fish 
Fig 4: H&E stained slides of liver and spleen 
Fig 5: H&E stained slides of kidney and gill 
Fig 6: Scup tail fin 
Fig 7: GC/MS analyses of TCB content in pooled liver and muscle samples 
Chapter 5: 
Fig 1: PCB congeners used in the study 
Fig 2: Metabolism of TCB congeners in hepatic microsomes of feral scup 
Fig 3: Inhibition of 3,3',4,4'-TCB metabolism in feral scup 
Fig 4: TCB I cytochrome P450 binding spectrum 
Fig 5: XAD column profiles of 3,3',4,4'-TCB metabolites 
11 
Page 
40 
43 
45 
46 
47 
48 
49 
52 
57 
59 
77 
79 
83 
85 
87 
91 
93 
95 
110 
I 11 
113 
115 
I19 
121 
126 
134 
141 
142 
144 
146-147 
LIST OF FIGURES, continued Page 
Chapter 5: 
Fig 6: XAD column profiles of2,2',5,5'-TCB metabolites 148-149 
Fig 7: Rate of metabolism of TCB congeners in vitro versus immunodetectable 
P450 in scup hepatic nticrosomes 152-153 
Fig 8: Mean rate of TCB metabolism versus mean content of immunodetectable 
cytochromes P450 in scup hepatic microsomes 
Fig 9: Inhibition of alkoxyresorufin 0-dealkylase activities by TCB congeners 
Fig 10: Po1yclonal antibody inhibition of metabolic activities in scup 
Chapter 6: 
Fig 1: Immunoblot of hepatic nticrosomes from pilot whale with MAb 1-12-3 
Fig 2: Correlation between hepatic microsomal EROD activity and immuno-
detectable CYP1A content in pilot whales 
Fig 3: SDS-PAGE imrnunoblots of cetacean liver nticrosomes with anti-CYP2B 
154-155 
158 
159 
176 
177 
polyclonal antibodies 179 
Fig 4: Rate of metabolism of 3,3',4,4'-TCB versus immunodetectable CYP1A 
content and EROD activity in cetacean liver microsomes 180 
Fig 5: Inhibition of EROD activity in beluga microsomes by TCB and ANF 182 
Fig 6: Inhibition of enzyme activities in beluga microsomes by ANF 183 
Fig 7: XAD column profiles of 3,3',4,4'-TCB metabolites in beluga 184 
Chapter 7: 
Fig 1: Dithionite difference spectrum of beluga liver microsomes 194 
Fig 2: Fluorescence spectra of PROD reaction mixtures 195 
Fig 3: Immunoblot of beluga hepatic microsomes with MAb I- I2-3 I96 
Fig 4: SDS-PAGE imrnunoblot of beluga hepatic microsomes with monoclonal 
anti-scup P450E and polyclonal anti-mouse CYP1AI 196 
Fig 5: Correlations ofCYP1A1 content to length and to native cytochrome P450 196 
Fig 6: Correlations between monooxygenase activity and CYP1A in beluga 197 
Fig 7: SDS-PAGE imrnunoblots of beluga liver nticrosomes with antibodies 
against CYP2B forms 198 
Fig 8: SDS-PAGE imrnunoblot of beluga liver microsomes with polyclonal 
anti-rat CYP2E1 198 
Fig 9: Benzo[a]pyrene metabolite profile from a male beluga 198 
Fig I 0: CYP 1 A 1 content in beluga liver nticrosomes versus concentration of 
non-ortho and mono-ortho PCBs in blubber samples of the same animals 20 I 
I2 
ABBREVIATIONS 
Ah: 
AHH: 
ANF: 
BaP: 
BNF: 
BSA: 
eDNA: 
cprnldpm: 
CYP: 
OCB: 
DMSO: 
ECOD: 
7-ER: 
EROD: 
HAH: 
HCB: 
H&E: 
HSI: 
IHC: 
IgG: 
!SF: 
IHC: 
MAb: 
3-MC: 
MCB: 
MROD: 
NAD(P)H: 
O.D.: 
pAb: 
PAH: 
PB: 
PBS: 
PCB: 
PeCB: 
aromatic hydrocarbon 
aromatic hydrocarbon hydroxylase 
a.-naphthoflavone 
benzo[a]pyrene 
~-naphthoflavone 
bovine serum albumin 
complementary DNA 
counts I disintegrations per minute 
cytochrome P450 
dichlorobiphenyl 
dimethyl sulfoxide 
ethoxycoumarin 0-deethylase 
7-ethoxyresorufin 
ethoxyresorufin 0-deethy lase 
halogenated aromatic hydrocarbons 
hexachlorobiphenyl 
hematoxylin and eosin stain 
hepatosomatic index 
immunohistochemistry 
immunoglobulin G 
isosafrole 
immunohistochemistry 
monoclonal antibody 
3-methy ]cholanthrene 
monochlorobipheny I 
methoxyresorufin 0-demethylase 
nicotinamide adenine dinucleotide (phosphate) 
optical density 
polyclonal antibody 
polycyclic aromatic hydrocarbons 
phenobarbital 
phosphate buffered saline 
polychlorinated biphenyl 
pentachlorobiphenyl 
13 
ABBREVIATIONS, continued 
PROD: 
SAR: 
TCA: 
TCB: 
TCDD: 
TCDF: 
J.l.: 
J!Ci: 
UGT: 
pentoxyresorufin 0-depentylase 
structure-activity relationship 
trichloroacetic acid 
tetrachlorobiphenyl 
2,3, 7 ,8-tetrachlorodibenzo-p-dioxin 
2,3, 7 ,8-tetrachlorodibenzofuran 
micro 
microCurie 
UDP-glucuronosyl transferase 
14 
CHAPTER ONE 
Introduction 
15 
Introduction 
The study of pollutant effects in marine animals is of broad interest to the biological 
sciences, firstly because responses in these organisms shed light on the health of the 
ecosystem, and secondly because these species serve as important models for pollutant 
effects on human health. Biological oceanography, which focuses on the interaction of 
marine organisms with their environment, must also consider the influence of 
anthropogenic chemicals in that environment, and how the presence of such compounds 
may affect life within the ocean. The world's oceans have increasingly become polluted 
with anthropogenic organic contaminants, including polycyclic aromatic hydrocarbons 
(PAH) and halogenated aromatic hydrocarbons (HAH). Even seemingly remote areas are 
now found to have detectable concentrations of these chemicals (Fowler, 1990). Marine 
animals may take up organic pollutants from all compartments of the ecosystem, including 
the sediments (benthic fish and invertebrates that live and feed at the bottom), the water 
column (via the gills in fish), and the other organisms (marine mammals and fish that feed 
near the top of food webs). Once internalized, organic contaminants may elicit a wide 
range of effects, from grossly visible tissue damage to subtle alterations in the levels of 
gene transcription. Perturbations thus occur at many levels, from the most fundamental to 
the most macroscopic: molecular, biochemical, cellular, histological , systemic, 
organismal, population effects, and ecosystem effects. There is a complex interplay 
between the toxic effects that are manifest at each level, and in many cases, changes 
detectable at one level may shed light on those that will occur at higher levels, or on those 
that have occurred at lower levels. This dissertation provides an integrated picture of the 
changes elicited at several levels by one environmental toxicant. 
Central to the question of toxicant effect is the question of toxicant elimination, a 
means by which effects can be relieved. To some degree, organic contaminants may be 
eliminated in an unaltered form: in the urine and feces, in exchange across the gills (fish), 
in the eggs at spawning (fish), in parturition and lactation (mammals). However, many 
organic contaminants, including P AH and HAH, are highly lipophilic and tend to partition 
into fat (Chiou, 1985), making their elimination particularly slow. In such cases, 
metabolism becomes an important route for elimination, particularly those metabolic 
pathways that generate products that are more hydrophilic than is the parent compound. 
One group of enzymes that achieves such metabolism in vertebrate animals is the 
cytochromes P450. This is a family of microsomal monooxygenase enzymes that acts 
upon an almost endless list of substrates, including endogenous compounds (e.g. steroids 
and fatty acids), naturally occurring, exogenous compounds (PAH and plant metabolites) , 
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and synthetic, exogenous compounds (HAH and many drugs). Cytochromes P450 act by 
binding to hydrophobic compounds and introducing a single oxygen atom, usually bonded 
to a substrate carbon atom, thus rendering the compound more water-soluble. Following 
the oxygenation of a xenobiotic substrate by P450, two pathways are possible: (1) the 
intermediate compound may undergo further metabolism by "Phase II" enzymes to generate 
a highly polar, (often) nontoxic product which is excreted from the cell or organism; or (2) 
the intermediate may form covalent adducts with cellular proteins (including P450 itself) or 
DNA, potentially resulting in toxicity, carcinogenesis, or mutagenesis. The fate of the 
xenobiotic compound is dependent upon the rate of formation of the oxygenated 
intermediates, the chemical stability of those intermediates, and the presence of Phase II 
enzymes (Nebert and Gonzalez, 1987). Cytochromes P450 are thus of crucial importance 
in determining the fate and effects of organic pollutants that are taken up by vertebrate 
animals. Thus, the study of the regulation of P450 in marine vertebrates is central to the 
understanding of their responses to environmental contaminants. 
At the core of this dissertation is an investigation of the suite of interactions that 
occur between the HAH compound 3,3',4,4'-tetrachlorobiphenyl (TCB), and the 
microsomal monooxygenase enzyme cytochrome P4501Al (CYPlAl). TCB is one of a 
class of compounds that binds to the cytosolic Ah (aromatic hydrocarbon) receptor in 
vertebrates, thus eliciting the induction of CYP1A proteins, as well as several other 
enzymes involved in xenobiotic metabolism (Nebert and Gonzalez, 1987). CYPlA 
proteins, in tum, act in the primary metabolism of TCB and other Ah receptor ligands. 
Thus TCB and CYPlAl act to mutually regulate each other's levels in the organism. 
Studies conducted with whole-animal and cell culture systems from several vertebrate 
classes (teleost fish, mammals, birds) indicate that TCB and similar compounds, in 
substrate-binding to CYPlA proteins, cause decreased CYPIA enzyme activity and 
catalytic efficiency (inhibition). In addition, studies in a few species have indicated that 
exposure to increasing concentrations of TCB results in decreasing tissue concentrations of 
CYPlA protein or mRNA. Such an effect is intriguing, from a compound that has 
classically been identified as a CYPlA inducer. This issue of multi-leveled CYPlA 
"suppression" by TCB is of great interest to enzymology, as the mechanisms have been 
largely undescribed. But it is also an important question to biological oceanography, since 
chlorobiphenyls are a prevalent class of marine pollutant that are taken up by fish, and that 
can bring about toxic effects with potential repercussions at the population level. 
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Cytochrome P450 Structure and Function 
The cytochromes P450 are a family of heme-containing, monooxygenase enzymes 
that are found in the endoplasmic reticulum and mitochondria of most eukaryotic cell types. 
Various forms have been identified in species as diverse as animals, plants, fungi, and 
bacteria. The bacterial system is similar to that found in eukaryotic mitochondria and will 
not be addressed here. In the endoplasmic reticulum of eukaryotic cells, P450 is a terminal 
electron acceptor in the membrane-bound enzyme system depicted below (Peterson and 
Prough, 1986). 
NADPH ~ cytochrome c (P450) reductase ---4 cytochrome P450 
~ / 
NADH ) cytochrome b5 reductase cytochrome b5 
Along the primary path of electron flow, NADPH passes two electrons to a flavoprotein 
reductase, which contains both FAD and FMN prosthetic groups. The reductase then 
passes the electrons sequentially to the P450. In some cases, the second of the two 
electrons received by P450 is donated by cytochrome b5, which itself may be reduced by 
either reductase. The passage of electrons between reductase and P450 may be dependent 
upon the frequency of collisions of the two proteins within the membrane, and upon proper 
orientation of collisions. The rate of reduction of P450 is greatly enhanced when it is 
bound to a substrate (Ingelman-Sundberg, 1986). 
The cytochrome P450 active site contains an iron protoporphyrin IX prosthetic 
group, which consists of one iron atom coordinated to four pyrrole rings. The iron is also 
coordinated to a cysteine residue of the surrounding protein by a thiolate ligand (Black and 
Coon, 1986), and a sixth iron coordination site is available for interaction with oxygen or 
various substrates and inhibitors. The heme group is surrounded by hydrophobic amino 
acids which comprise the substrate binding domain of the enzyme. The enzyme is buried 
in the phospholipid membrane of the endoplasmic reticulum, with some parts exposed on 
the cytoplasmic face. The phospholipids act to facilitate the P450/reductase association, 
help to maintain the conformation of the P450, and influence the enzyme/substrate binding 
interaction (lngelman-Sundberg, 1986). It has been demonstrated that cytochromes P450 
carry out stereoselective oxidation of their substrates, which suggests a specific substrate 
orientation within the active site during catalysis. 
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The catalytic cycle of cytochrome P450 is iJlustrated below, with Fe representing 
the heme iron in the cytochrome P450 active site. The cycle proceeds as follows (McMurry 
and Groves, 1986; Ortiz de Montellano, 1986): 
[Fe+3]---~ [Fe +3] [RH] --7)[Fe +2] [RH] 
[Fe +2] [RH] 
I 
02 
-~) [Fe] [RH] --~ 
I 
0 
[Fe +3] + ROH 
) 
(1) substrate binding to enzyme, by hydrophobic interactions with the protein surrounding 
the heme, to give a high-spin ferric complex; (2) transfer of one electron from reductase, 
reducing the iron to the ferrous form; (3) covalent binding of molecular oxygen to the iron 
atom in the heme active site, to generate a ferrous P450-dioxygen complex; (4) transfer of a 
second electron from reductase or b5 to the heme iron; (5) cleavage of the dioxygen bond, 
with incorporation of the distal oxygen into a water molecule; (6) transfer of the second 
oxygen atom from iron to the substrate; (7) dissociation of the oxygenated product from the 
enzyme, regenerating the ferric low-spin state of the enzyme. Reactions that are carried out 
by the above scheme include hydrocarbon hydroxylation, olefin epoxidation, aromatic 
hydroxylation (often preceded by epoxidation), nitrogen and sulfur oxidation, and 0 -
dealkylation of ethers and other oxygen derivatives. These transformations are involved in 
the metabolism and biosynthesis of steroids, as well as the metabolism of xenobiotics, 
including drugs , plant products, combustion products, and environmental contaminants. 
In addition, cytochrome P450 can catalyze substrate-independent autooxidation reactions, 
in which bound oxygen is converted to either one molecule of hydrogen peroxide or two 
molecules of water. 
The superfamily of cytochromes P450 is comprised of a number of distinct gene 
products, with broad and overlapping substrate specificities. These enzymes are capable of 
binding and oxygenating a vast array of xenobiotic and physiological compounds, although 
those involved in biosynthetic pathways generally display more narrow substrate-
specificities than those that are devoted to xenobiotic metabolism. At least 221 different 
P450 genes have been identified, in 36 gene families, as defined by percent similarity of 
protein sequence (Nelson et al., 1993). It is theorized that four of these families (P450 1 -
P4504) have evolved in animals in response to exposure to plant metabolites and decayed 
plant products (Nebert and Gonzalez, 1987). Evidence for this theory lies in the finding 
that these four families are involved in xenobiotic metabolism, and that many xenobiotic 
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substrates (including some drugs and combustion products) are plant-derived. 
Physiological functions have been ascribed to some genes in these four families, but for 
others such as CYPlAl , no physiological function is yet known. Table 1 provides a 
partial list of these gene products, including some known inducers (Nebert and Gonzalez, 
1987; Stegeman, 1989; Nelson et al. , 1993; Savas et al. , 1994). 
TABLE 1: Selected Cytochrome P450 Gene Products 
subfarnil~ Erotein trivial names regulation 
P4501A CYPlAl rat c, rat BNF-B, PAH, planar PCB, 
mouse P1 TCDD 
CYP1A2 rat d, rat ISF-G, PAH, planar PCB, 
mouseP3 TCDD, ISF 
P4501B CYPlBl ratEF PAH, TCDD 
P4502A CYP2Al rat a P AH, planar PCB 
P4502B CYP2Bl rat b, rat PB-B PB, non-planar PCB 
CYP2B2 rate PB, non-planar PCB 
P4502C CYP2C7 rat f PB, constitutive 
P4502D CYP2D1- 2D5 rat db1- db5 constitutive 
P4502E CYP2El ratj ethanol, starvation 
P4503A CYP3Al- 3A2 rat pen 1 - pcn2 steroids, PB 
P4504A CYP4Al rat LAro clofibrate 
Cytochrome P450 Regulation 
Cytochromes P450 fall into two groups with distinct regulatory mechanisms 
(Waterman et al., 1986): those forms that metabolize physiological or endogenous 
substrates are generally regulated endogenously, with constitutive levels determined by 
cellular signaling chemicals such as peptide hormones; those forms that metabolize 
xenobiotic or exogenous substrates are largely modulated by substrate induction. Induction 
commonly occurs via an enhanced transcription of the P450 gene, but in many cases also 
involves a post-transcriptional component, such as enhanced stabilization of existing P450 
protein (e.g. CYP2E 1; Song et al., 1986). The division of P450 enzymes into two 
categories is not so clear-cut, however, for many inducible enzymes are also regulated by 
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endogenous factors . For example, mammalian CYPIA and CYP2B are inducible by 
exogenous PAH and PB, respectively, and are also under endogenous regulation which 
determines level of transcriptional activity at different stages of development (Nebert and 
Gonzalez, 1987). Endogenous regulation results in enzyme levels that vary with 
developmental stage, sex, and cell or tissue type. 
The regulation of CYPIA enzymes is currently the best characterized of all 
inducible P450s. Induction occurs principally at a transcriptional level, upon exposure to 
Ah receptor ligands, many of which are also CYPIA substrates. The current model 
describing the process is as follows (Nebert and Gonzalez, 1987; Stegeman and Hahn, 
1994): (1) the ligand crosses the plasma membrane into the cell, and binds with the 
cytosolic Ah (aromatic hydrocarbon) receptor; (2) a heat shock protein (hsp90) dissociates 
from the Ah receptor upon ligand binding, and the ligand/receptor complex then 
translocates to the nucleus, which involves dimerization with the Ah receptor nuclear 
translocator (ARNT) protein; (3) the ligand/receptor complex binds to specific sequences 
of DNA identified as xenobiotic responsive elements (XREs), resulting in transcriptional 
activation of genes encoding CYP1Al, CYP1A2, and several Phase IT metabolic enzymes; 
(4) enhanced CYP1A mRNA concentrations bring about increased production of CYP1A 
protein(s); (5) these proteins may then bind and/or metabolize the ligand molecules. 
Organic xenobiotic compounds thus promote their own metabolism, which may activate 
them to more toxic or carcinogenic forms, and may effect their detoxification and 
elimination. The degree of induction is a function of both inducer concentration and 
inducer efficacy. Higher concentrations often result in greater induction, but exceptions to 
this have been observed (for example, PCBs discussed below). The most potent CYPIA 
inducer yet described is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) , which has been 
found to be 10,000 times more potent an inducer of monooxygenase activity than 3-
methylcholanthrene in mouse (Poland and Glover, 1974). 
Cytochrome P450 in Marine Vertebrates 
Many P450 enzymes have been identified in several fish species, including rainbow 
trout, scup, cod, perch, plaice, and little skate (Stegeman and Hahn, 1994). Several teleost 
forms are thought to be homologous with inducible mammalian P450 enzymes, including 
CYPIA, CYP2B, CYP2E, CYP3A, and CYP4A. Such assignments are based upon 
immunochemical cross-reactivity, similarity of catalytic function, and in some cases 
sequence similarity. Other fish P450s have been found to be present constitutively, and 
some are known to serve specific physiological functions such as steroid metabolism. 
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P450E from the marine fish scup (Stenotomus chrysops) has recently been 
sequenced, and was determined to be a CYP1A1 form (Morrison et al. , submitted). 
Studies of the regulation of teleost CYPlAl have indicated many similarities to regulation 
in mammals. Exposure to Ah-receptor agonists results in an increased level of CYPIAI-
encoding mRNA, which is followed in time by increased CYP1Al protein content and 
catalytic activity (Kloepper-Sams and Stegeman, 1989). Ah receptor has been identified in 
several species of bony fish (Hahn et al., 1994), indicating that CYP1Al induction in these 
species is likely mediated by this receptor, as it is in mammals. CYP1Al is induced in fish 
by many of the same compounds that induce mammalian CYPIAl, including high 
molecular weight PAH and coplanar PCB, but unlike mammalian CYPIAl, is apparently 
not induced by mono-ortho-substituted PCB (Gooch et al., 1989). Questions concerning 
CYP1Al induction in fish are addressed in chapters 2 and 3 of this thesis. 
P450B from the marine fish scup is believed to be homologous to members of the 
mammalian CYP2B subfamily, based upon immunochemical cross-reactivity of scup 
P450B and rat CYP2B1 (Stegeman et al., 1990a; Stegeman et al., 1990b). Furthermore, 
theN-terminal amino acid sequence of P450B is about 50% identical to the same region of 
rat CYP2B 1/2 (Stegeman and Hahn, 1994). The mechanism of regulation of the putative 
teleost CYP2B is not yet known. Treatment of fish with known inducers of mammalian 
CYP2B has consistently failed to bring about increased levels of microsomal activities that 
are catalyzed by mammalian CYP2B (reviewed in chapter 5). It is not yet known whether 
fish CYP2B responds to a different suite of inducers than do the mammalian forms, or 
whether fish CYP2B is not inducible by exogenous compounds. Such questions will 
require further investigation, and are addressed briefly in chapter 5 of this thesis. 
Far less is known about cytochromes P450 in marine mammals. P450 systems 
have been identified and partially characterized in a few cetacean species, namely minke 
whale (Goks~yr et al., 1986; Goks~yr et al., 1988), short-finned pilot whale, killer whale, 
striped dolphin (Watanabe et al., 1989), beluga whale (White et al., 1994 ), and long-finned 
pilot whale (chapter 6). Proteins have been detected in liver microsomes from minke 
whale, beluga whale, and long-finned pilot whale by cross-reaction with antibodies raised 
against CYP1A1 (Goks~yr et al., 1988; Goks~yr et al., 1989; White et al., 1994). All 
cetacean species examined catalyzed EROD, ECOD, and AHH activities, which are 
characteristic ofCYP1A in mammals. Thus it is fairly certain that cetaceans express a 
CYPIA homologue, which appears to be inducible by exposure to coplanar PCB (White et 
al., 1994). It is unclear, however, whether cetaceans express a CYP2B homologue that is 
similar to CYP2B in terrestrial mammals. Catalytic activities characteristic of mammalian 
CYP2B are consistently low in cetacean samples, including aldrin epoxidase activity 
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(Watanabe et al., 1989), PROD activity (White et al., 1994), and metabolism of 2,2',5,5'-
TCB (chapter 6). Immunochemical studies with antibodies raised against rat CYP2B l/2B2 
have detected no cross-reacting proteins in minke whale (Goks~yr et al., 1989), beluga 
whale (White et al., 1994), or long-finned pilot whale (chapter 6). It is possible that 
cetaceans do not express a protein homologous to mammalian CYP2B, consistent with the 
divergent evolution of terrestrial and marine mammals. Questions concerning CYP1A and 
CYP2B expression and activity in cetaceans are addressed in chapters 6 and 7 of this 
thesis. 
Polychlorinated Biphenyls: Distribution, Toxicity, Metabolism 
Polychlorinated biphenyls (PCBs) are a group of 209 compounds composed of a 
pair of aromatic rings, joined by a single carbon-carbon bond, with various patterns of 
chlorine substitution on the remaining 10 carbon atoms. Positions of chlorine substitution 
have been numbered 2 - 6 on one ring and 2' - 6' on the second ring, which are also 
referred to as the ortho, meta, and para positions of substitution, with respect to the central 
bond (see diagram below). 
3 2 ortho 
4 para 
5 6 
PCBs are entirely synthetic, first created in 1881, and were used heavily by the 
electrical industry from the 1940s to the 1970s, thus leading to their global distribution. 
Widespread, environmental contamination by PCBs was first discovered in 1966 by a 
Swedish scientist (Jensen, 1966), and later by a group of Americans (Risebrough et al., 
1968), in analysis of wildlife and human specimens. Since these early discoveries, PCBs 
have been detected throughout the globe, in water, soil, sediment, biota, and air (Tanabe, 
1988; Fowler, 1990). Of the total volume of PCBs ever synthesized, it is estimated that 
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31% has been released into the environment, 65% is "land-stocked" (either still in use in 
electrical equipment or deposited in landfills), and 4% has been degraded or incinerated 
(Tanabe, 1985). Of the 31% that comprises the environmental load, it is estimated that 
97% is retained in coastal sediments and open ocean water. 
Adverse human health effects of PCBs were first reported as early as the 1930s, in 
exposed industrial workers (Schwartz, 1936). Early reported conditions included "yellow 
atrophy of the liver" and "dermatitis" (Schwartz, 1936; Collier, 1943; Schwartz, 1943). 
Extensive work since that time has identified PCBs as neurotoxic, genotoxic, hepatotoxic, 
immunotoxic, and toxic to reproductive systems in mammals (Safe, 1984; Safe, 1992). 
Far less is known about PCB toxicity in teleost species, but effects are thought to include 
growth inhibition, impaired bone development, reproductive impairment (McFarland and 
Clark, 1989), and immune suppression (Spitsbergen et al., 1988c). PCB toxicity and 
histopathology in fish is addressed in chapter 4 of this thesis. 
In laboratory mammals, the oxidative metabolism of PCBs is catalyzed primarily by 
cytochromes P450. Structure-activity relationships appear to govern the metabolism of 
PCBs by P450, with chlorine position determining which P450 enzyme carries out the 
transformation. In rat liver, hydrocarbon-inducible CYP1A forms metabolize congeners 
with halogenated substituents at one or both para positions, and with adjacent unsubstituted 
ortho-meta carbons, while phenobarbital-inducible CYP2B forms (CYP2B 1, CYP2B2) 
metabolize congeners with adjacent, unsubstituted meta-para positions (Kaminsky et al., 
1981; Kennedy et al., 1981; Shimada and Saw abe, 1983; Mills et al., 1985; Ishida et al., 
1991). In addition, it was observed that PCB congeners with two or more ortho 
substituents are more rapidly metabolized by rat CYP2B than by CYP1A, while congeners 
lacking ortho substituents are more rapidly metabolized by rat CYP1A than by CYP2B. 
There is currently no direct information concerning the role of cytochromes P450 in PCB 
metabolism in fish, or in marine mammals. These issues are addressed in chapters 5 and 6 
of this thesis, respectively. 
Interaction Between Polychlorinated Biphenyls and Cytochromes P450 
PCBs were first identified as inducers of cytochrome P450 in 1973 (Alvares et al., 
1973), in a study that suggested that PCB mixtures may induce both "PH-inducible" 
(P450) and "MC-inducible" (P448) proteins. Later investigations of individual PCB 
congeners were able to determine "structure activity rules" for the induction of various 
P450 forms by the different PCB congeners in rat (Parkinson et al., 1980; Parkinson et al., 
1983). These studies found the following: the coplanar PCB congeners (lacking ortho 
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substituents) induced CYP1A1, CYP1A2, and CYP2Al ; the PCB congeners with two or 
more ortho substituents induced CYP2B 1 and CYP2B2; the mono-ortho substituted PCB 
congeners induced all five of these P450 enzymes, thus earning the name "mixed-type" 
inducers. Induction patterns in fish have proved to be somewhat different. As discussed 
above, no chemical has yet been found to induce the putative CYP2B form in fish. The 
coplanar PCB congeners were found to be potent inducers of CYP 1 A 1 in scup, but those 
congeners with one or two ortho substituents induced neither CYP1Al nor total P450 
content (Gooch et al ., 1989). 
The coplanar PCB congeners, in addition to acting as inducers of CYP1A enzymes, 
have also been shown to inhibit CYPIA activity in vivo and in vitro. These congeners 
include 3,3',4,4'-tetrachlorobiphenyl (TCB, IUPAC #77), 3,3',4,4',5-
pentachlorobiphenyl (PeCB, IUPAC #126), and 3,3',4,4',5,5'-hexachlorobiphenyl 
(HCB, IUPAC #169). As increasing doses of coplanar PCB are administered, decreasing 
rates of hepatic CYP 1 A enzyme activity and decreasing catalytic efficiencies have been 
observed. This has been found in fish (Melancon and Lech, 1983; Miranda et al., 1990; 
Monosson and Stegeman, 1991; Lindstrom-Seppa et al., 1994), rat (Voorman and Aust, 
1988), and in cultured hepatocytes from fish (Hahn et al., 1993), rat (Sawyer and Safe, 
1982), and bird (Rodman et al., 1989; Kennedy et al., 1993). The latter studies have not 
found, or have not reported, a decrease in CYP1A protein content to accompany the 
decrease in rate of CYPIA enzyme activity. Several in vitro studies have indicated that 
TCB and HCB act as competitive or mixed inhibitors of CYPI A activity in hepatic 
microsomes or in reconstituted systems (Voorman and Aust, 1987; DeMatteis et al., 1989; 
Gooch et al., 1989). The reduced CYP1A activity in the aforementioned studies, without a 
drop in CYP1 A protein content, is likely due to such inhibition. This would involve the 
residual PCB in hepatic microsomes binding to the CYP1A active site, and inhibiting the 
binding and catalysis of the substrate of interest. 
Other investigators have reported a decline in rate of CYP 1 A enzyme activity, 
accompanied by a drop in the content of CYP1A protein, when higher doses of TCB were 
administered. These studies have included work with fish (Gooch et al. , 1989), cultured 
bird hepatocytes (Sinclair et al., 1984; Lambrecht et al. , 1988; Sinclair et al., 1989; 
Lorenzen and Kennedy, in preparation), and cultured porcine aorta endothelial cells 
(Stegeman et al., in press). Still other investigators have observed reduced expression of 
CYP1A mRNA, in fish exposed to higher TCB doses as compared to those exposed to 
lower total doses (Wirgin et al. , 1992; Celander and Forlin, submitted). The mechanisms 
by which TCB elicits down-regulation of CYP1A protein and mRNA are largely unknown, 
and are the subject of investigation of chapter 2 in this thesis. 
25 
Goals of Dissertation Research 
The disruption of CYP1A1 functioning by TCB, as described above, may pose a 
serious threat to the health of marine fish, for the CYP 1 A 1 enzyme system appears to play 
a critical role in the metabolism and detoxification of organic contaminants in these species. 
The central goal of the dissertation work was thus to describe the mechanisms by which 
TCB can regulate CYP1 A 1 expression, content, and activity in the marine fish scup 
(Stenotomus chrysops). A long-term, dose-response study was conducted, in which 
groups of fish were treated with either a low (strongly inducing) TCB dose or a high 
(strongly inhibitory) TCB dose. Samples from this study were employed to address 
several questions (chapters 2, 3, and 4). 
Chapter 2: 
(1) What is the time-course of the response of hepatic CYP I A 1 to 0.1 mg/k.g TCB versus 
5.0 mg/k.g TCB, in terms of CYP1A1 mRNA content, CYPlAl protein content, and 
CYP1Al catalytic activity? 
(2) What is the range of hepatic TCB concentrations that are associated with CYPIAI 
induction; what is the range of hepatic TCB concentrations that are associated with 
CYPIAI inhibition and/or suppression? 
(3) Are the inhibition of activity and suppression of protein content by the high TCB dose 
specific for CYPIAI, or general to some group of hepatic proteins? 
(4) At what level(s) of control does TCB exert a negative effect on CYP1A1: 
transcription, mRNA stability, translational, protein stability, enzyme activity? 
(5) What are the mechanism(s) by which TCB exerts a negative effect on CYPIAI ? 
Chapter 3: 
(1) What is the level of CYP1Al protein content in various organs and cell types, 
following treatment of fish with 0.1 mg/k.g TCB or 5.0 mglk.g TCB? 
(2) Does the level of CYP1A1 expression vary with TCB dose in the extrahepatic organs? 
(3) What organs and what cell types show suppressed CYP1Al content at the high TCB 
dose? 
Chapter4: 
(1) Does treatment with 0.1 mglkg TCB or 5.0 mg/k.g TCB elicit histopathology or toxicity 
in scup? 
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(2) What organs and cell types are targeted for pathology by TCB? 
(3) Can histopathology explain the suppressed CYPlAl content caused by a high TCB 
dose? 
A series of in vitro studies was designed, to further explore the role of CYPIAI in the 
disposition of 3,3',4,4'-TCB. Studies were also included to explore the role of the 
putative scup CYP2B in the disposition of 2,2',5,5'-TCB. 
Chapter 5: 
(1) Can scup metabolize 3,3',4,4'-TCB and 2,2',5,5'-TCB to aqueous-soluble products 
in vitro? 
(2) What role do scup CYPIAI and scup CYP2B play in the oxidative metabolism of these 
PCB congeners in vitro? 
Chapter 6: 
(1) Can hepatic microsomes from beluga whale (Delphinapterus leucas) and pilot whale 
(Globicephala melaena) metabolize 3,3',4,4'-TCB and 2,2',5,5'-TCB to aqueous-soluble 
metabolites? 
(2) What role does cetacean CYPIA play in these activities? 
(3) Do cetaceans express enzymes homologous to mammalian CYP2B forms? 
Chapter 7: 
This is a published investigation of the hepatic cytochrome P450 enzyme system in the 
beluga whale (Delphinapterus leucas). 
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CHAPTER TWO 
3,3',4,4'-Tetrachlorobiphenyl Elicits Induction, 
Inhibition, and Inactivation of Cytochrome P4501Al in 
Teleost Liver in vivo and in vitro 
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Abstract 
The polychlorinated biphenyl congener 3,3',4,4'-tetrachlorobiphenyl (TCB) is a known 
inducer of cytochrome P4501A (CYPIA) enzymes in vertebrates, but it has recently been 
recognized as an inhibitor of CYPIA as well. Evidence also suggests that it may inactivate 
or down-regulate CYPIA, but the mechanisms of such inactivation and down-regulation 
have been largely unknown. We investigated TCB action by treating the marine fish scup 
(Stenotomus chrysops) by intraperitoneal injection with two doses of TCB, 0.1 mg/kg and 
5.0 mg/kg, and sampling groups of animals over a 16 day time-course. The low dose of 
TCB brought about a strong induction of hepatic CYP1A1 mRNA (20-fold), protein (12-
fold), and catalytic activity (15-fold), with maxima on days 2, 5, and 5, respectively, at 
levels sustained for 12 days. Similarly, TCB concentration in the livers of these animals 
was maximal on day 5 and declined thereafter. The high dose of TCB caused an induction 
of CYP1A1 mRNA equal to that with the low dose, but CYP1A1 protein content was only 
weakly induced (4-fold), and rates of CYP1A 1 activity were near control levels, from day 
2 through 12. By day 16, however, the levels of CYP1Al protein and activity in animals 
receiving the high TCB dose were similar to those in animals treated with the low dose. 
This increase on day 16 corresponded to a reduced hepatic TCB content by day 16, in the 
fish treated with 5.0 mg/kg. The two TCB doses caused similar, slight elevations in 
expression of cytochrome b5 (2-fold), NADPH cytochrome c (P450) reductase (0.5-fold), 
and UDP-glucuronosyl transferase (2-fold). Neither dose had a strong influence on hepatic 
content of microsomal cytochrome P450B (a putative CYP2B form) or P450A (a putative 
CYP3A form). These in vivo data indicate that high hepatic concentrations of TCB act at 
post-transcriptional level to cause a specific reduction in CYP1A1 protein content. 
Incubation of scup hepatic microsomes with TCB plus NADPH caused a time-dependent 
loss of CYP1A1 catalytic capacity and a simultaneous conversion of P450 to the inactive 
form P420 (50% in 30 minutes) ; neither effect was seen in the absence of cofactor. The 
rate of production of reactive TCB metabolites was slight, suggesting a possible role for 
mechanism-based CYP1A1 inactivation in vivo, but the rate was too slow to account for 
the inactivation and denaturation seen in vitro. The addition of azide to microsomal 
incubations containing TCB and NADPH caused a complete inactivation of microsomal 
CYP1A1 within 10 minutes. Azide is an inhibitor of catalase activity, and is also known to 
form azidyl radicals in the presence of hydroxyl radical, thus azide-enhanced inactivation of 
CYP1A1 suggests the production of reactive oxygen species by CYPlAl. The in vitro 
data indicate that TCB occupation of the CYP1A1 active site elicits enhanced production of 
reactive oxygen species, which appear to play a role in CYPlAl inactivation in vitro and 
may play a role in reduced CYP1A1 content in vivo. 
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Introduction 
3,3',4,4'-Tetrachlorobiphenyl (TCB) has long been recognized as a potent inducer 
of cytochrome P4501A (CYP1A) enzymes in vertebrate species, including mammals 
(Parkinson et al., 1980; Parkinson et al., 1983) and fish (Gooch et al., 1989). TCB is a 
component of commercial polychlorinated biphenyl (PCB) mixtures, which are widespread 
environmental contaminants that have been found to elicit reproductive damage, as well as 
neurotoxic, genotoxic, hepatotoxic, and immunotoxic effects in mammals (reviewed in 
Safe, 1984; Safe, 1992). The coplanar PCB congeners, 3,3',4,4'-tetrachlorobiphenyl 
(TCB, IUPAC #77), 3,3',4,4',5-pentachlorobiphenyl (PeCB, IUPAC #126), and 
3,3',4,4',5,5'-hexachlorobiphenyl (HCB, IUPAC #169) are Ah receptor agonists in 
mammals and elicit a suite of toxic effects similar to those elicited by 2,3,7 ,8-
tetrachlorodibenzo-p-dioxin. Ah receptor has been identified in fish species (Hahn et al., 
1994), thus CYPlA induction in fish, by TCB and other aromatic hydrocarbons, is likely 
mediated by ligand binding to this receptor. In turn, CYP1A is involved in the primary 
metabolism ofTCB in both mammals (Shimada and Sawabe, 1983; Mills et al., 1985; 
Ishida et al., 1991) and fish (chapter 5). 
Depending upon the dose administered, TCB has been found to induce, inhibit, 
and/or suppress hepatic CYP1A in vivo. At relatively low doses (e.g. 0.1 mg/kg), TCB 
brings about a strong, transcriptional induction of CYP1A1 in fish (Gooch et al., 1989). 
When higher doses of TCB or the other coplanar congeners (PeCB, HCB) are 
administered, several investigators have noted decreased rates of hepatic CYP1A enzyme 
activity, as compared to animals receiving lower doses. This observation has been made in 
fish (Melancon and Lech, 1983; Miranda et al., 1990; Monosson and Stegeman, 1991 ; 
Lindstrom-Seppa et al., 1994), rat (Voorman and Aust, 1988), and in cultured hepatocytes 
from fish (Hahn et al., 1993), rat (Sawyer and Safe, 1982), and bird (Rodman et al., 1989; 
Kennedy et al., 1993). The latter studies have not found, or have not reported, a decrease 
in CYP1A protein content to accompany the decrease in rate of CYP1A enzyme activity. 
Several in vitro studies have indicated that TCB and HCB act as competitive or mixed 
inhibitors of CYPlA activity in hepatic microsomes or in reconstituted systems (Voorman 
and Aust, 1987; DeMatteis et al., 1989; Gooch et al. , 1989). The loss of CYP1A activity 
in the aforementioned studies, without a drop in CYPIA protein content, is likely due to 
such inhibition. This would involve the residual PCB in hepatic microsomes binding to the 
CYPlA active site, and inhibiting the binding and catalysis of the substrate of interest. 
Other investigators have reported a decline in rate of CYP1A enzyme activity, 
accompanied by a drop in the content of CYP 1 A protein, when higher doses of TCB were 
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administered. These studies have included work with fish (Gooch et al., 1989), cultured 
bird hepatocytes (Sinclair et al., 1984; Lambrecht et al., 1988; Sinclair et al., 1989; 
Lorenzen and Kennedy, in preparation), and cultured porcine aorta endothelial cells 
(Stegeman et al., in press). Still other investigators have observed reduced expression of 
CYPlA rnRNA, in fish exposed to higher TCB doses as compared to those exposed to 
lower total doses (Wirgin et al., 1992; Celander and Forlin, submitted). The mechanisms 
by which TCB elicits down-regulation of CYP1A protein and rnRNA are largely unknown. 
In the present study we have sought to characterize the specificity and mechanisms 
of CYP1Al down-regulation by TCB. We describe the time-course of CYP1A1 response 
to two different doses ofTCB, and relate CYPIA1 content to TCB concentration in liver. 
We report that relatively low hepatic TCB concentrations are associated with a strong, 
transcriptional induction of CYP1A1, whereas higher hepatic TCB concentrations bring 
about a much weaker induction of CYP1A1 protein and enzyme activity, even though 
expression of CYPlAl rnRNA remains high. This down-regulation appears to be specific 
to CYPIAl, and not general to microsomal enzymes, or even to cytochromes P450. In 
vitro studies suggest that suppressed CYPlAl protein content is a result of oxidative 
inactivation of the enzyme, occurring during TCB occupation of the CYP1A 1 active site. 
Materials and Methods 
Chemicals 3,3',4,4'-Tetrachlorobiphenyl (TCB , IUPAC #77) was purchased from 
Pathfinder (St. Louis, MO). Purity of TCB was greater than 99% by GC/ECD and 
GC/MS analysis. Further analysis by high resolution (5000 resolution) mass spectrometry 
(VG Autospec) and selective ion monitoring showed that the potent Ah receptor agonist 
3,3',4,4',5-pentachlorobiphenyl was not a contaminant of the TCB, with a detection limit 
of 0.001%. Ethoxyresorufin and pentoxyresorufin were from Molecular Probes (Eugene, 
OR). All other chemicals used were of the highest grade available from commercial 
suppliers, and were similar to those used previously in this laboratory. 
Animals and dissection Scup (Stenotomus chrysops) were caught by angling in Vineyard 
Sound, MA in August, 1991. Fish were held in flowing seawater tanks at 20"C for 
fourteen months prior to experimental use, and were maintained on a diet of Purina trout 
chow and frozen squid. Prior studies in our laboratory indicate that the bulk of 
environmental contaminants are depurated from the tissues of fish that are held in aquaria 
for one year, and that these fish show little CYP1A1 expression. At the time of the dosing, 
experimental animals (mixed sex) were gonadally immature and weighed 76- 276 grams. 
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Individuals were injected intraperitoneally with either com oil (carrier controls) or with 
3,3',4,4'-tetrachlorobiphenyl (TCB) dissolved in com oil, at either 0.1 mg TCB/ kg body 
weight or 5.0 mg TCB/ kg body weight. A group of uninjected fish was used as a "zero" 
point in the time-course. Individuals were held in flowing seawater tanks at 2o·c until 
sampling (1 day to 18 days) or until death from toxicity. Fish were fed Purina trout chow 
once weekly, and were never fed within the three days prior to killing. At each time point, 
a group of 4 or 5 animals from each treatment group were killed by cervical transection and 
dissected immediately. Liver and muscle sections for GC analysis were rinsed in methanol 
and stored in acid-washed vials at -2o·c until analysis. Liver sections for RNA preparation 
and microsome preparation were removed and frozen in liquid nitrogen within one to two 
minutes of death. Tissues remained in liquid nitrogen until microsome preparation or RNA 
isolation. Prior studies in our laboratory indicate that enzyme degradation does not occur to 
any appreciable degree in scup tissue stored at liquid nitrogen temperatures (unpublished 
observations). Hepatic microsomal fractions were prepared by differential centrifugation, 
as previously described (Hahn and Stegeman, 1994), and microsomal protein content was 
measured with the bicinchoninic acid method (Smith et al., 1985), using bovine serum 
albumin as a standard. None of the treatments caused a change in hepatosomatic index, 
gonadosomatic index, or in a morphometric index of body weight to surface area (data in 
chapter 4). Microsomal yield ranged from 6 to 28 mg endoplasmic reticulum/ g liver, and 
was not different between the various treatment groups. 
Hepatic microsomes from feral scup were used for in vitro studies. These animals 
were caught by angling in Tarpaulin Cove, MA in the summer of 1988. Animals were 
killed immediately upon capture, and livers were stored in liquid nitrogen until microsome 
preparation. Microsomes were prepared from pooled samples, consisting of livers from 20 
- 70 fish each. 
Monooxygenase system The content of hepatic microsomal cytochrome P450 was 
determined from dithionite difference spectra of CO-treated samples (Stegeman and Binder, 
1979). Cytochrome b5 was measured in liver rnicrosomes using NADH difference 
spectra, as previously described (Stegeman and Binder, 1979). 
Immunoblotting Western blot analysis of microsomal samples was performed as described 
previously (Kloepper-Sams et al., 1987; Stegeman et al., 1991). The three primary 
antibodies used were raised against the three principal P450 forms isolated from scup liver: 
monoclonal antibody 1-12-3 (Park et al. , 1986), raised against scup P450E (a CYP1A1 
homologue); polyclonal 7-94, raised against scup P450B (a likely CYP2B homologue; 
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Stegeman et al., 1990a), and polyclonal 7-93, raised against scup P450A (a possible 
CYP3A homologue; Celander et al., 1994). Each antibody forms a strong reaction with its 
own immunogen in Western blots, and each forms negligible cross-reactions with the other 
two scup P450 forms (Kloepper-Sams et al., 1987; Gray, unpublished). Secondary 
antibodies used were alkaline phosphatase linked goat-anti-mouse IgG and goat-anti-rabbit 
lgG. Relative content of each protein in the microsomal samples was measured by 
densitometric scanning of immunoreactive bands with a video imaging system (Masterscan, 
Scanalytics, division of CSPI, Billerica, MA). In the case of P450E, protein was 
quantified by comparison of optical density in the samples to optical density in standards 
with known P450E content. 
Enzyme assays Ethoxyresorufin 0-deethylase (EROD) activity was measured in hepatic 
microsomes at 32•c with a fluorometric kinetic assay, using a Cytofluor 2300 fluorescence 
plate reader (Millipore), as described previously (Hahn et al., 1993). Pentoxyresorufin 0-
depentylase (PROD) activity was measured similarly, but substrate was used at 5 J.lM 
nominal concentration rather than 2 J.lM (as for EROD). NADPH-cytochrome c (P450) 
reductase activity was measured at 3o·c by monitoring absorbance at 550 nm, as described 
previously (Stegeman et al., 1979). UDP-glucuronosyl transferase activity (UGT) was 
measured in liver microsomes at room temperature, according to published procedures 
(Andersson et al., 1985). The assay contained 0.3 M KH2P04 (pH 7.0), 1.3 mg/ml 
digitonin detergent, 0.2 mM p-nitrophenol as substrate, 2.7 mg/ml UDPGA (omitted from 
blanks), and 1.1 - 3.7 mg/ml microsomal protein. 
RNA preparation Liver pieces weighing 100 to 150 mg were taken from each fish for 
RNA isolation. Two pooled RNA samples were prepared from each scup treatment group, 
each pooled sample consisting of equally sized liver pieces from two or three fish. Liver 
sections that had been frozen in liquid nitrogen were powdered in liquid nitrogen and total 
RNA was isolated according to the guanidinium thiocyanate procedure of Chirgwin 
(Chirgwin et al., 1979; Clemens, 1986). Modifications were as follows: instead of two 
high-speed centrifugation steps to clarify the RNA solution, RNA pellets were washed 
once in 4M LiCl to remove glycogen, followed by two washes in 95% ethanol to remove 
the salt. Total RNA was quantified on a Shimadzu UV-260 spectrophotometer, by diluting 
samples in water and measuring the absorption at 260 nm minus absorption at 300 nm. 
Northern blotting Samples of total RNA (10 J..Lg per lane, as determined spectrally) were 
denatured in formamide/formaldehyde, and separated in a 1% agarose I 2.2 M 
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formaldehyde gel, using 20 mM MOPS running buffer, according to standard protocols 
(Sambrook et al., 1989). RNA was transferred from the gel to a positively charged nylon 
membrane (Amersham Hybond) in 20x sse buffer (Sambrook eta!., 1989), and 
subsequently cross-linked to the membrane with a Fotodyne DNA transfer lamp (30 sec uv 
irradiation). Dried membrane was pre-hybridized for one hour at 60°e, in a buffer 
composed of 6x SSPE, 0.5% SDS, lOx Denhardt's solution, and 100 mg/ml calf thymus 
DNA. Hybridization was carried out at 42oe for approximately 20 hours, with a 32p_ 
labeled probe (see below) in a buffer composed of 5x SSPE, 0.1% SDS, 2x Denhardt's 
solution, and 50% formamide. Probed membranes were washed for 30 minutes at 42oe 
with 2x SSe, 0.1% SDS, and exposed to Kodak X-OMAT AR film for various amounts 
of time. Relative amount of eYPIA1 mRNA in each probe-reactive band was determined 
by measuring optical density (O.D.) of bands using gel plotting macros in NIH Image 1.54 
software. Some reported values for eYP1A1 mRNA were normalized to total poly A 
mRNA in each sample (see below). 
For analysis of eYP1Al mRNA, a eDNA probe containing 75% of the scup 
eYP1A1 coding region was prepared. The probe hybridizes to eYP1Al nucleotides 259-
1443, corresponding to amino acids 88-481 (Morrison eta!., submitted). The probe was 
radiolabeled with a Boehringer-Manheim random-primed DNA labeling kit, using [a-32p] 
deTP (Amersham), and was cleaned with a NAeS Prepac column (BRL, Inc.) according 
to manufacturers' instructions. 
Dot blotting To determine the amount of total poly A mRNA loaded in each lane of the 
Northern blots, dot blots were conducted on duplicate samples using a polyT probe. A 
Millipore Milliblot apparatus was used, with an Amersham Hybond positively charged 
nylon membrane. Samples consisted of 10 Jlg total RNA (determined spectrally), brought 
to a volume 50 Jll in TE buffer (10 mM Tris, pH 7.5, 1 mM EDTA), 30 Jll 20x SSe, and 
20 Jll 37% formaldehyde. Samples were heated to 60oe for 15 minutes and then chilled on 
ice. Wells of the dot blot apparatus were pre-washed with 20x SSe, samples were applied 
(each added at 4 , 2, 1, 0.5, 0.25, and 0.125 Jlg RNA), and 20x sse was applied to the 
wells again. RNA was cross-linked to the membrane using a Fotodyne DNA transfer lamp 
(as above). 35s-Iabeled polyT probes were prepared, and blots were hybridized, 
according to Hollander and Fomace (1990). 
Total polyT bound to each dot (total poly A mRNA in each dot) was quantified by 
cutting the membrane into equal sized squares, each containing one dot, adding each square 
to a vial containing 5 ml Scintiverse II scintillation fluid (Fisher Scientific), and counting 
the samples on a Beckman LS5000TD liquid scintillation counter using a wide window (0-
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670). The entire range of loadings gave a linear response (cpm polyT versus J.Lg RNA 
loaded), so the I Jlg loading was selected for normalizing Northern blot results. 
Normalized CYPIAl mRNA content in each pooled liver sample was calculated as follows: 
relative CYPIAI mRNA O.D. I relative poly A mRNA cpm, 
where "relative CYPIAI mRNA O.D." was calculated by dividing the O.D. for each 
Northern blot band by the O.D. of the strongest band (giving values of 0- 1), and "relative 
poly A mRNA cpm" was calculated by dividing the cpm for each dot blot band (lJ.Lg RNA 
loadings) by the cpm for the dot of the uninjected fish pool. 
The relative content of CYPIAI mRNA in Northern blots was determined in two 
ways: (1) by normalizing to total polyA mRNA per sample, with dot blotting, and (2) by 
normalizing to total RNA content in each sample, determined spectrally. The two methods 
gave almost identical patterns of relative CYP 1 A 1 mRNA expression among the samples. 
TCB residues Content of 3,3',4,4'-tetrachlorobiphenyl was quantified in pooled samples, 
consisting of liver or muscle sections from all fish within a treatment group. Tissue 
extraction followed AOAC Method 983.21 (Helrich, 1990). Samples were mixed with 
sodium sulfate and pet ether, homogenized, and serially extracted with pet ether. Extracts 
were cleaned up on a Florisil column and concentrated under nitrogen. Extracts were 
analyzed for TCB by gas chromatography with electron capture detection (GCIECD) using 
an HP 5890 Series II GCIECD. Confirmation of the TCB was performed by gas 
chromatography with mass spectrometry (GC/MS) using an HP 5890/5970 GC/MS by 
monitoring molecular ions 110, 150, 184, 220, 222, 290, 292, and 294. The 
fragmentation pattern of each sample was compared to the TCB standard and TCB was 
quantified with m/z 292. Measured concentrations of TCB were corrected for extraction 
efficiency using the recovery of 4,4'-dibromooctafluorobiphenyl (DBOFB) which was 
spiked into each sample prior to extraction, and were quantified relative to the internal 
standard 2,4,5,6-tetrachloro-m-xylene (TCMX). Recoveries of DBOFB ranged from 60 to 
96% with an average of 76%. The average recovery of TCB matrix spikes was 110%. 
The precision of duplicate analyses was within 3%. 
Statistics Statistical differences between treatments were determined with a non-parametric 
randomization test, which allowed pairwise comparisons between each of the three 
treatments, taking into account the entire time-course. Xijk = measurement for fish k, at 
time j, under treatment i. The null model is that the distribution of Xijk depends only on j 
(i.e. while there may be a time effect, there is neither a treatment effect nor an individual 
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fish effect). The alternative model is that the distribution of Xijk depends on both j and i 
(i.e. there is both a time effect and a treatment effect). The test statistic was: 
where 
3 ni nij 3 ni nij 
:L :L :L (Xijk - X.j-)2 :L :L :L (Xijk - Xij-)2 
i=l j=l k=l i=l j=l k=1 
3 
X.j.= :L 
i=1 
nij 3 
:L Xijk 1 :L nij 
k=1 i=1 
and _ Dij 
Xij.= :L Xijk/nij. 
k=1 
That is, X.j. is the sample mean for all fish at time j and Xij. is the sample mean for all fish 
·under treatment i at time j. The test statistic measures the improvement in the residual sum 
of squares by using treatment means instead of an overall mean at each time. 
The distribution of the test statistic was estimated under H0 by randomly permuting 
the treatment labels on the fish at each time point and calculating the value of the test 
statistic. The significance level (p-value) was estimated by the proportion of such 
permutations for which the value of the test statistic exceeded the observed value. 
In vitro studies of CYPIAI modification The methods of Shimada and Sato (1978) were 
used, with modifications, to assess covalent binding of TCB metabolites to microsomal 
protein. Incubations were performed at 3o·c (fish) or 3TC (rats) under air in a shaking 
incubator. The I ml assay contained 1 mg microsomal protein from feral scup, scup treated 
with 2,3, 7 ,8-tetrachlorodibenzofuran (3 J..Lglkg; Hahn and Stegeman, 1994 ), or rat treated 
with 3-methylcholanthrene (20 mg/kg; Melancon et al., 1990), 2 J..LM I4c-labeled TCB 
(52.1 mCi/mrnol, Pathfinder, St. Louis, MO) dissolved in acetone, 50 mM Tris, pH 7.6, 
and O.I mM EDT A. Analysis of the I4c-labeled TCB by gas chromatography revealed no 
hydrophobic contaminant peaks(> 99% pure); small polar contaminants were completely 
removed by dissolving the TCB in hexane and extracting twice with NaOH. After a 2-
minute pre-incubation, reactions were initiated with I mM NADPH and run for 60 minutes. 
Assays were stopped with 1.5 ml of 10% ice-cold trichloroacetic acid (TCA) followed by 
centrifugation at 5000g for 30 minutes, to precipitate protein. Pellets were washed several 
more times, to remove parent TCB and TCB products which were not covalently linked to 
protein. The 1.5-ml washes were as follows: lx IO% TCA, 2x 80% methanol, 2x 
methanol: diethyl ether (1: 1), 2x n-hexane, 2x 80% methanol. The final wash was 
determined to have 14c levels near background. Protein-bound metabolites were 
quantified by dissolving the final pellet in 1 N NaOH and measuring 14c in the pellet with 
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liquid scintillation counting on a Beckman LS5000TD counter. Metabolic activity was 
determined by subtracting the pellet radioactivity of control incubations, in which no 
NADPH cofactor was added. 
Hepatic microsomes from both feral scup and scup treated with 3-
methylcholanthrene (20 mg/kg, chapter 5) were incubated at 3o·c for 30 minutes in a Tris 
buffer (as above), with or without TCB (1 .5 J..LM in DMSO), and with or without NADPH 
cofactor (1 mg/ml), and analyzed spectrophotometrically for cytochrome P450 content as 
above. Microsomal protein content in the incubations was 0.5 mg/ml. Additional 
incubations were conducted in the presence of sodium azide (1 mM). 
In vitro studies of CYP I A I inactivation Hepatic microsomes from feral scup were 
incubated at 1 mg/ml in 50 mM Tris, pH 7 .6, and O.I mM EDTA, with the addition of 
either 3,3',4,4'-TCB (1.5 J..LM in acetone), 2,2',5,5'-TCB (1.5 J..LM in acetone), or acetone 
alone, and in the presence or absence of NADPH (1.5 mg/ml). Incubations were 
performed at 3o·c under air in a shaking incubator. At I5 minutes, 30 minutes, and 60 
minutes, aliquots of each incubation were removed for measurement of EROD activity. To 
the aliquot of incubation, EROD buffer was added (1 00 mM Tris, 100 mM NaCl, pH 8) to 
a final concentration of 2 J..LM 7-ethoxyresorufin (7-ER) substrate. NADPH was also 
added, to those microsomal incubations that had been conducted in the absence of 
NADPH. The rate of 7-ER 0-deethylation was monitored spectrally for 3 minutes, as 
previously described (Klotz et al. , 1984). The entire experiment was conducted twice, and 
each time, each incubation was performed in triplicate. An identical set of incubations was 
conducted, and analyzed for NADPH cytochrome c (P450) reductase activity at each time 
point, assayed by monitoring absorbance at 550 nm as previously described (Stegeman et 
al. , 1979). 
In a similar set of studies, hepatic microsomes from feral scup were incubated with 
or without NADPH, in the presence of either 1.5 J..LM TCB, 1.5 J..LM benzo[a]pyrene (BaP), 
or no substrate. Some incubations included exogenous catalase (bovine liver, Sigma, 800 
units/ml), and some included sodium azide (1 mM) to inhibit endogenous catalase. 
Aliquots of the incubations were removed at times 0, 10, 20, and 30 minutes, for 
fluorometric determination ofEROD activity, as described previously (Hahn et al., 1993). 
All experiments were conducted twice, and each time, each incubation was performed in 
duplicate. 
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Results 
Hepatic monooxy~enase components 
Content of total P450 in hepatic microsomes was strongly induced by 0.1 mglkg TCB on 
days 2 to 16 (Fig 1A). Maximal induction was attained by day 5 (3-fold increase over com 
oil controls), and was sustained until the end of the time-course. Total P450 was not 
significantly induced by 5.0 mg/kg TCB on days 2 to 12. However, on day 16, of the four 
fish treated with 5.0 mg/kg, two had very low P450 levels (similar to all other fish 1reated 
with 5.0 mglkg TCB, and similar to controls), while two had strongly induced P450 
(similar to levels in fish treated with 0.1 mg/kg TCB). 
The specific content of cytochrome b5 was increased approximately two-fold by 
TCB treatment (days 5, 16). Unlike P450, the increase in b5 content was similar at the two 
TCB doses (Fig 1B). 
Hepatic microsomes were immunoblotted with antibodies raised against the three 
major P450 forms expressed in scup liver: P450E (a CYP1Al homologue; Park et al., 
1986), P450B (a probable CYP2B homologue; Stegeman et al., 1990a), and P450A (a 
possible CYP3A homologue; Celander et al., 1994) (Fig 2). CYPIAI content was 
strongly induced by 0.1 mg/kg TCB, reaching a peak on day 5 (12-fold induction over 
control) and showing signs of subsequent decline (Fig 2A). In contrast, CYP1A1 was 
only weakly , but significantly, induced in fish treated with 5.0 mg/kg TCB, also reaching a 
peak on day 5 (4-fold induction over control). Of the four fish treated with 5.0 mg/kg TCB 
and sampled on day 16, the two that had elevated levels of total P450 also had two-fold 
more CYP1A1 than did the two fish with low total P450 content. 
The molar increases in CYP1A1 accounted for approximately 85% of the molar 
increases in total P450, over control levels (Table I). Thus both the strong induction in 
total P450 at 0.1 mg/kg, and the "suppressed" induction of total P450 at 5.0 mg/kg, were 
primarily due to differences in CYPIAI content. 
Differences between groups were less clear for hepatic P450B (Fig 2B) and P450A 
(Fig 2C). The content of both proteins showed temporal patterns resembling the changes 
in content of CYP 1 A 1. Thus, both P450B and P450A showed an initial increase in 
enzyme content (days 2, 5) followed by a decline in the fish treated with 0.1 mglkg, and 
enzyme content was closer to control values in the fish treated with 5.0 mg/kg (day 5). 
However, content of both enzymes varied widely within each treatment group (large 
standard deviations about the means), suggesting regulation by factors apart from TCB 
treatment. Furthermore, the differences in mean enzyme content between treated and 
control groups were far smaller for P450B and P450A than for CYP 1 A 1. 
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Figure 1. Hepatic microsomal content of total cytochrome P450 (A) and cytochrome b5 
(B), determined spectrally as described in Methods. X-axis is number of days subsequent 
to injection, y-axis is enzyme content in nmol enzyme/ mg microsomal protein. Each point 
represents the mean and standard deviation (n-1) of measurements on four or five fish per 
treatment group. Plot symbols are: square, com oil control, open circle, 0.1 mglkg TCB, 
closed circle, 5.0 mglkg TCB. Cytochrome P450 content is significantly greater in the 0.1 
mglkg treatment group than in the other two groups at p ::; 0.0006. Cytochrome b5 content 
is significantly greater in both TCB treatment groups than in controls at p ::; 0.0002. 
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TABLE I 
Induction of Total Hepatic Cytochrome P450 due to CYPlAl 
Total P450 
(pmolfmg) a 
P450 Induction 
over Control b 
CYPIAI 
(pmolfmg) a 
CYP I A I Induction 
over Control b 
%P450 Induction 
due to CYPlAl 
control 
178 ± 71 
27 ± 0.1 
O.I mg/kg TCB 
538 ± 75 
360 
332 ± 33 
305 
85% 
5.0 mg/kg TCB 
278 ±53 
100 
111 ±51 
84 
84% 
a Values represent mean± SD (n-1) forfive fish (TCB-treated) or four fish (control). 
Animals were sampled on day 5 (TCB) or day 4 (control) after treatment. 
b Determined by subtracting enzyme content in control fish from enzyme content in TCB-
treated fish. Units are pmolfmg. 
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Figure 2. Hepatic microsomal content of CYPlAl (A), P450B, the putative CYP2B (B), 
and P450A, the putative CYP3A (C), determined by immunoblotting as described in 
Methods. X-axis is number of days subsequent to injection, y-axis is enzyme content in 
pmol/ mg microsomal protein (A) and in relative optical density/ j.l.g (A, B, C). Each point 
represents the mean and standard deviation (n-1 ) of measurements on four or five fish per 
treatment group. Plot symbols are: square, com oil control, open circle, 0.1 mglkg TCB, 
closed circle, 5.0 mg/k:g TCB. CYPIAI content is significantly different between each of 
the three treatment groups (p ~ 0.0003). P450B content is significantly different between 
control and 5.0 mg/k:g, and between 0.1 mg/k:g and 5.0 mg/k:g (p ~ 0.008), but is not 
different between 0.1 mglk:g and control. P450A content is significantly different between 
control and 0.1 mg/k:g only (p = 0.05). 
42 
-00 400 -e 00 75 A :::3 
............ 
............ 
- 0 s 300 d 50 
-& 200 ._.. 
~ ~ 
< < 25 ~ 100 ~ ~ ~ r 0 u 0 
0 lO 20 
-00 10 
:::3 8 
............ 
0 6 
d 
._.. 4 
1::0 2 0 
II) 
~ 0 
~ 
-2 
0 lO 20 
- 10 00 c :::3 8 ............ 
0 6 d 4 ._.. 
< 2 ~ ~ 0 ~ 
-2 
0 10 20 
time (days) 
43 
Microsomal enzyme activities 
Several enzyme activities were measured in hepatic microsomes (Figs 3 and 4), to 
determine whether suppression of enzyme content by TCB was specific for CYP1A1. 
Ethoxyresorufin 0-deethylase (EROD) activity, catalyzed principally by CYP1A1 in fish 
(Klotz et al., 1983), was strongly induced by 0.1 mg/kg TCB, reaching maximal levels by 
day 5 that were sustained until the end of the experiment (Fig 3A). The 15-fold induction 
in EROD activity on day 5 mirrored the 12-fold induction in CYPIA1 content on day 5. In 
fish treated with 5.0 mglkg TCB, there was no induction of EROD activity above control 
levels from days 1 through 12, even though there was a significant induction in CYPIAI 
protein content in these groups. Suppressed EROD rates at the high dose are consistent 
with competitive inhibition ofEROD activity by residual TCB in microsomes (e.g. Gooch 
et al., 1989), and indicate that TCB is retained in the CYP1A1 active site. As with total 
P450 and CYP 1 A I , an exception occurred on day 16, at which time the two fish treated 
with 5.0 mg/kg TCB that had elevated CYPlAI content also had strongly induced EROD 
activity, while EROD rates remained low in the other two fish. 
Pentoxyresorufin 0-depentylase (PROD) activity displayed a profile almost 
identical to that of hepatic EROD activity (Fig 3B). Although PROD is largely catalyzed by 
CYP2B enzymes in mammals (Burke et al., 1985), the catalyst(s) for this activity in 
teleosts have not been identified. The pattern seen here suggests that CYP1A1 contributes 
to this activity in scup that have been treated with a CYP1A inducer. 
NADPH cytochrome c (P450) reductase activity was induced approximately 50% in 
treated scup (days 5 - 16), and levels did not differ between the two TCB doses (Fig 4A). 
Hepatic microsomal UGT activity with p-nitrophenol was induced approximately two-fold 
in fish treated with TCB and sampled on day 5 (Fig 4B). Rates were statistically equivalent 
in fish treated with the two TCB doses. 
Hepatic CYPI A 1 mRNA expression 
Content of CYPIA1 mRNA was quantified in two pooled samples from each treatment 
group, each sample consisting of liver tissue from 2 or 3 fish. Northern blots of total RNA 
were performed with a eDNA probe containing 75% of the scup CYPIAI coding region , 
which hybridized to a single band in each sample (Fig 5). The relative content of CYPIAI 
mRNA was similar in fish administered the two TCB doses, with maximum expression on 
days 1, 2, and 5, which diminished by day 12 (Fig 6). In fish treated with 0.1 mg/kg 
TCB, mRNA content continued to decline by day 16, whereas fish receiving the higher 
dose seemed to express a second peak in CYPIAI mRNA content on day 16. The mRNA 
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Figure 3. Hepatic microsomal EROD activity (A) and PROD activity (B), determined 
fluorometrically as described in Methods. X-ax.is is number of days subsequent to 
injection, y-ax.is is rate of enzyme activity in pmol/ mini mg microsomal protein. Each 
point represents the mean and standard deviation (n-1) of measurements on four or five fish 
per treatment group. Plot symbols are: square, com oil control, open circle, 0.1 mglkg 
TCB, closed circle, 5.0 mg/kg TCB. For both activities, rates in the 0.1 mg/kg group were 
significantly greater than controls at p S 0.0001, and rates in the 0.1 mg/kg group were 
significantly greater than the 5.0 mglkg group at p S 0.005. 
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Figure 4 . Hepatic microsomal NADPH reductase activity (A), and UGT activity (B), 
measured spectrally as described in Methods. Y -axes are rates of enzyme activity in nmoll 
mini mg microsomal protein. (A) X-axis is number of days subsequent to injection. Each 
point represents the mean and standard deviation (n-1) of measurements on four or five fish 
per treatment group. Plot symbols are: square, com oil control, open circle, 0.1 mglkg 
TCB, closed circle, 5.0 mglkg TCB. Rate of activity is significantly greater in both TCB 
treatment groups than in controls at p ~ 0.004. (B) Bars represent means and standard 
deviations (n-1) of measurements on 4 samples each. Assays were performed on animals 
sampled on day 4 (control) or 5 (TCB treated). Rates in the two TCB treatment groups 
were statistically equivalent, and rates in each were statistically elevated over control fish (p 
~ 0.01), based on a one-way ANOV A. 
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Figure 5. Northern blot of hepatic CYP1A1 mRNA in pooled scup samples. Each sample 
consists of pooled liver tissue from 2 or 3 fish. Samples of total RNA (1 0 J..l.g per lane) 
were separated on an agarose gel, transferred to nylon membrane, and probed with a 32p_ 
labelled eDNA probe containing 75% of the scup CYP1A1 coding region, as described in 
Methods. Samples in the lanes are as follows: (1) time zero (uninjected), (2) day 1, 0.1 
mglkg (3) day 1, 5.0 mg/kg, (4) day 2, 0.1 mg/kg, (5) day 2, 5.0 mg/kg, (6) day 4, corn 
oil, (7) day 5, 0.1 mg/kg, (8) day 5, 5.0 mg/kg, (9) day 12, 0.1 mg/kg, (10) day 12, 5.0 
mg/kg, (11) day 12, corn oil, (12) day 16, 0.1 mg/kg, (13) day 16, 5.0 mg/kg with 
induced P450 content, (14) day 16, 5.0 mg/kg with uninduced P450 content, (15) day 18, 
corn oil, ( 16) day 34, 0.1 mglkg. 
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Figure 6. Hepatic CYPIAI mRNA content, determined as described in Fig 6. X-axis is 
number of days subsequent to injection, y-axis is relative content of CYPIAI mRNA, 
determined by measuring the optical density of Northern blot bands and normalizing to total 
RNA content in each sample, determined spectrally. Each point represents the mean and 
standard deviation (n-1) of measurements on two samples per treatment group, each sample 
consisting of liver sections from 2 or 3 fish. Plot symbols are: square, com oil control, 
open circle, 0.1 mg/kg TCB, closed circle, 5.0 mg/kg TCB. Content of total poly A mRNA 
was measured in some samples by dot blotting, and CYPIAI mRNA content determined 
by normalizing to total poly A rather than to total RNA. Both methods of normalizing gave 
very similar results for relative CYPlAl mRNA content among the samples. 
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Figure 7. GC/MS analysis ofTCB content in pooled liver samples from TCB-treated fish . 
X-axis is number of days subsequent to injection. Y-axis is TCB concentration in Jlg TCB/ 
g liver dry weight; left axis is concentration in fish treated with 0.1 mg/kg, right axis is 
TCB concentration in fish treated with 5.0 mglkg (note the difference in scale). Each point 
is a measurement on a single sample, consisting of pooled tissue sections from all 4 or 5 
fish in each treatment group. Plot symbols are: open circle, 0.1 mg/kg TCB, closed circle, 
5.0 mg/kg TCB. 
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content in the latter group was particularly high in the livers of the two fish that had 
elevated P450 content on day 16. 
TCB residues 
TCB content was measured in pooled liver samples from each treatment group (Fig 7). 
The average dry weight in liver samples was determined to be 25% of the wet weight; dry 
weights are presented here. In fish treated with 0.1 mg/kg TCB, the TCB content in liver 
reached a maximum concentration of 0.015 J..Lgl g liver on day 5. In fish treated with 5.0 
mglkg TCB, the TCB content in liver did not reach a maximum until day 12, at which time 
the concentration was 2.2 J..Lg TCBI g liver. At both doses, hepatic TCB content on day 16 
was substantially lower than the peak concentration. Analysis of bile residues indicates that 
this depuration was due to both metabolism and to loss of parent compound (White et al., 
in preparation). 
CYPl A 1 modification in vitro 
TCB was metabolized to reactive forms in vitro, which bound covalently to microsomal 
proteins, at a very slight rate (Table 2). The rate of TCB activation in hepatic microsomes 
from feral scup was 1.5 pmol metabolites covalently bound to total protein I hour 
incubation I mg microsomal protein added to incubation. The rate was similar in hepatic 
microsomes from scup treated with a CYPIA inducer (2,3,7,8-tetrachlorodibenzofuran). 
In contrast, hepatic microsomes from rat treated with a CYP I A inducer (3-
methylcholanthrene) produced covalently-bound TCB metabolites at a rate of 99 
pmoVminlmg in our hands. 
Incubation of hepatic microsomes from feral scup with TCB, or with TCB plus 
NADPH, had no demonstrable effect on spectrally detectable cytochrome P450 (not 
shown). However, the pool of feral scup microsomes used had an approximate CYPIAI 
content equal to only 15% of the total P450: Therefore, similar incubations were 
conducted using a microsomal sample from a 3-methylcholanthrene-treated scup, which 
had an approximate CYPI A 1 content equal to 45% of the total P450. Incubation of hepatic 
microsomes for 30 minutes with TCB plus NADPH caused the conversion of 
approximately 40-50% of the cytochrome P450 to the denatured form, cytochrome P420 
(Fig 8; Table 3). This conversion appeared quantitative, with P420 accounting for almost 
all of the P450 that was lost, assuming that extinction coefficients in scup are similar to 
those in rat (Omura and Sato, 1964). No P450 loss or P420 formation was seen in 
incubations containing TCB alone or NADPH alone (not shown), indicating a requirement 
for both substrate binding and electron transport in the enzyme denaturation. 
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TABLE2 
Metabolites of 3,3',4,4'-TCB Covalently Bound to Microsomal Protein 
microsomes a reaction 14c-TCB b pmollhrlmg d 
Feral scup +NADPH 269.0 1.5 
-NADPH 101.7 c 
TCDF scup +NADPH 154.8 1.8 
-NADPH 53.5 
MCrat +NADPH 5790.8 99.3 
-NADPH 49.3 
a Microsomes were incubated with 14c-TCB +1- NADPH for 60 minutes, followed by 
precipitation and solvent-washing, to determine amount of TCB covalently bound to 
microsomal protein. Samples were from feral scup (killed immediately upon capture), 
depurated scup treated with 2,3,7,8-tetrachlorodibenzofuran (TCDF, 3 J!glkg), or rat 
treated with 3-methylcholanthrene (MC, 20 mg/kg) . Rates of EROD activity were similar 
in TCDF scup and MC rat, suggesting a comparable degree of CYPlAl induction. 
b Disintegrations per minute from 14c-TCB, measured in washed microsomal pellet as 
described in Methods. Each value is a mean of duplicate assays. 
c Higher background radioactivity in feral scup is due to a different batch of 14c-TCB 
substrate used. 
d Rates are expressed as pmol metabolites binding to total microsomal protein I hour 
incubation I mg microsomal protein added to incubation. Rates were calculated by 
subtracting the - NADPH blanks from the+ NADPH values, then dividing by specific 
activity of the substrate. 
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Figure 8. Spectrophotometric analysis of cytochrome P450 in hepatic microsomes from 3-
methylcholanthrene-treated scup. Microsomes were incubated for 30 minutes at 30"C, 
either without additions (right), or with the addition of both TCB and NADPH (left), and 
P450 content was analyzed by measuring the dithionite difference spectrum on CO-treated 
samples. Cytochrome P450 absorbs at approximately 446-449 nm, the shoulder at 425 nm 
(right) is a contaminating chromophore in this microsomal sample, and the peak at 420 nm 
(left) is due to the cytochrome P450 degradation product cytochrome P420. 
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TABLE3 
Cytochrome P450 Content and EROD Activity in Microsomal Incubations at 30 Minutes 
incubation P45oa ERODb 
no additions 100% 100% 
NADPH 100% 100%, 100% 
TCB 100% 71%,75%C 
TCB+NADPH 50%, 58% 30%, 31% 
azide+ NADPH 47%, 55% 65%,72% 
azide+TCB 74%, 89% 4Q%C 
azide + TCB + NADPH 18%, 21 % 1%, 2% 
Microsomes were incubated at 3o·c for 30 minutes with the specified additions. Individual 
measurements from duplicate experiments are reported, as a percentage of the enzyme 
content or activity in control incubations (containing no additions). 
a Cytochrome P450 was analyzed spectrophotometrically, in a hepatic microsomal sample 
from a 3-methylcholanthrene-treated scup (20 mg/kg) (chapter 5). 
b EROD activity was analyzed fluorometrically, in a pooled microsomal sample from livers 
of several feral scup. Incubations with azide addition alone had 100% EROD activity. 
c Strong inhibition ofEROD activity without a comparable P450 loss, in the samples that 
were pre-incubated with TCB and without NADPH, is presumably due to competitive 
inhibition. 
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Hepatic microsomes from feral scup were similarly incubated with or without TCB 
and with or without NADPH cofactor, and analyzed for CYP1Al content by immunoblot. 
None of the incubation conditions altered the quantity of immunodetectable CYP1A 1, as 
measured with MAb 1-12-3 (not shown). This result indicates that the native (P450) and 
denatured (P420) forms of the enzyme have the same electrophoretic molecular weight, and 
suggests that actual degradation of the enzyme does not occur during a one hour incubation 
in vitro. 
CYPIAI inactivation in vitro 
Hepatic microsomes from feral scup were similarly pre-incubated with or without TCB, 
and with or without NADPH cofactor, and aliquots removed for measurement ofEROD 
activity over the course of one hour (Fig 9A). Rates of EROD activity were unchanged 
following pre-incubation of microsomes with NADPH alone. TCB addition alone reduced 
microsomal EROD activity by 50% at time zero, and activity remained the same throughout 
the one hour incubation. This loss, which was neither time-dependent nor cofactor-
dependent, was presumably due to reversible inhibition of EROD activity by parent TCB 
(e.g. Gooch et al., 1989). Pre-incubation ofmicrosomes with both TCB and NADPH 
under conditions supporting TCB metabolism (chapter 5) caused a progressive drop in 
EROD activity with time (Fig 9A), below that due to TCB inhibition alone, indicating 
substrate-dependent enzyme inactivation. 
In a parallel experiment, microsomes were pre-incubated with TCB and/or 
NADPH, and assayed for NADPH cytochrome c (P450) reductase activity over one hour 
(Fig 9B). There was no effect on reductase activity, suggesting that TCB interacts directly 
with the P450 and not with the reductase to cause the inactivation. In a second parallel 
experiment, microsomes were pre-incubated with 2,2',5,5'-TCB and/or NADPH, and 
assayed for EROD activity over one hour (Fig 9C). 2,2',5,5'-TCB is metabolized in scup 
hepatic microsomes but is not metabolized by scup CYP1A1 (chapter 5). EROD activity 
was unchanged by any of the incubation conditions with this ortho-substituted congener. 
Similar incubations were conducted in the presence of exogenous catalase, an 
H202 scavenger. Catalase addition (800 units/rnl) did not prevent the CYPlAl 
inactivation occurring in microsomes with 3,3',4,4'-TCB and NADPH. Profiles were 
similar to those in Fig 9A (not shown). 
Microsomal incubations were similarly conducted, with the addition of sodium 
azide. Azide is known to inhibit catalase activity, thus allowing the accumulation of any 
H202 that is produced in the microsomes. Azide has also been found to be converted to 
azidyl radical in the presence of hydroxyl radical (Reinke et al., 1994), which likely 
54 
contributes to its mechanism of action. In the absence of substrate, pre-incubation with 
azide and cofactor caused a slight (28-35%) inactivation of microsomal CYP1A1 by 30 
minutes (Fig 1 OA). In the presence of TCB substrate, however, incubation with azide and 
cofactor caused a 97% loss of CYP1A1 catalytic capacity within 10 minutes (Fig lOB), 
exceeding the loss seen in incubations containing TCB and cofactor alone. Addition of 
azide without exogenous NADPH caused no time-dependent changes in microsomal EROD 
activity under any of the incubation conditions (data not shown). Data for 30 minute 
incubations are summarized in Table 3. 
Strong inactivation was not seen in the presence of azide plus BaP, a rapidly 
metabolized substrate compared to TCB (chapter 5). Addition of BaP alone to microsomes 
caused a 70% inhibition of microsomal EROD activity at time zero (Fig IOC vs. lOA). 
This inhibition was largely released by 10 minutes in the presence of NADPH (Fig 1 OC). 
Prior work (Stegeman et al., 1981) indicates that 100% of the BaP added at the 
concentration here should have been metabolized by feral scup microsomes within 10 
minutes. Azide addition caused slight inactivation ofCYPIAI during microsomal BaP 
metabolism: activity was decreased by 29% in the first 10 minutes of incubation, as 
compared to incubations with BaP and NADPH alone (Fig lOC). After a 30 minute 
incubation in the presence of azide, cofactor, and BaP (and BaP metabolites), activity was 
decreased by 42%, as compared to incubations with BaP and NADPH alone (Fig 1 OC), a 
similar loss to that seen in incubations without substrate (Fig 1 OA). Thus the rapid and 
complete inactivation seen with TCB does not occur in the presence of substrates in 
general. Furthermore, the finding that azide enhances inactivation suggests that an 
increased production of reactive oxygen species occurs in microsomes in the presence of 
TCB and cofactor (see Discussion). 
Analysis of spectral cytochrome P450 content in azide-containing incubations 
demonstrated that azide plus cofactor caused the conversion of P450 to P420, similar to 
that shown in Fig 8. However, the P450 loss was greatly enhanced in the presence of 
azide, cofactor, and TCB (Table 3), again suggesting enzyme oxidation during the process 
of substrate binding and electron transport. The degree of P450 loss in the presence of 
azide, NADPH, and TCB (approximately 80%) indicates that inactivation was not specific 
for CYP1A1 under this condition. 
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Figure 9. Enzyme inactivation by TCB in vitro. Hepatic microsomes from feral scup were 
incubated + or - TCB ( 1.5 J.lM), and + or- NADPH cofactor, and aliquots of the 
incubations were removed at 0, 15, 30, and 60 minutes for spectrophotometric 
measurement of residual enzyme activity in microsomes. (A) Incubations with 3,3',4,4'-
TCB, assayed for EROD activity. (B) Incubations with 3,3' ,4,4'-TCB, assayed for 
NADPH cytochrome c (P450) reductase activity. (C) Incubations with 2,2',5,5 '-TCB, 
assayed for EROD activity. X -axis is the length of time of microsomal incubations, y-axis 
is the rate of catalytic activity in the incubations at given time points. Each point represents 
the mean and standard deviation (n-1) of catalytic activity in 6 assays (triplicate samples in 
two separate experiments). 
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Figure 10. CYP1A1 inactivation in the presence of azide in vitro. Hepatic microsomes 
from feral scup were incubated+ or- substrate (1.5 ~),+or- NADPH cofactor, and+ 
or - sodium azide (1 mM), and aliquots of the incubations were removed at 0, 1 0, 20, and 
30 minutes for fluorometric measurement of residual EROD activity in microsomes. (A) 
Microsomal incubation without substrate. (B) Microsomal incubation with 1.5 ~ TCB. 
(C) Microsomal incubation with 1.5 J.l.M BaP. X-axis is the length of time of microsomal 
incubations, y-axis is the rate of EROD activity in the incubations at given time points. 
Each point represents the mean EROD rate of duplicate assays from a single experiment. 
Each experiment was conducted twice, giving similar results. 
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Discussion 
The apparent inhibition of CYP1A catalytic activity by the Ah receptor agonist 
3,3',4,4'-TCB was first demonstrated in studies of rainbow trout hepatic microsomes 
(Melancon and Lech, 1983). Here we provide evidence demonstrating that the strong 
negative effect of 3,3',4,4'-TCB on hepatic CYP1A1 activity involves suppression of 
CYP1 A 1 protein content. Lower doses of TCB (0.1 mglkg) elicit transcriptional activation 
of CYP1A1 in scup, with elevated CYP1A1 mRNA content that is followed in time by 
elevations in CYPIAI enzyme content and CYP1A1 enzyme activity, consistent with 
previous observations of CYP1Al induction in teleosts (e.g. Kloepper-Sams and 
Stegeman, 1989). At higher doses (5.0 mg/kg), TCB elicits a similar transcriptional 
activation, with elevated CYP1A1 mRNA expression at early time points, but this is 
followed by only a very weak induction of CYPIAl enzyme content and activity. This 
effect, which is dose-dependent in vivo, is shown further to be highly specific for 
CYP1A1 , and in vitro experiments suggest that it may involve inactivation ofCYPlAl by 
oxidation of the P450 active site. 
Specificity of suppression by TCB in vivo 
Whereas high doses of TCB elicited suppressed microsomal content of CYP 1 A I protein, 
many other microsomal proteins were not negatively affected by the high TCB dose. 
Rather, content of cytochrome b5, NADPH P450 reductase, and UGT were each elevated 
to the same extent by both TCB doses. The turnover rate of NADPH P450 reductase in 
mammals, 48-72 hours (Ernster and Orrenius, 1965; Omura et al. , 1967; Arias et al., 1969; 
Kuriyama et al., 1969), is similar to that of teleost CYPlAl, 39 hours (Kloepper-Sams and 
Stegeman, 1994 ); the turnover rate of cytochrome b5 in mammals, 100 hours (Okada and 
Omura, 1978), is approximately twice as long. Any general destabilization would likely 
have affected expression of all of these enzymes, as they are similarly located and have 
comparable half-lives. The fact that TCB did not affect expression of these enzymes 
indicates that it does not act by a general mechanism, such as cellular toxicity, membrane 
degradation, accelerated turnover of all microsomal protein, or reduced translation of all 
cellular mRNA. Histopathological examination of the livers of these TCB-treated fish 
indicated no degenerative or necrotic damage, and all histological alterations seen were 
similar at the two TCB doses (chapter 4), further suggesting that TCB was not acting as a 
general hepatotoxicant at the high dose. 
TCB also had minimal effect on the expression and activity of other cytochromes 
P450. Although the content of total cytochrome P450 was decreased at the high TCB dose 
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as compared to the low dose, the negative effect on CYP1A1 can account for the majority 
of that decline (Table 1) Prior investigations of fish treated with polychlorinated aromatics 
have also noted that a large portion of the P450 induction is accounted for by CYP1A1 
induction (Gooch et al., 1989; Hahn and Stegeman, 1994). Content of the putative scup 
CYP2B and the putative scup CYP3A were somewhat lower in fish treated with 5.0 mglkg 
as compared to those treated with 0.1 mglkg, but the differences between treatments were 
of a very small magnitude compared to CYPlAl (y-axes, Fig 2), and the wide range of 
values within each treatment group made it difficult to define a specific "TCB effect". 
Nonetheless, it is possible that the mechanisms which cause suppressed CYP1Al protein 
content (discussed below) may exert a weak effect on other P450 enzymes as well. 
In a previous study (Gooch et al. , 1989), as in the present study, scup treated with 
5.0 mglkg TCB had significantly lower rates ofEROD activity on day 5 than did scup 
treated with a lower TCB dose ( 1.0 mg/kg). However, the rates of aminopyrine N-
demethylase (APND) activity and estradiol 2-hydroxylase (E20H) activity were similar on 
day 5 at the two TCB doses (Gooch et al., 1989). The monooxygenase activities APND 
and E20H are not catalyzed by CYP1A1 in scup (Stegeman et al., 1985; Snowberger and 
Stegeman, 1987), further indicating that the suppressive effect of TCB is specific for the 
CYP1A1 protein. 
Dose dependence of suppression by TCB in vivo 
The induction and suppression of CYP1A1 protein were related to the concentration of 
TCB in liver. In fish administered 0.1 mg/kg TCB, the level of CYP1A1 induction was 
directly correlated with the amount of TCB in liver. Thus, the maximum TCB 
concentration on day 5 coincided with maximum CYP1Allevels on day 5, and on days 12 
and 16 both TCB content and CYP1A1 expression were diminished. In fish administered 
5.0 mg/kg TCB, hepatic TCB content was relatively high on days 5 and 12 (0.6 and 2.2 
J..Lg/g) and CYP1A1 content was apparently suppressed at these time points, whereas on 
day 16 hepatic TCB content was reduced in the pooled sample (0.4J..Lg/g) and CYP1Al 
content and activity were elevated in two of the four fish. Thus, TCB depuration seems to 
be associated with a release of EROD inhibition, with increased content of CYP1A1 
mRNA, and with a slightly increased content of CYP1A1 protein, in two fish sampled on 
day 16. The elevated level of CYP1A1 mRNA following depuration suggests that TCB 
may suppress CYP1A1 expression at a transcriptional level, as has been indicated in other 
studies (Wirgin et al. , 1992; Celander and Forlin, submitted). In the present study, 
however, transcriptional regulation cannot account for the suppressed levels of CYP1A1 
protein on days 2 through 12. 
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The residue data suggest that suppression of CYP1 A 1, at multiple levels (a pre-
translational level , the level of protein content, and the level of enzyme activity), is linked to 
TCB concentrations in excess of 0.4J.Lg TCB/g liver dry weight, or 0.1J.Lg TCB/g liver wet 
weight. This value is approximate, as TCB content was measured in pooled samples, and 
inter-individual variation in hepatic TCB content was likely. Gooch et al. (1989) reported 
inhibition of microsomal EROD activity in scup livers with TCB concentrations exceeding 
2J.Lg/g wet weight; our results suggest an even more sensitive system. Hepatic 
concentrations of TCB in feral fish from highly contaminated sites have been reported in 
the 0.1 J.Lglg wet weight range. Winter flounder from New Bedford Harbor, MA were 
reported to have TCB concentrations ranging from 0.009 to 0.263 J.Lg/g liver wet weight 
(Monosson and Stegeman, 1991). Our data indicate that TCB could elicit suppression of 
CYP1A1 content or activity in fish living in polluted areas, as has been suggested 
previously (Elskus et al. , 1989; Monosson and Stegeman, 1991 ). Such suppression may 
compromise the animal's ability to effectively'metabolize other pollutant compounds that 
are CYP1Al substrates and that co-occur with TCB in the environment, including 
polycyclic aromatic hydrocarbons. 
Mechanism of post-transcriptional suppression 
The decreased content of both immunodetectable CYP1A1 protein and spectrally detectable 
P450 holoenzyme in TCB-treated fish suggests the possible involvement of several 
mechanisms: (A) reduced CYP1A1 rnRNA translation; (B) reduced synthesis of the P450 
heme moiety; or (C) enhanced CYP1A1 protein degradation. A previous study ofTCB-
treated scup (Gooch et al. , 1989) found that CYP1A1 rnRNA isolated on day 5 from fish 
treated with 5.0 mg/kg TCB was competent for in vitro translation. Furthermore, Northern 
blot analysis (Fig 5) showed that the electrophoretic migration of the CYP1A1 rnRNA was 
the same at the two doses. It thus appears that scup treated with a high TCB dose express a 
full and translatable CYP1A1 message, arguing against reduced translation (A). 
TCB exposure has previously been reported to inhibit heme synthesis in chick 
embryo hepatocytes (Sassa et al., 1986; Sinclair et al., 1986). However, in the present 
study CYP1A1 was the only microsomal heme protein with strongly reduced content at the 
high TCB dose as compared to the low dose. Cytochrome b5 was equally elevated at the 
two doses, and content of total cytochrome P450 never dropped below basal levels in fish 
treated with the high dose, suggesting that a "constitutive" P450 pool was unaffected by 
TCB. Sustained hepatic concentrations of the latter hemoproteins argues against a depleted 
heme pool to explain reduced CYP1A1 content (B). 
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Evidence from both in vivo and in vitro studies suggests that TCB may elicit 
enhanced CYP1A1 protein degradation (C), which could explain the reduced CYP1A1 
content seen in fish treated with 5.0 mg/kg TCB. Firstly, the strong in vivo suppression 
by TCB was specific for CYP 1 A 1, which is a principal catalyst for the metabolism of TCB 
in scup hepatic microsomes (chapter 5). A reduced enzyme content at the high TCB dose 
was not seen for proteins that are apparently co-induced with CYP1A1 (cytochrome b5, 
UGT), nor was strong suppression seen for other cytochromes P450, consistent with the 
suppression being related to TCB metabolism or active-site binding. Secondly, the in vivo 
suppression by TCB was only seen in epithelial cells of liver, kidney, and gill; endothelia 
of all organs examined had an equally strong CYP1A1 induction at the two TCB doses 
(chapter 3). Prior investigations (Stegeman et al., 1982; Stegeman et al. , 1989) indicate 
that the ratio of NADPH cytochrome c reductase : cytochrome P450 is one order or 
magnitude lower in scup heart (where all of the P450 is endothelial) than in scup liver 
(where most of the P450 is epithelial). Limiting quantities of reductase enzyme in 
endothelia may be expected to result in lower P450 catalytic activity in these cells, even 
with highly induced P450 content. In the present study, the "suppressed" P450 content in 
epithelia, but not in endothelia, is consistent with suppression being dependent upon 
electron transfer to P450, which may be greater in the epithelial cells due to abundant 
reductase. 
If the reduced CYP1A1 content in vivo is indeed the result of enzyme degradation 
rather than decreased enzyme biosynthesis, one may expect to see CYP1A1 degradation 
products in imrnunoblots. The fact that we did not see such products may indicate either 
(1) the principal degradation products are not recognized by the anti-CYP1A1 MAb 1-12-3, 
(2) the quantities of such products are below the limits of detection of the assay used, or (3) 
the protein is rapidly broken down into amino acids or small peptides upon synthesis. The 
latter may involve modification of the enzyme, during interaction with TCB, in such a way 
as to mark it for proteolysis. 
Evidence from in vitro studies further supports the hypothesis that suppressed 
CYP1Al content in vivo is related to TCB metabolism or active-site binding. Hepatic 
microsomal P450 is denatured (Fig 8) and CYPlAl is inactivated (Fig 9A) in the presence 
of TCB plus cofactor. We speculate that the majority of the spectral P450 loss under this 
condition was due to CYP1A1loss. The requirement of both TCB and cofactor for the 
inactivation and denaturation implies a process involving electron transfer to and TCB 
binding in the CYP1A1 active site. The fact that 2,2',5,5'-TCB, which binds weakly if at 
all to the scup CYP1A1 active site (Gooch et al., 1989) and is not a substrate for scup 
CYP1Al (chapter 5), did not inactivate CYPIAI in vitro (Fig 9C) further supports the 
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suggestion that inactivation requires active site binding. Inactivation of the enzyme during 
substrate-binding and electron transport may be caused by either a reactive TCB metabolite 
formed in the active site (mechanism-based inactivation), or a reactive oxygen species 
generated in the active site (oxidative inactivation), as discussed below. 
Mechanism-based inactivation 
In mechanism-based inactivation, substrate is metabolized by P450 to a reactive 
intermediate that can form covalent attachments to the P450 apoenzyme or to the heme 
moiety, irreversibly inhibiting enzyme activity (Ortiz de Montellano and Reich, 1986). 
Studies with rat hepatic microsomes and reconstituted systems(Shimada and Sawabe, 
1983) have shown that TCB is metabolically activated by CYP1A enzyme(s) to reactive 
form(s) that binds covalently to cellular proteins, including CYP1A. Similarly, we detected 
covalent binding to rat microsomal protein of TCB metabolites generated in rat 
microsomes, but the rate of TCB activation and binding in scup hepatic microsomes was 
very low (Table 2). At the rate measured in microsomes from feral scup, reactive TCB 
metabolites would be expected to affect only 3% of the microsomal CYP1A1 pool in one 
hour, even if one assumes that all of the covalent binding seen was to CYP1Al. 
Furthermore, spectral analysis of microsomal P450 following incubation with TCB plus 
NADPH indicated that there was no heme loss from the enzyme (Fig 8), excluding the 
possibility that TCB formed covalent adducts with the P450 heme that went undetected due 
to heme loss. Thus mechanism-based inactivation cannot account for the rapid CYPIA1 
inactivation seen in vitro (Table 3). 
It is nonetheless noteworthy that TCB conversion to active metabolites (those that 
can form covalent attachments to cellular proteins) comprises approximately 16% of the 
total TCB metabolism in feral scup microsomes: aqueous-soluble metabolites are generated 
at a rate of approximately 7.8 pmollhr/mg (chapter 5), and protein-bound metabolites at 
approximately 1.5 pmol/hr/mg. Despite such slow metabolism in vitro, appreciable 
amounts of TCB metabolites have been detected in the bile of TCB-treated scup (White et 
al., in preparation). Thus reactive metabolite formation and mechanism-based inactivation 
may play some role in CYPIA1 depletion in vivo. The very slow rate of metabolism in 
vitro further indicates that an aqueous-soluble TCB metabolite is not responsible for the 
rapid CYPIA1 inactivation and denaturation seen in microsomes. 
Oxidative inactivation 
Oxidative inactivation of P450 has been associated with catalytic uncoupling, occurring 
when electron transport is uncoupled from monooxygenation. This is seen when a poorly 
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metabolized substrate or unmetabolized pseudosubstrate binds to the P450 active site, 
stimulating electron flow to and oxygen activation in the active site as would a well-coupled 
substrate, but the activated oxygen is incorporated into substrate at a low or negligible rate 
(Ullrich and Diehl, 1971; Staudt et al., 1974). Some of the 02 that is activated but is not 
utilized for substrate monooxygenation can then be converted to H202 (Nordblom and 
Coon, 1977; Loosemore et al., 1980; Kuthan and Ullrich, 1982), via a direct breakdown of 
the activated P450-peroxy complex (Karuzina and Archakov, 1994). H202 may be 
converted to other reactive oxygen species including hydroxyl radical , which are believed 
to cause oxidative modifications to either the P450 apoenzyme or to the heme, ultimately 
leading to accelerated enzyme degradation (Karuzina and Archakov, 1994). 
The CYP1A1 inactivation and denaturation due to TCB plus NADPH were greatly 
enhanced upon addition of sodium azide (Table 3). Azide is an inhibitor of catalase activity 
and thus prevents the degradation of H202 that is produced in microsomes. Azide has also 
been found to be converted to azidyl radical, in the presence of hydroxyl radical (Reinke et 
al., 1994). Azidyl radical may be formed in or near the P450 active site, and may be 
capable of directly attacking the enzyme, along with the reactive oxygen species present. 
Thus azidyl radical may be acting to enhance and accelerate the destructive process that 
would normally be carried out by oxygen radicals alone. The apparent destructive action of 
azide may therefore involve both catalase inhibition and azidyl radical formation. 
Irrespective of which azide mechanism predominates, this result implies that reactive 
oxygen species are generated in microsomes as reducing equivalents are passed to the 
CYP1A1!TCB complex. Enzyme inactivation and denaturation due to azide were 
comparatively slight in the absence of substrate, or in the presence of the rapidly 
metabolized substrate BaP (Fig 1 0), consistent with prior work showing that some H202 
production occurs in microsomes in the absence of substrate or in the presence of a tightly-
coupled substrate (Nordblom and Coon, 1977; Guengerich, 1978; Kuthan and Ullrich, 
1982). 
In further support of our interpretations, De Matteis and colleagues (De Matteis et 
al., 1989; DeMatteis et al. , 1991; DeMatteis et al., 1993) have reported that addition of 
TCB plus NADPH to hepatic microsomes, after treatment with CYP1A1 inducers, 
stimulated the oxidative degradation of bilirubin. These investigators, too, have postulated 
a mechanism involving catalytic uncoupling of CYPIA1 by TCB binding, and have 
postulated that reactive oxygen species may be responsible for the bilirubin degradation. 
The latter studies have not addressed effects on P450 itself. In the present study, 
experiments with azide provide strong evidence for the generation of reactive oxygen 
species in the TCB/NADPHICYP1Al microsomal system, which target CYP1A1 itself for 
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denaturation. It is interesting to note that reactive oxygen, presumably synthesized in the 
CYPlAl active site, can target both CYPlAl and bilirubin for degradation, but apparently 
does not affect cytochrome b5, UGT, or NADPH reductase in vivo (this study). 
Exogenous catalase did not offer protection from enzyme inactivation by TCB plus 
NADPH. Similar findings have been made by other investigators studying catalytic 
uncoupling (Loosemore et al., 1980). This may imply that the destructive agent directly 
attacking P450 is a reactive oxygen species other than H202, for example hydroxyl radical, 
which is formed from H202 in the metal-catalyzed Fenton reaction (Halliwell and 
Gutteridge, 1986). The apparently paradoxical azide/catalase results may then be explained 
as follows: if hydroxyl radical is formed rapidly in the active site from H202, then 
additional H202 degradation in the medium by exogenous catalase may not affect enzyme 
inactivation; however, azide inhibition of the endogenous catalase in the medium may lead 
to H202 accumulation in the medium, and hence inhibited flow of H202 from the active 
site into the medium due to a loss of the concentration gradient, thus enhancing hydroxyl 
radical formation in the active site and consequent enzyme inactivation. Alternatively, it is 
possible that azide is not acting as a catalase inhibitor in this system, but is simply 
interacting with the destructive hydroxyl radicals in the active site to form a second 
destructive species in the active site, azidyl radical. Hydroxyl radical is highly reactive and 
will thus combine at or very close to its site of formation (Halliwell and Gutteridge, 1986). 
It will be formed from H202 in vivo at the points in the cell where metal catalysts of the 
Fenton reaction are located. Thus biological damage from H202 that is mediated by 
hydroxyl radical will only occur at or near metal ion complexes that catalyze the Fenton 
reaction (Halliwell and Gutteridge, 1986). It is interesting to speculate that the cytochrome 
P450 heme may act as a Fenton catalyst in vitro and in vivo, although this has not yet been 
demonstrated. 
Characteristic of an uncoupler, TCB was found to be a tightly-bound but poorly 
metabolized substrate for scup CYPIAl in vitro (chapter 5). Interestingly, Hesse and 
Wolff ( 1977) reported catalytic uncoupling during the binding of the pseudosubstrate 
2,2',4,4',6,6'-hexachlorobiphenyl, and of the poorly metabolized substrate 2,2',5,5'-
tetrachlorobiphenyl, to hepatic microsomal cytochrome P450 from phenobarbital-treated 
rabbits. We speculate that the slow, uncoupled metabolism of the higher chlorinated 
biphenyls may be due to steric hindrance from the bulky chlorine substituents on each side 
of the molecule, which could block oxygenation at the adjacent, unsubstituted carbon 
atoms. Hindered oxygenation of substrate could then result in prolonged substrate 
occupation of the active site, and in the production of reactive oxygen species during such 
occupation, which may in tum inactivate the enzyme. While oxidative CYPlAl 
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inactivation would be expected to occur at any concentration of TCB, it may not be 
detectable in vivo in livers with a high CYP1A1 :TCB ratio (i.e. in animals receiving lower 
TCB doses). 
In summary, we have demonstrated that 3,3',4,4'-TCB brings about a strong, 
transcriptional induction of scup CYP 1 A 1, acts as a reversible inhibitor of CYP 1 A 1 
catalytic activity, and simultaneously elicits a post-translational suppression of CYP1A1 
protein content in vivo. This suppression appears to involve direct interactions between 
TCB and CYP1A1, and in vitro evidence strongly implicates oxidative inactivation in the 
reduced CYP1A1 protein content. Given the strong inactivation, TCB may be a useful 
selective inhibitor in establishing CYP1A1 catalytic activities. Furthermore, our results 
establish that TCB should not be utilized as a simple CYP1Al inducer in in vivo studies, as 
host of other complex interactions also take place. 
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CHAPTER THREE 
Temporal Pattern of Induction of Cytochrome P450 I A I 
in Multiple Organs and Cell Types of the Marine Fish Scup 
Treated with Low and High Doses of 3,3',4,4'-Tetrachlorobiphenyl 
69 
Abstract 
Cytochrome P4501A1 (CYP1Al) plays an important role in both the metabolism and the 
activation of organic contaminants, including polycyclic aromatic hydrocarbons and 
halogenated aromatic hydrocarbons. Regulation of CYP1A1 has been studied extensively 
in teleost liver, but very little is known about the dose-response and time-course patterns 
of CYP1A1 induction in target cells of extrahepatic organs of fish . In the present study the 
marine fish scup (Stenotomus chrysops) was treated with the CYP1A1 inducer 3,3',4,4'-
tetrachlorobiphenyl (TCB) at two doses, 0.1 mg/kg and 5.0 mglkg, and animals were 
sampled at time points from 1 to 16 days after treatment. Sections of liver, kidney, gill, 
intestine, spleen, heart, and gonad were analyzed for CYP1A1 content with 
immunohistochemistry, and microsomes from liver, kidney, and gill were analyzed for 
CYP1A1 content by immunoblot. Immunoblot analysis showed strong CYP1Al induction 
in liver, kidney, and gill of animals treated with 0.1 mg/kg TCB, and a comparatively 
weaker induction throughout the time-course in liver, kidney, and gill of animals treated 
with 5.0 mglkg TCB. In immunohistochemistry, vascular endothelium of all organs 
showed CYPIA1 induction by day 1, which reached a maximum of intensity and 
prevalence on day 12, and did not attenuate by the end of the experiment. This temporal 
pattern of induction in endothelium did not differ between the two TCB doses. Fish treated 
with the high dose had greater CYP1A1 induction in mucosal epithelium of both duodenal 
and caecal sections of intestine than did fish treated with the low dose, reflecting higher 
inducer concentration passing through the intestine. Spleen of fish treated with both doses 
had strong CYP1 A 1 induction in vascular endothelia of major arterioles, and spleen of fi sh 
treated with the high dose also had moderate induction in the capillary endothelia. 
Similarly, both doses of TCB elicited a strong CYP 1 A 1 induction in the endocardia of 
major vessels of the bulbus arteriosus, and the high dose also elicited a weak induction in 
capillary endothelia of the bulbus. In some epithelial cell types, CYP1A1 induction was 
greater in fish treated with 0.1 mg/kg TCB than in fish treated with 5.0 mglkg TCB, at 
certain time points: hepatocytes, renal tubules, renal collecting ducts, and gill epithelia. In 
kidney and gill , the "reduced" CYP1Al content at the high dose reflected a reduced 
percentage of strongly induced cells, whereas the "reduced" induction in liver at the high 
dose reflected a weaker CYPIAI staining in all hepatocytes, as compared to the low dose. 
The apparent suppression of induction in kidney and gill of fish treated with 5.0 mg/kg 
TCB may be related to degree of tissue pathology, which was more severe in these organs 
at the high dose. Reduced CYPlAl content in liver seems to be related to a specific 
interaction between TCB and CYPIA1 , rather than to general pathology. 
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Introduction 
Cytochrome P4501A1 (CYP1Al) plays a critical role in the activation and 
detoxification of a large group of lipophilic organic contaminants, including polycyclic 
aromatic hydrocarbons and halogenated aromatic hydrocarbons (Stegeman and Hahn, 
1994). The binding of planar aromatic hydrocarbons to the cytosolic Ah receptor in 
mammals mediates a transcriptional induction of CYP 1 A enzymes, resulting in increased 
content of CYP1A proteins in the endoplasmic reticulum, and increased rates of metabolism 
of substrates/ inducers (Nebert and Gonzalez, 1987). The identification of hepatic Ah 
receptor in fish (Hahn et al., 1994), and the similarity in timing of the induction response 
between teleost and mammalian hepatic CYP1A1 (Kloepper-Sams and Stegeman, 1989), 
indicates that a similar mechanism of induction operates in teleosts. Although CYP1A1 
induction has been studied extensively in teleost liver, less is known about the responses of 
extrahepatic CYP 1 A I to Ah receptor agonists, and in particular very little is known about 
the time-course and dose-response patterns of induction in target cells of extrahepatic 
organs. Extrahepatic CYP1A1 induction may prove to play a critical role in both the 
detoxification and the activation of environmental substrates in fish, particularly in organs 
such as gill and intestine that are directly exposed to the environment. 
CYP1Al enzymatic activity has been documented in most organs of fish, including 
liver, kidney, gonad, intestine, gill, heart, muscle, and others (Stegeman et al., 1979). 
Exposure to Ah receptor agonists has been found to increase rates of microsomal CYPIAI 
activity in several teleost organs, including liver and kidney (Bend et al., 1974), intestine 
(Van Veld et al., 1988), gill (Miller et al., 1989), and heart (Stegeman et al., 1989). 
Induction of CYP 1 A 1 protein has been documented in multiple organs of fish exposed to 
Ah receptor agonists, including liver, kidney, gill, heart, intestine, gonad, spleen, brain, 
and olfactory epithelium (Lorenzana et al., 1988; Miller et al., 1988; Miller et al., 1989; 
Stegeman et al., 1989; Smolowitz et al., 1991; Smolowitz et al. , 1992; Buchmann et al., 
1993; Lindstrom-Seppa et al., 1994). In many extrahepatic organs, the major site of 
induction has been identified as vascular endothelium (Miller et al., 1989; Stegeman et al., 
1989; Smolowitz et al., 1991; Stegeman et al., 1991), specifically in gill, heart, gonad, 
spleen, and brain. In some organs, including liver, kidney, gill, and intestine, induction 
has also been observed in epithelial cell types (Smolowitz et al., 1991; Smolowitz et al., 
1992; Lindstrom-Seppa et al., 1994). CYP1A1 induction in multiple organs has also been 
observed in chronically exposed fish from the wild (Stegeman et al. , 1991), with vascular 
endothelium being the most common site of induction in these fish. 
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A recent study (Smolowitz et al. , 1991) has provided a thorough 
immunohistochemical survey of CYP1A1 induction in multiple organs and cell types of the 
marine fish scup (Stenotomus chrysops) treated with 3,3',4,4'-tetrachlorobiphenyl (TCB). 
TCB is an Ah receptor agonist that acts as a CYP1A1 inducer, a CYP1A1 inhibitor (Gooch 
et al., 1989), and a CYP1A1 substrate (chapter 5) in teleost fish. TCB is a component of 
commercial polychlorinated biphenyl (PCB) mixtures, which occur as ubiquitous 
contaminants in marine environments (Tanabe, 1988; Fowler, 1990). TCB and the other 
coplanar PCB congeners bring about a suite of toxic effects in mammals, similar to those 
elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (reviewed in Goldstein and Safe, 1989). 
The study of Smolowitz and colleagues (Smolowitz et al., 1991) described induction at 
only a single time-point after treatment (day 5), and in response to only a single high TCB 
dose (I mg/kg). The present study extends these findings by describing the degree of 
CYP 1 A I induction from day I to day 16 after treatment, in several cell types of 7 organs in 
scup, in response to two different doses of TCB: O.I mg/kg and 5.0 mglkg. We report that 
strong induction is evident by day 1 in some cell types, including atrial endocardia (both 
doses) and gill epithelia (high dose). Induction attenuates by day 16 in some epithelial cell 
types, particularly at the low dose, but is sustained in the vascular endothelium of all 
organs examined. Induction was stronger at the high dose than at the low in mucosal 
epithelium of intestine, and capillary endothelium of spleen and bulbus arteriosus. 
However, the low dose elicited a stronger overall induction than did the high dose in gill 
epithelia, renal tubules and collecting ducts, and hepatocytes. 
Materials and Methods 
Chemicals 3,3',4,4'-Tetrachlorobiphenyl (TCB, IUPAC #77) was purchased from 
Pathfinder (St. Louis, MO). Purity of TCB was greater than 99% by GC/ECD and 
GCIMS analysis. Further analysis by high resolution (5000 resolution) mass spectrometry 
(VG Autospec) and selective ion monitoring showed that the potent Ah receptor agonist 
3,3',4,4',5-pentachlorobiphenyl was not a contaminant of the TCB, with a detection limit 
of 0.001%. For immunohistochemistry, the Universal Immunoperoxidase Staining Kit 
(Murine) (Signet Laboratories, Dedham, MA) was used. All other immunohistochemical 
reagents were similar to those used previously in this laboratory (Smolowitz et al., 199I ). 
Reagents for biochemistry were of the highest grade available from commercial suppliers. 
Animals and Dissection Scup (Stenotomus chrysops) were caught by angling in Vineyard 
Sound, MA in August 1991. Fish were held in flowing seawater tanks at 2o·c for 
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fourteen months prior to experimental use, and were maintained on a diet of Purina trout 
chow and frozen squid. Prior studies in our laboratory indicate that the bulk of 
environmental contaminants are depurated from the tissues of fish that are held in aquaria 
for one year, and that these fish show little CYP1A1 expression. At the time of the dosing, 
experimental animals (mixed sex) were gonadally immature and weighed 76 - 276 grams. 
Individuals were injected intraperitoneally with either corn oil (carrier controls) or with 0.1 
mg/k.g or 5.0 mglkg 3,3',4,4'-tetrachlorobiphenyl (TCB) dissolved in corn oil. A group of 
uninjected fish was used as a "zero" point in the time-course. Individuals were held in 
flowing seawater tanks at 20°C until sampling (1 day to 18 days) or until death from 
toxicity. Fish were fed Purina trout chow once weekly, and were never fed within the 
three days prior to killing. At each time point, a group of 4 or 5 animals from each 
treatment group were killed by cervical transection and dissected immediately. 
Sections of liver, kidney, and gill for biochemistry were removed from the fish and 
frozen in liquid nitrogen within one to five minutes of death. Tissues were held in liquid 
nitrogen until microsome preparation. Prior studies in our laboratory indicate that enzyme 
degradation does not occur to any appreciable degree in scup tissue stored at liquid nitrogen 
temperatures (unpublished observations). Microsomal fractions were prepared from frozen 
liver, kidney, and gill by differential centrifugation, as previously described (Hahn and 
Stegeman, 1994), and microsomal protein content was measured with the bicinchoninic 
acid method (Smith et al., 1985), using bovine serum albumin as a standard. Sections of 
liver, posterior kidney, gonad, heart, gill, spleen, and intestinal caecum and duodenum 
were removed and immediately fixed in 10% neutral buffered formalin (pH 7.4). Spleen 
was only sampled on days 0, 12, and 16; all other organs were sampled at each time point. 
After one week of fixation, tissues were embedded in paraffin using standard methods 
(Luna, 1968). 
Biochemistry For biochemical analyses, a hepatic microsomal fraction was prepared from 
each individual fish. Kidney and gill microsomal fractions were obtained from tissue 
pieces of equal size from all fish within a given treatment group (i.e. dose and time point) , 
and pooled for analyses. Microsomal fractions from liver, kidney, and gill were analyzed 
for content of cytochrome P4501A1 (CYP1A1) by Western blot analysis, as described 
previously (Kloepper-Sams et al., 1987; Stegeman et al., 1991). Antibodies used were 
monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E (a CYP1A1 
homologue), and alkaline phosphatase linked goat-anti-mouse IgG as the secondary 
antibody. Relative content of CYP1A1 in the microsomal samples was measured by 
densitometric scanning of immunoreactive bands with a video imaging system (Masterscan, 
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Scanalytics, division of CSPI, Billerica, MA), and comparison of optical density in the 
samples to optical density in standards with known P450E content. 
Microsomal fractions from liver, kidney, and gill were analyzed for rates of 
ethoxyresorufin 0-deethylase (EROD) activity , which is catalyzed by CYP1A1 in scup 
(Stegeman et al., 1985). EROD activity was measured at 32•c with a fluorometric kinetic 
assay, using a Cytofluor 2300 fluorescence plate reader (Millipore), as described 
previously (Hahn et al., 1993). Protein concentration in the EROD assays was 
approximately 0.05 mg/mJ for liver (1 J..Ll hepatic microsomal protein per 200 J..Ll assay), 
0.05- 0.3 mg/mJ for kidney, and 0.2- 0.7 mg/ml for gill (10 J..Ll kidney or gill microsomal 
protein per 200 !J.l assay). 
Immunohistochemistry Paraffin blocks were chilled in ice water, and 5 J..Lm sections were 
obtained, mounted on Superfrost-plus slides (Baxter), and allowed to dry at room 
temperature for at least 24 hours. Tissue sections on slides were deparaffinated in clearant 
(Americlear histology clearing solvent) for 6 minutes. Tissues were then hydrated 
successively in 100% ethanol (2 min), methanol containing 0.5% hydrogen peroxide (to 
block endogenous peroxidase, 45 min), 95% ethanol (2 min), 80% ethanol (1 min), 70% 
ethanol (1 min), water (15 min), and finally 1% BSA/PBS (;:::5 min). Hydrated tissue 
sections were stained using an indirect peroxidase stain (Universal Immunoperoxidase 
Staining Kit (Murine), Signet Laboratories, Dedham, MA) with MAb 1-12-3 as the primary 
antibody. This antibody has been found to bind specifically to CYP1A1 in tissue sections 
(Miller et al. , 1989). 
After hydration in 1% BSA/PBS, slides were soaked for 20 minutes in normal goat 
serum, to block nonspecific attachment of the secondary antibody (goat anti-mouse IgG). 
Slides were then incubated in MAb 1-12-3 (1 J..Lg/ml) in 1% BSA/PBS for two hours ; 
negative control slides were incubated in a non-immune serum, specifically mouse 
myeloma IgG (1.8 J..Lg/ml ; UPC-10, IgG2A, Organon Teknika, West Chester, PA) in 1% 
BSA/PBS for 2 hours. These incubations were followed by one wash with BSA/PBS, and 
a 20 minute incubation with secondary antibody, goat anti-mouse IgG. Slides were 
washed again in BSA/PBS, incubated for 20 minutes in peroxidase-linked nonspecific 
mouse IgG, washed twice more, and exposed to 3-arnino-9-ethylcarbazole color developer 
for 30 minutes. This color developer precipitates a red stain at all immunoreactive sites. 
Stained sections were washed in water and mounted in 90% glycerol/PBS. For each organ 
examined, sections from all 65 fish plus negative control slides were stained together in a 
single run. 
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Scoring of CYP1Al content CYP1A1 content was quantified in several cell types of seven 
organs from each fish, by scoring with a subjective index. CYPlAl-specific staining in 
each cell type was scored for intensity as follows: 0 =no stain, 1 =weak, 2 = moderate, 3 
=strong, or "heterogeneous", meaning that populations of cells within a tissue variously 
stained weakly, moderately, or strongly. CYP1A1-specific staining was scored for 
prevalence as follows: 0 = no stain, 1 = rare cells staining, 2 = multifocal (many cells or 
patches of cells) staining, 3 =pervasive (most cells of a given type within the tissue) 
staining. In most cases, a "score" of CYP1A1 expression was calculated as the product of 
the intensity and the prevalence scores. In heart there was an exceptionally wide range in 
intensity of stain, and in all cases staining was pervasive, so endocardia of each chamber 
were scored for intensity only, from 0 to 5: 0 =no stain, 1 =very weak, 2 =weak, 3 = 
moderate, 4 = strong, 5 = very strong. 
Photographs 35 mm color slides (EPY 64 Tungsten Ektachrome) were taken of 
immunostained microscope slides and scanned into Adobe Photoshop software (v. 2.5.1 
for Macintosh) using a Kodak RFS 2035 slide scanner. Images were scaled and labeled 
using Adobe Photoshop, and were printed on a Kodak XL photographic printer. No image 
enhancement, contrast adjustment, or color adjustment was used to modify the figures. 
Results 
Microsomal biochemistry 
Content of immunodetectable CYP1A1 was measured in microsomal fractions of kidney 
and gill from control and TCB-treated scup, and patterns of expression were compared to 
those in liver microsomes from the same fish (Fig 1 ). In kidney and liver of fish treated 
with 0.1 mg/kg TCB, CYP1A 1 induction peaked on day 5 and attenuated by day 16. In 
gill microsomes from the same fish , induction peaked later (day 12), and CYP1Al content 
seemed to attenuate by day 16. In fish treated with 5.0 mg/kg TCB, substantially less 
CYP1A1 was detected in kidney and liver throughout the time course, and in gill on day 
12. 
Rates of CYPlAl-catalyzed EROD activity in kidney, gill, and liver microsomes 
were generally consistent with patterns of CYP1A1 expression (Fig 2). The low dose of 
TCB brought about a strong induction of activity in all three organs, peaking on day 5 in 
liver and kidney and on day 12 in gill. In the extrahepatic organs, induction of EROD 
activity seemed to attenuate by day 16. In fish treated with the high dose, however, there 
was minimal EROD induction in kidney, no EROD induction in liver (days 1-12), and 
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Fig 1. Immunodetectable CYP1A1 content in kidney, gill, and liver microsomes ofTCB-
and com oil-treated scup. Microsomal proteins were separated on SDS-PAGE, transferred 
to nitrocellulose by electroblotting, and incubated with MAb 1-12-3, which was raised 
against the CYP1A1 homologue from scup liver. X-axis is the number of days subsequent 
to injection, y-axis is enzyme content in pmol P450E equivalents/ mg microsomal protein. 
For kidney and gill, each point is a measurement on a single pooled sample, composed of 
equally-sized tissue sections from 4 or 5 fish per treatment group. For liver, each point is 
the mean and standard deviation of measurements on 4 or 5 individuals per treatment 
group. Plot symbols are: square, com oil control, open circle, 0.1 mg/kg TCB, closed 
circle, 5.0 mg/kg TCB. 
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Fig 2. Rates of EROD activity in kidney, gill, and liver microsomes of TCB- and corn oil-
treated scup. EROD activity was assayed fluorometrically, as described in Methods. X-
axis is the number of days subsequent to injection, y-axis is rate of activity in pmoll min/ 
mg microsomal protein. For kidney and gill, each point is the mean of two measurements, 
on a single pooled sample, composed of equally-sized tissue sections from 4 or 5 fish per 
treatment group. For liver, each point is the mean and standard deviation of measurements 
on 4 or 5 individuals per treatment group. Plot symbols are: square, corn oil control, open 
circle, 0.1 mg/kg TCB, closed circle, 5.0 mg/kg TCB. 
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reduced EROD induction in gill (days 5 and 12), despite modest increases in CYPlAl 
content in all organs at this dose. Suppressed EROD rates are consistent with competitive 
inhibition of EROD activity by residual TCB in rnicrosomes (e.g. Gooch et al ., 1989). 
EROD inhibition in the liver was released by day 16 in some fish treated with 5.0 mglkg 
TCB, consistent with our finding that the bulk of the TCB was depurated from livers by 
this time point (chapter 2). 
Although the absolute rates of EROD activity were far higher in liver than in 
extrahepatic organs of TCB-treated animals, both the specific activity (pmol EROD activity/ 
min/ pmol CYPlAl) and the fold-induction were greater in the extrahepatics. For example, 
in the group of fish treated with 0.1 mg/kg TCB and sampled on day 5, specific activities 
were 8 pmol/rninlpmol for liver, 14 for gill, and 23 for kidney. In the same group of fish, 
there was a 15-fold induction of EROD activity in liver, a 28-fold induction in gill, and a 
232-fold induction in kidney, as compared to com oil controls sampled on day 4. 
Immunohistochemistry 
CYP1A1 content was evaluated by scoring each cell type for intensity of CYPlAl -specific 
stain (0 - 3) and for prevalence of CYP1 A 1-specific stain (0- 3). Unless stated otherwise, 
cells from com-oil treated fish did not stain specifically for CYP1A1. No cells stained in 
any of the control sections incubated with non-immune serum (mouse myeloma IgG) as a 
primary antibody. 
Liver CYPlAl-specific stain was pervasive, occurring in all cells, in both the 
hepatocytes and the pancreatic tissue of all TCB-treated fish . Intensity of stain in the 
hepatocytes ranged from weak to strong in TCB-treated fish , and was significantly 
different between doses on day 5 (Figs 3B and 3C), at which time all low-dose fish 
received a score of 3 (strong) and all high-dose fish received scores of 1 or 2 (weak or 
moderate). Scores for hepatocyte induction are represented graphically in Fig 4A. 
Intensity of stain in the pancreas ranged from weak (days 1 - 5) to moderate (days 12- 16), 
and stain scores did not differ between the two doses. CYPlAl-specific stain in sinusoidal 
endothelia was weak/ rare on day 1 and strong/ pervasive on days 12 and 16 at both doses 
(Fig SA). 
Kidney CYPl A 1-specific stain was pervasive in renal tubule epithelia of most 
TCB-treated fish. Intensity of stain in the tubules was always heterogeneous, with 
populations oftubules variously staining weakly, moderately, or strongly. On days 2 
through 16, the percentage of renal tubules staining strongly was greater in fish treated with 
the low dose than in fish treated with the high dose of TCB, whereas the percentage of 
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TABLE I 
CYPIAI Induction in Renal Tubules ofTCB-Treated Scup a 
Day 
2 
5 
12 
16 
%weak 
wob 
18 ± 5 c 
10±6 
26 ± 19 
24 ± 10 
0.1 mg/kg 
% medium 
50± 14 
26±6 
27±5 
36± 22 
% strong % weak 
wob 
32 ± 16 37 ± 36 
64± 8 26± 12 
47 ± 15 26±6 
40±23 54± 15 
5.0 mg/kg 
% medium % strong 
55± 32 9±9 
39 ± 14 35 ±24 
40± 12 34± 14 
27 ± 14 19 ± 8 
a Kidney sections ofTCB-treated fish were stained immunohistochemically for CYPlAl , 
as described in Methods. 100 renal tubules were counted from each individual kidney and 
assigned a score of either weak, medium, or strong for intensity of CYP 1 A ]-specific 
staining. 
b On day one after treatment, tubules in each section stained homogeneously, and all 
tubules within each kidney section were scored as either weak or medium. 
c Each measurement is a mean ± standard deviation for 4 or 5 fish in each treatment group. 
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Fig 3. Immunohistochemical analysis of CYP1A1 induction in liver and kidney. (A) Liver 
of fish treated with com oil and sampled on day 4 (lOOx). Section showing no specific 
stain. (B) Liver of fish treated with 0.1 mg/kg TCB and sampled on day 5 (lOOx). Section 
showing strong/ pervasive stain in hepatocytes. (C) Liver of fish treated with 5.0 mglkg 
TCB and sampled on day 5 (1 OOx). Section showing moderate/ pervasive stain in 
hepatocytes, mild stain in pancreatic tissue (p ). (D) Kidney of fish treated with com oil and 
sampled on day 4 (1 OQx). Section showing no specific stain in renal tubules (T), dark 
patches are melanomacrophage aggregates (m). (E) Kidney of fish treated with 0.1 mglkg 
TCB and sampled on day 12 (lOOx). Section showing heterogeneous stain in renal tubules 
(T), dark patches are melanomacrophage aggregates (m). (F) Kidney of fish treated with 
5.0 mglkg TCB and sampled on day 12 (lOOx). Section showing heterogeneous stain in 
renal tubules (T). 
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Fig 4. Time-course of CYP I A I induction in immunostained epithelial cells. (A) 
Hepatocytes, (B) renal tubule epithelia, (C) kidney duct epithelia, (D) gill epithelia in non-
proliferative regions, (E) mucosal epithelia of duodenum. X-axis is the number of days 
subsequent to injection, y-axis (A, C, D, E) is the staining score (intensity x prevalence), 
derived as described in Methods, or y-axis (B) is the percentage of strongly staining renal 
tubules, determined as described in Table I. Each point is the mean score for 4 or 5 fi sh 
per treatment group. Plot symbols are: square, corn oil control , open circle, 0.1 mg/kg 
TCB, closed circle, 5.0 mg/kg TCB. 
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Fig 5. Time-course ofCYPlAl induction in immunostained endothelial cells. (A) Liver 
sinusoidal endothelia, (B) kidney vascular endothelia, (C) duodenum vascular endothelia, 
(D) atrial endocardia, (E) gonad vascular endothelia. X-axis is the number of days 
subsequent to injection, y-axis (A, B, C, E) is the staining score (intensity x prevalence), 
or y-axis (D) is the is the intensity of stain, derived as described in Methods. Each point is 
the mean score for 4 or 5 fish per treatment group. Plot symbols are: square, corn oil 
control, open circle, 0.1 mg/kg TCB, closed circle, 5.0 mg/kg TCB. 
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tubules staining weakly was greater in fish treated with the high dose (Table 1 and Figs 3E 
and 3F). Induction in renal collecting duct epithelia ranged from weak/ multifocal on day 1 
to moderate/ pervasive on days 2- 12, and was more intense on days 5 and 12 in the fish 
receiving the low TCB dose. Induction scores for kidney epithelia are presented 
graphically in Figs 4B and 4C. Induction in kidney vascular endothelium was similar to 
that in liver, with moderate/ multi focal stain by day 1, strong/ pervasive stain on days 12 
and 16, and no dose-dependent differences in scores (Fig 5B). 
Gill All com oil-treated fish had heterogeneous/ multifocal CYP1Al staining in the 
gill pillar (endothelial) cells (Fig 6A), with some cells not staining and others staining 
weakly, moderately, or strongly. This is consistent with prior results (Miller et al., 1989) 
showing CYP1Al staining in the pillar cells of depurated scup. In TCB-treated fish, pillar 
cell staining was pervasive (all or most cells stained) and heterogeneous at all time points 
(Figs 6B and 6D), and induction did not attenuate by day 16. 
Gill epithelial cells had a heterogeneous/ multifocal pattern of CYP1Al induction in 
most TCB-treated fish, and did not stain in corn oil-treated fish. TCB treatment elicited a 
proliferation of epithelial cells between the secondary lamellae of gills (Fig 6D), which is 
described in a separate paper (chapter 4). Proliferation was evident by day 5, and was 
consistently more severe in fish treated with the higher TCB dose. The newly proliferative 
epithelia did not stain for CYP1Al, whereas the epithelial cells surrounding secondary 
lamellae in non-proliferative regions did stain for CYPlAl (Figs 6B and 6D). Thus, 
overall CYP 1 A 1 induction per unit tissue was greater at the low dose, which contained 
fewer proliferative (non-staining) cells. The pattern of CYP 1 A 1 induction in the non-
proliferative gill epithelia is presented graphically in Fig 4D. Prevalence of epithelial stain 
peaked on day I in fish treated with 5.0 mg/kg, and declined concomitantly with the onset 
of cell proliferation (chapter 4). 
There was a strong CYP1A1 induction in some TCB-treated fish in clusters of cells 
located at the base of each primary gill filament (Fig 6C). Examination of hematoxylin and 
eosin-stained slides suggests that these immunoreactive cells are chondrocytes. This cell 
type has previously been found to stain for CYPIAI in environmentally exposed fish 
(Stegeman et al., unpublished results). 
Intestine In fish treated with 0.1 mglkg, CYPIAI induction generally occurred 
along the lumenal face of the mucosal epithelial cells (Fig 7B). In fish treated with 5.0 
mglkg, CYP1Al induction was more intense and penetrated further into the mucosal 
epithelium, especially on days 5 and 12 (Fig 7C). At both doses induction in the mucosal 
epithelium was maximal on days 5 and 12 (Fig 4E), and the mean scores on day 16 were 
lower than those in fish sampled on day 12. The temporal pattern of CYP1A1 induction in 
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vascular endothelium of intestine was similar to that in liver (Fig 5C), with moderate/ 
multifocal stain on day 1, strong/ pervasive stain on day 12, and no dose-dependent 
differences in scores. Neither the mean intensity of stain, nor the temporal pattern of 
induction, differed substantially between duodenal and caecal sections of intestine, in both 
epithelia and endothelia. 
Spleen The vascular endothelium of major arterioles in spleen stained strongly and 
pervasively for CYP1A1 on days 12 and 16, at both TCB doses (Figs 7E and 7F). In 
addition, the capillary endothelium stained moderately and pervasively for CYP1A1 in all 
fish treated with 5.0 mg/kg and sampled on day 12, in half of the fish treated with 5.0 
mg/kg and sampled on day 16 (2 of 4), but in only one fish of 8 treated with 0.1 mg/kg and 
from which spleen was sampled (Fig 7F). 
Heart Endocardial cells of the atrium stained very weakly for CYP1A1 content 
(scoring 1 on a scale of 0 - 5) in several of the corn oil-treated fish (Fig 8A). The intensity 
of CYP 1 A 1 induction by TCB was stronger in atrial endocardia than in any other cell type 
examined in the organism, with scores of moderate to strong on day 1 (Fig 8C) and strong 
to very strong on days 5, 12, and 16 at both doses (Fig 5D). Ventricular endocardia 
stained very weakly to weakly on day 1 and moderately to strongly by day 12, with no 
difference between doses. The endocardia of the bulbus arteriosus stained weakly on day 1 
and strongly by day 5 at both doses (Fig 8B), in most animals staining more intensely than 
ventricle and less intensely than atrium. In several (70%) of the fish treated with 5.0 mg/kg 
TCB and sampled on days 5, 12, and 16, there was a weak immunoreactive stain in an 
unidentified cell type of the bulbus arteriosus, possibly capillary endothelia. This cell type 
also stained very weakly in two fish treated with 0.1 mg/kg TCB and sampled on days 5 
and 12, respectively. 
Gonad Vascular endothelium was the only cell type that stained for CYP1A1 in 
gonad of both male and female fish exposed to TCB (Fig 8D). Staining ranged from 
moderate to strong and from multifocal to pervasive on days 5 and 12 (Fig 5E). There was 
no marked difference in induction between the sexes nor between the two TCB doses. 
Discussion 
In this study we show that the Ah receptor agonist TCB elicits a time-dependent 
induction of CYP1A1 in multiple organs of the marine fish scup, with intensity of 
induction in various cell types being either positively or negatively correlated with 
increasing dose of inducer. The results for day 5 are summarized in Table 2. In some cell 
types examined, the two TCB doses elicited a similar degree of induction, despite the 50-
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Fig 6. Immunohistochemical analysis of CYPI A I induction in gill. (A) Gill of fish treated 
with corn oil and sampled on day 4 (200x). Section showing CYP1A1 stain in pillar cells 
(p), no stain in epithelia (e). (B) Gill of fish treated with 0.1 mglkg TCB and sampled on 
day 12 (200x). Section showing heterogeneous CYP1A1 stain in pillar cells (p) and 
epithelial cells (e). (C) Gill of fish treated with 0.1 mglkg TCB and sampled on day 2 
(lOOOx). Section showing CYPIAl stain in chondrocytes (all ovoid cells in figure). (D) 
Gill offish treated with 5.0 mg!kg TCB and sampled on day 12 (200x). Section showing 
proliferation of epithelial cells between the secondary lamellae (*), CYPlAl stain in pillar 
cells all along the lamellae, and in epithelial cells in non-proliferative areas of lamellae. 
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Fig 7. Immunohistochemical analysis of CYPlAl induction in intestine and spleen. (A) 
Duodenum of fish treated with corn oil and sampled on day 4 (100x). Section showing no 
specific stain, L indicates lumen of intestine. (B) Caecum of fish treated with 0.1 mg/kg 
TCB and sampled on day 5 ( 1 OOx). Section showing moderate stain along lumenal edge of 
mucosal epithelia, indicated are lumen (L) and goblet cells (g). (C) Caecum of fish treated 
with 5.0 mg/kg TCB and sampled on day 12 (lOOx). Section showing strong/ pervasive 
stain in mucosal epithelia, indicated are lumen (L) and goblet cells (g). (D) Spleen of fish 
treated with com oil and sampled on day 16 (I OOx). Section showing no specific stain, 
dark patches are melanomacrophage aggregates (m). (E) Spleen of fish treated with 0.1 
mglkg TCB and sampled on day 12 (lOOx). Section showing strong CYP1Al stain in 
vascular endothelia of major arterioles (A), dark patches are melanomacrophage aggregates 
(m). (F) Spleen of fish treated with 5.0 mg/kg TCB and sampled on day 16. Section 
showing strong CYP1A1 stain in vascular endothelia of major arterioles (A), moderate 
stain in vascular endothelia of sinusoids (s), dark patches are melanomacrophage 
aggregates (m). 
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Fig 8. Immunohistochemical analysis of CYPlAl induction in heart and gonad. (A) Heart 
of fish treated with com oil and sampled on day 12 ( 1 OOx). Section showing very weak 
CYP1A I stain in endocardia of atrium (a), no stain in ventricle (v). (B) Bulbus arteriosus 
(heart) of fi sh treated with 5.0 mglkg TCB and sampled on day 16 ( I OOx). Section 
showing very strong stain in vascular endothelia, weak stain in capillary endothelia. (C) 
Heart of fi sh treated with 5.0 mg/kg TCB and sampled on day I (1 OOx). Section showing 
strong CYP1 A 1 stain in atrial endocardia (a), very weak stain in ventricular endocardia (v). 
(D) Representative gonad sections from TCB treated fish. Top: ovary of fish treated with 
5.0 mg/kg TCB and sampled on day 12, bottom: testis of fish treated with 0.1 mg/kg TCB 
and sampled on day 5. Sections showing strong/pervasive stain in vascular endothelia (e). 
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TABLE2 
CYPIAI Induction in Multiple Cell Types ofTCB-Treated Fish on Day 5 
0.1 mglkg TCB 5.0 mg/kg TCB 
Cell Type Intensity a Prevalence b Intensity Prevalence 
Liver 
hepatocyte +++ +++ +I++ +++ 
pancreatic epithelium + +++ + +++ 
sinusoidal endothelium +++ ++ ++ ++ 
Kidney 
renal tubule ++I+++ +++ +1++1+++ +++ 
renal duct +I++ +++ +I++ +++ 
vascular endothelium +++ +++ ++I+++ +++ 
Gill 
epithelium (non-proliferative) ++I+++ +I++ ++I+++ ++ 
pillar endothelium ++I+++ +++ ++I+++ +++ 
Intestine 
duodenal mucosa +I++ +++ +++ +++ 
caecal mucosa ++ +++ ++I+++ +++ 
vascular endothelium ++I+++ ++ ++I+++ ++ 
Spleen (day 12) c 
arteriole endothelium +++ +++ +++ +++ 
capillary endothelium ++ +++ 
Heart 
atrial endocardium +++ +++ ++I+++ +++ 
ventricular endocardium ++ +++ ++ +++ 
bulbus endocardium ++I+++ +++ ++I+++ +++ 
bulbus capillary endothelium -I+ ++ 
Gonad 
ovary endothelium ++I+++ ++I+++ ++I+++ ++I+++ 
testis endothelium +++ +++ ++I+++ ++I+++ 
a Intensity is the density of peroxidase stain ( + = weak, ++ = moderate, +++ = strong) 
b Prevalence is the frequency of stained cells (+=rare,++= multifocal , +++=pervasive) 
c Spleen was not sampled on day 5, so day 12 scores are shown 
Note: in vehicle-treated fish, the only cell types staining for CYPlAl were gill pillar 
endothelium and atrial endocardium, as described in Results. 
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fold difference in dose: pancreatic tissue of liver, gill pillar endothelium, endocardium of 
the major vessels in all three heart chambers, and vascular endothelium of intestine, spleen 
(major arterioles), and gonad. In a few cell types, induction was stronger (either more 
intense or more prevalent) in fish treated with the high TCB dose: gill epithelia (day 1), 
intestinal mucosa, and capillary endothelia of spleen and bulbus arteriosus. Interestingly, 
induction was stronger in some epithelial cell types in the fish treated with the low TCB 
dose: hepatocytes (day 5), renal collecting ducts and tubules, and total gill epithelia (the 
mean of proliferative and non-proliferative cells). 
In every organ of each fish examined, induction was seen in one or more cell types 
within 24 hours of treatment. CYP1A1 content reached a peak of prevalence and intensity 
on day 5 in the following epithelia: hepatocytes, renal tubules, and intestinal mucosa. In 
contrast, the CYP1A1 stain in the vascular endothelium of these three organs reached a 
peak of prevalence and intensity on day 12. In several epithelial cell types, there was the 
suggestion of attenuation of CYP 1 A 1 signal by day 16, particularly in fish treated with 0.1 
mglkg TCB (Fig 4). This is consistent with our finding (chapter 2) that hepatic TCB 
residues decline in these fish by day 16. By contrast, CYP 1 A 1 induction in the 
endothelium of most organs did not decline by day 16 at either dose. In fact, CYP1A1 
induction remained moderate to strong in vascular endothelium of every organ examined in 
a single fish that was treated with 0.1 mg/kg TCB and killed on day 34 after treatment (data 
not shown). These findings are consistent with those of Hahn and Stegeman (1994), who 
found sustained CYP1A1 induction in microsomal preparations of heart and gill from scup 
treated with the Ah receptor agonist 2,3,7,8-tetrachlorodibenzofuran. The sustained 
induction in the latter study may have been due largely to an induction in endothelial cells of 
heart and gill. 
Vascular endothelium CYP1A1 was induced in vascular endothelium of every 
organ examined, and in some tissues (spleen, heart, gonad) this was the only cell type 
showing CYP1A1 induction, consistent with earlier observations in scup (Smolowitz et al., 
1991). With intraperitoneal treatment, TCB may be absorbed directly into the bloodstream 
without first passing through the liver or intestine for possible metabolism. Rapid blood-
mediated distribution ofTCB is indicated by moderate CYP1Al induction in vascular 
endothelium of organs throughout the body, within 24 hours of TCB treatment. 
CYPlAl induction in vascular endothelium and endocardium generally did not 
differ between the two TCB doses. In some organs (liver, kidney, gonad), the mean score 
for CYPlAl staining on day 5 was greater at the low dose than at the high dose (Table 2), 
but in each case the induction increased between days 5 and 12 (Fig 5), such that equal, 
strong endothelial induction was seen on day 12 in all organs. Equivalent induction by the 
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two doses may suggest that the low dose was sufficient to elicit maximal CYPlAl 
induction in this cell type. Conversely, the equivalent induction suggests that the high dose 
did not cause a reduced CYPlAl induction in this cell type, as it did in some epithelia 
(discussed below). Alternatively, it is possible that our staining and scoring methods 
cannot discern subtle differences in degree of induction in these small cells. In studies with 
cultured porcine aorta endothelial cells, degree of CYP 1 A 1 induction has been found to be 
directly correlated with TCB dose, with the exception of cells treated with very high doses 
(Stegeman et al., in press), demonstrating that vascular endothelia can express greater 
CYPlAl in response to greater inducer concentration. A dose-response study with fish 
endothelial cells is needed. 
Gonad Vascular endothelium was the only cell type showing CYPlAl induction in 
either male or female gonad. Even toxic TCB doses (5.0 mg/k.g) still did not elicit 
CYP1A1 induction in germinal cells. Similarly, in female fathead minnow exposed to TCB 
via the water, endothelium was the only cell type that stained for CYPlAl in ovary, despite 
appreciable TCB accumulation in this organ (Lindstrom-Seppa et al ., 1994). In an earlier 
study of TCB-treated scup (Smolowitz et al., 1991 ), weak induction was noted in 
ovigerous lamellar epithelium and spermatic duct epithelium, but no induction was seen in 
eggs or sperm. 
Heart As in the present study, other recent investigations of fish treated with 
CYP 1 A 1 inducers have found stronger CYP 1 A 1 induction in atrial endocardium than in 
endocardial cells of ventricle or bulbus arteriosus (Smolowitz et a!. , 1991; Stegeman et al., 
1991). This is the first report of CYPlAl induction in a cell type of the bulbus arteriosus 
that we have tentatively identified as capillary endothelium. Induction in this cell type was 
seen weakly in many fish exposed to 5.0 mg/k.g, and very weakly in two fish exposed to 
0.1 mglk.g TCB. A similar pattern of induction to that in bulbus arteriosus was seen in 
spleen endothelium, and is discussed below. 
Spleen CYPlAl was strongly induced in the vascular endothelium of the major 
arterioles of spleen at both TCB doses. Additionally, there was a distinct, though 
moderate, induction in the capillary endothelium of many fish treated with 5.0 mglk.g TCB. 
This is consistent with a greater penetration of TCB into the organ at higher doses. We 
speculate that at lower TCB doses, CYPlAl in endothelia of major arterioles may be 
capable of binding and sequestering a large fraction of the TCB, thereby preventing 
downstream flow of the compound. A similar sequestering function has been postulated 
for CYP1A2 binding of TCDD in mouse liver (Poland et al., 1989). At higher TCB doses, 
however, a greater concentration of TCB in blood may exceed the endothelial cells' 
"capacity" for sequestration, allowing CYPIAI induction by TCB in downstream cells. 
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The capillary endothelia in the present study consistently stained more weakly than did the 
arteriole endothelia, possibly indicating that a lower concentration of inducer was reaching 
the capillaries, and consistent with inducer sequestration in the arterioles. This finding 
further supports our suggestion (Stegeman et al., 1989; Smolowitz et al., 1991) that 
vascular endothelium may serve as a first site of defense against blood-borne xenobiotics in 
many vertebrate organs. The hypothesis regarding inducer sequestration is currently being 
tested in teleost endothelial cells. 
Intestine CYPlAl induction in mucosal epithelia occurred primarily along the 
lumenal edge of cells, the edge that comes into contact with gut contents, in fish treated 
with 0.1 mglkg. In fish treated with 5.0 mg/kg, induction in mucosal epithelia was more 
intense at the lumenal edge and penetrated further into the cells from the lumenal face. 
Studies with mice and rats indicate that a substantial fraction of administered TCB is 
excreted in feces, both as parent compound and as metabolites (Yoshimura et al., 1987; 
Klassen Wehler et al., 1989), thus necessitating passage through the intestine. In fish too, 
PCB has been found to be excreted as parent compound in bile (Stein et al., 1984). We 
report the presence of both TCB and TCB metabolites in the bile of these scup (White et 
al., in preparation). Bile residue data indicate that metabolite production was suppressed in 
fish administered 5.0 mg/kg TCB, as compared to those treated with 0.1 mg/kg, possibly 
due to lower hepatic CYP1A1 content in the high-dose group. Thus fish treated with the 
low dose had appreciable quantities of TCB metabolites and very little parent TCB in bile, 
whereas those treated with the high dose had small amounts of metabolites and very high 
concentrations of parent TCB in bile (White et al., in preparation). Given the lumenal 
induction in mucosal epithelia and given the TCB in bile, we assume a biliary route of 
exposure of intestinal mucosa to TCB. The bile residue data imply that mucosal epithelia in 
fish treated with 5.0 mg/kg were exposed to far higher concentrations of TCB than were 
the mucosal epithelia in fish treated with 0.1 mg/kg, explaining the substantial difference in 
degree of CYPIAl induction between doses. The intensity of CYPIAl induction was 
similar in duodenal and caecal sections, both of which are located near the site where the 
bile duct drains into the intestine in scup. 
Gill CYPlAl induction in both gill pillar (endothelial) cells and gill epithelial cells 
was heterogeneous at both TCB doses, with cells of each type variously staining weakly, 
moderately, or strongly. In the present study the fish were held in a constant flow-through 
tank, thus TCB was unlikely to accumulate in the water, and gill was likely exposed via the 
bloodstream. Among the fish treated with 0.1 mglkg TCB, CYPlAl content in gill 
microsomes peaked at a later time point than did CYP1Al in liver and kidney microsomes 
(Fig 1 ), indicating that TCB content may have peaked later in gill. This is in agreement 
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with prior studies showing a much slower apparent elimination of PCB from gill than from 
any other organ of treated fish (Guiney et al., 1977; O'Connor and Pizza, 1987), and is 
consistent with gill being a major site of PCB egress from the organism, as has been 
suggested previously (O'Connor and Pizza, 1987; Miller et al. , 1989). 
TCB elicited a proliferation of epithelial cells between the secondary lamellae of gill , 
which was particularly pronounced in fish treated with 5.0 mg/kg. The newly formed 
epithelial cells did not stain for CYP1A1; epithelial cell induction was observed only on 
secondary lamellae without proliferation, or at the tips of secondary lamellae that had 
proliferating cells at the base (Fig 6D). Thus microsomal CYP1Al in gill was greater at the 
low dose than at the high dose, since substantially less gill tissue was composed of 
proliferating epithelia at the low dose. Our results are consistent with a growing body of 
evidence suggesting that Ah receptor acts differently in proliferating and differentiating 
cells, often showing a lower responsiveness in actively proliferating epithelia (e.g. Traber 
et al. , 1992). In the present study, administration of an Ah receptor agonist apparently 
affects cell proliferation, and such proliferation in tum seems to affect Ah receptor action. 
Kidney CYP 1 A 1 induction in renal tubules was heterogeneous at both TCB doses, 
with whole tubule cross-sections staining either weakly, moderately, or strongly for 
CYPIA1 content. Heterogeneity of induction in renal tubule epithelia has been noted 
previously in studies of fish exposed to Ah receptor agonists (Smolowitz et al. , 1991 ; 
Smolowitz et al. , 1992), but has not previously been described quantitatively. In fish 
treated with the high dose, a smaller percentage of the tubules stained strongly, and a 
greater percentage stained weakly, than in fish treated with the low dose (Table 1). Thus 
microsomal CYP1A1 content, a measure of mean expression across the tissue, was greater 
at the low dose. 
In a separate study describing the histopathology of these fish (chapter 4 ), we 
report that TCB treatment elicited degeneration and necrosis of renal tubules. By day 12, 
TCB-treated kidneys displayed chronic necrosis mixed with regeneration, indicated by the 
presence of both necrotic tubular epithelia and new, cuboidal epithelia. Fish treated with 
the high dose displayed more cell necrosis, and hence more generation of new tissue, than 
did fish treated with the low dose. The weakly irnmunostaining foci in kidney sections 
from high-dose fish included both strongly necrotic tubules and seemingly healthy, 
regenerated tubules. We therefore speculate that the weaker overall induction in renal 
epithelia at the high dose may have been related to tissue pathology: severely necrotic cells 
and newly formed cells may generally express less CYPIA1 than do older, healthier cells. 
Liver In the livers of animals sampled on day 5, CYPIAl staining in hepatocytes 
was strong/ pervasive in those treated with 0.1 mglkg, and was weak to moderate/ 
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pervasive in those treated with 5.0 mg/kg. Thus the "reduced" induction in the liver of fish 
treated with the high TCB dose was qualitatively different from that in kidney and gill. 
Whereas the kidney and gill of fish treated with 5.0 mglkg had a reduced percentage of 
strongly staining epithelial cells, the liver of these fish had weaker CYP1A1 staining in 
most if not all hepatocytes. A difference between doses was only apparent on day 5 (Fig 
4A); by day 12 the induction remained at a moderate level in the high-dose fish, and had 
already begun to decline in the low-dose fish. These results are confirmed by immunoblot 
data (Fig 1), which indicate a sizable difference in hepatic CYP1A1 content between doses 
on day 5, followed by a decline in CYP1A1 content at the low dose and a consequent 
closing of the "gap" between doses. 
In sinusoidal endothelium, by contrast, CYP1Al was generally induced to the same 
degree by both TCB doses. Although mean endothelial induction was stronger on day 5 at 
the low dose than at the high dose, induction increased between days 5 and 12 at the high 
dose (unlike in the hepatocytes), such that strong and pervasive induction occurred on day 
12 at both doses . The difference in time-course for endothelial induction by the two doses 
may be due to differences in TCB disposition at the two doses: we found that hepatic TCB 
concentration peaked on day 5 at the low dose, and on day 12 at the high dose (chapter 2). 
The "suppressed" induction in liver epithelia, but not endothelia, may be due to greater 
TCB concentration in epithelia than in endothelia, as has been found in studies of rat treated 
with TCB by intraperitoneal injection (Durham and Brouwer, 1989). In addition, 
differences between epithelial and endothelial CYP1A1 content may be related to different 
rates of substrate turnover by CYP1Al in the two cell types (see below). 
Although CYP1A1 was induced to an equal extent by the two TCB doses in 
endothelial and pancreatic cells of the liver, total microsomal CYP1Al was significantly 
higher in livers of fish receiving the low TCB dose. Morphometric analysis of trout liver 
indicates that approximately 80% of the liver volume is occupied by hepatocytes (Hampton 
et al., 1989). Thus differences in CYPlAl expression in hepatocytes largely shape the 
profile seen in liver microsomes. 
Further analysis of hepatic microsomes from these scup (chapter 2) indicated that 
CYP1A1 was the only enzyme with strongly reduced content in animals treated with 5.0 
mg/kg TCB. All other enzymes examined (cytochrome b5, NADPH cytochrome c 
reductase, UDP glucuronosyl transferase, the putative scup CYP2B, and the putative scup 
CYP3A) were expressed at nearly equal levels in livers of fish treated with 0.1 mglkg and 
5.0 mglkg. Furthermore, in vitro studies in liver (chapter 2) indicate that TCB occupation 
of the CYP1Al active site promotes the inactivation of CYP1Al in the presence of 
NADPH, which appears to involve the production of H202 or other reactive oxygen 
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species in the active site. We speculate that a similar mechanism may cause CYPIAl 
inactivation and degradation in vivo, and thus may account for the reduced content of 
immunodetectable CYPIAI in hepatic microsomes (Fig 1) and liver sections (Fig 3C) of 
fish treated with a high TCB dose. 
Whether TCB elicits the production of reactive oxygen in other tissues, and the 
resultant effects, are not now known. It is possible that reactive oxygen is partially 
responsible for the pathology seen in gill and kidney, and for the reduced CYPIAI content 
in gill and kidney epithelia of fish treated with 5.0 mg/kg TCB. It is noteworthy that 
"suppressed" CYP1A1 content at the high TCB dose was only seen in epithelial cells; 
endothelia of all organs examined had equally strong CYP1Al induction at the two doses. 
Prior investigations (Stegeman et al., 1982; Stegeman et al., 1989) indicate that the ratio of 
NADPH cytochrome c reductase : cytochrome P450 is ten-fold lower in scup heart (where 
all of the P450 is endothelial) than in scup liver (where most of the P450 is epithelial). 
Limiting quantities of reductase enzyme in endothelia may be expected to result in lower 
P450 catalytic activity in these cells, even with highly induced P450 content. If the rates of 
electron transport and substrate turnover are lower for endothelial CYPIA1 than for 
epithelial CYP1 A 1, the endothelia may have a lower potential to produce reactive oxygen 
species in the presence of TCB, which appears to be linked to suppressed enzyme content. 
It is possible that reactive oxygen species also contribute to the cell proliferation that has 
been observed in several organs of these TCB-treated scup (Moore et al., in preparation). 
All of these questions will warrant further examination, with both in vitro and in vivo 
studies. 
In summary, dose-response patterns for CYP1Al induction were found to differ 
substantially between cell types, with epithelia displaying a broader range of response than 
endothelia. The pervasiveness and persistence of CYP1Al in endothelium provides further 
evidence of the potential significance of CYPlAl induction in this cell layer of vertebrate 
organs, and is particularly noteworthy in light of the finding that endothelium is the most 
common site of induction in fish that have been chronically exposed in the wild (Stegeman 
et al. , 1991). Of the epithelia examined, intestinal mucosa responded to the higher dose 
with stronger induction, showing no signs of toxicity. Epithelial cells of liver, kidney, and 
gill showed lower overall induction in response to the higher TCB dose. Several factors 
may contribute to this unexpected response, including Ah receptor-mediated toxicity to 
epithelial cells, toxicity caused by the in situ production of reactive oxygen species, and 
oxidative inactivation of CYPIAI due to active-site binding by TCB. 
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CHAPTER FOUR 
Histopathological Analysis of 3,3',4,4'-Tetrachlorobiphenyl 
Toxicity in Multiple Organs of the Marine Fish Scup: 
a Time-Course and Dose-Response Study 
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Abstract 
Coplanar polychlorinated biphenyl (PCB) congeners elicit a suite of toxic effects in 
mammals, similar to those seen following treatment with 2,3,7,8-tetrachlorodibenzo-p-
dioxin, that are believed to be mediated by binding to the cytosolic Ah receptor. Although 
PCBs are widespread contaminants in marine environments, very little work has addressed 
the histopathology of fish treated with PCB, particularly in extrahepatic organs. In the 
present study the marine fish scup (Stenotomus chrysops) was treated with the Ah receptor 
agonist 3,3',4,4'-tetrachlorobiphenyl (TCB) by a single intraperitoneal injection at two 
doses, 0.1 mg/kg and 5.0 mg/kg. At time points from 1 to 16 days after treatment, groups 
of animals were killed and several tissues were fixed and stained for examination under 
light microscopy. Residue analysis indicated that hepatic TCB concentration was maximal 
on day 5 in fish administered 0.1 mg/kg, and on day 12 in fish administered 5.0 mg/kg, 
followed by a decline in TCB content at both doses. In all TCB-treated fish there was an 
increased basophilia of hepatocytes, suggesting proliferation of endoplasmic reticulum and 
a loss of lipid and glycogen stores. Hepatocyte nuclei were enlarged but regular in some 
TCB-treated fish . TCB-treated fish had a greater number of melanomacrophage aggregates 
in spleen than did vehicle-treated fish. In kidney, TCB treatment induced a dilation (day 5) 
and eventual necrosis (day 12) of renal tubules, hypocellularity of hematopoietic tissue, and 
disaggregation of melanomacrophage aggregates. Fish treated with 5.0 mg/kg TCB had 
aneurysm of gill tissue, and both TCB doses elicited hyperplasia of epithelial cells between 
the secondary lamellae of gills. Treatment with 5.0 mglkg TCB caused an apparent tail fin 
erosion in fish sampled on days 12 and 16, which was detectable in histological sections as 
inflammation and necrosis in epithelial tissue and an erosion of the calcified bone matrix. 
Plasma chemistry analysis indicated that treatment with 0.1 mg/kg TCB caused no change 
in the concentrations of electrolytes or nitrogenous waste products, but did cause an 
elevation in aspartate aminotransferase. Most histological alterations were induced by both 
0.1 mg/kg and 5.0 mg/kg TCB, but pathology was generally more severe or more 
extensive in tissues of fish treated with the higher dose. At both TCB doses, organ damage 
increased with time from day 1 to day 12. Among the fish treated with 5.0 mglkg, organ 
damage was equally severe (on average) on days 12 and 16, despite some TCB depuration 
by day 16. Among the fish treated with 0.1 mg/kg, organ damage was less severe in fish 
sampled on day 16 than on day 12. This lessening of pathology was correlated with 
substantial TCB depuration from tissues between days 5 and 16, and may suggest repair of 
some lesions. Mortality was seen among the fish treated with 5.0 mg/kg TCB, possibly 
due an impairment of kidney and gill functions. 
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Introduction 
Polychlorinated biphenyls (PCB) are ubiquitous and persistent contaminants in the 
marine environment (Tanabe, 1988; Fowler, 1990), that elicit a wide range of toxic effects 
in mammals including reproductive impairment, neurotoxic, genotoxic, hepatotoxic, and 
immunotoxic effects (reviewed in Safe, 1984; Safe, 1992). Far less is known about PCB 
toxicity in teleost species, but effects are thought to include growth inhibition, impaired 
bone development, reproductive impairment (reviewed in McFarland and Clark, 1989), and 
immune suppression (Spitsbergen et al. , 1988c). 
Liver histopathology in PCB-exposed fish has been examined in several studies. 
Some investigators have observed degenerative changes in liver of fish from PCB-
contaminated sites, including preneoplastic and neoplastic lesions (Myers et al., 1992; Dey 
et al., 1993), increase in size and number of melanomacrophage centers, hepatocellular 
hypertrophy, increased fatty vacuolation, and cell necrosis (Pierce et al., 1978). Fewer 
investigations have described liver pathology induced by controlled laboratory exposure of 
fish to PCB mixtures (Aroclors). Such studies have documented vacuolation of 
hepatocytes, dilation of rough endoplasmic reticulum in hepatocytes (Sivarajah et al., 
1978), irregular structure of hepatocyte nuclei (Hacking et al., 1978), and increased content 
of smooth endoplasmic reticulum in hepatocytes (K.launig et al., 1979). In contrast to the 
thorough investigations of teleost liver, very little information is available concerning PCB 
histopathology in extrahepatic organs of fish , and to our knowledge no studies have 
examined cellular alterations associated with exposure of fish to individual PCB congeners. 
3,3',4,4'-Tetrachlorobiphenyl (TCB) is a coplanar PCB congener and an Ah 
receptor agonist, thus belonging to the class of PCBs that elicit TCDD-like toxicity in 
mammals (reviewed in Goldstein and Safe, 1989). TCB is a potent inducer of the 
CYP1A1 homologue in fish (Gooch et al., 1989), that is metabolized slowly by teleost 
CYP1A1 to aqueous-soluble products in vitro and in vivo (chapter 5). In the present study 
we treated the marine fish scup (Stenotomus chrysops) with TCB at two doses, 0.1 mg/kg 
and 5.0 mg/kg, and killed animals over a 16 day time-course for examination of 
histopathology under light microscopy. TCB treatment induced lesions and/or cellular 
alterations in liver, spleen, kidney, gill, and tail fin. Most alterations were seen to occur at 
both TCB doses, although pathology was generally more severe or more extensive in fish 
exposed to the higher dose. The severity of lesions increased with time from day 1 to day 
12 at both doses. Tissues of fish treated with the low dose and sampled on day 16 were 
little different from controls, possibly suggesting that repair of lesions occurred 
concomitantly with TCB depuration. 
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Materials and Methods 
Chemicals 3,3',4,4'-Tetrachlorobiphenyl (TCB, IUPAC #77) was purchased from 
Pathfinder (St. Louis, MO). Purity of TCB was greater than 99% by GC/ECD and 
GC/MS analysis. Further analysis by high resolution (5000 resolution) mass spectrometry 
(VG Autospec) and selective ion monitoring showed that the potent Ah receptor agonist 
3,3',4,4',5-pentachlorobiphenyl was not a contaminant of the TCB, with a detection limit 
of 0.001%. 
Animals and Dosing Scup (Stenotomus chrysops)were caught by angling in Vineyard 
Sound, MA in August, 1991. Fish were held in flowing seawater tanks at 20°C for 
fourteen months prior to experimental use, and were maintained on a diet of Purina trout 
chow and frozen squid. Prior studies in our laboratory indicate that the bulk of 
environmental contaminants are depurated from the tissues of fish that are held in aquaria 
for one year, and that these fish show little CYP1A1 expression. At the time of the dosing, 
experimental animals (mixed sex) were gonadally immature and weighed 76 - 276 grams. 
Individuals were injected intraperitoneally with either corn oil (vehicle controls) or with 0.1 
mg/kg or 5.0 mg/kg 3,3' ,4,4'-tetrachlorobiphenyl (TCB) dissolved in com oil. A group of 
uninjected fish was used as a "zero" point in the time-course. Individuals were held in 
flowing seawater tanks at 20°C until sampling (1 day to 18 days) or until death from 
toxicity. Fish were fed Purina trout chow once weekly, and were never fed within the 
three days prior to killing. At each time point, a group of 4 or 5 animals from each 
treatment group were killed by cervical transection and dissected immediately. 
Histology Sections of liver, posterior kidney, gonad, heart, gill, spleen, intestinal caecum, 
and intestinal duodenum were removed from animals upon killing and immediately fixed in 
10% neutral buffered formalin (pH 7.4). Spleen was sampled on days 0, 12, and 16/18 
only, all other tissues were sampled at each time point. In addition, sections of tail fin were 
dissected from some fish sampled on day 16118, and these were de-calcified prior to 
embedding. After one week of fixation, tissues were embedded in paraffin using standard 
methods (Luna, 1968). Five J..Lm sections were cut from paraffin blocks, mounted on 
slides, and stained with hematoxylin and eosin (H&E). H&E-stained slides were examined 
under light microscopy for evidence of histopathology in all tissues. 
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Scoring of histopathology In the organs in which TCB treatment consistently elicited 
histopathology (liver, spleen, kidney, and gill), subjective indices were developed to 
measure the degree of alteration. Liver sections were scored for basophilia of hepatocytes, 
as follows: 
(0) hepatocyte cytoplasm is mostly white, apparently full of lipid or glycogen; 
(1) hepatocyte cytoplasm has diffuse, light purple coloring with some white patches; 
(2) hepatocyte cytoplasm is filled with hazy, purple/pink coloring under H&E stain; 
(3) hepatocyte cytoplasm is deep purple/blue under H&E stain. 
The number of melanomacrophage centers in spleen sections was determined by 
counting the number of discrete aggregates, on 1 OOx magnification, for three randomly 
selected fields on each slide. A number was determined for each individual fish spleen by 
averaging the three counts. 
Kidney sections were scored for severity of renal tubule lesions, as follows: 
(0) tubules are composed of normally-shaped cuboidal cells , most have small lumen; 
(1) tubule epithelia are still cuboidal, but many or most tubules have dilated lumen; 
(2) many tubule epithelia are flattened and some are necrotic, most tubules are dilated; 
(3) tubules contain both flattened (degenerative) and cuboidal (regenerative) epithelia, 
most tubules have necrotic epithelia and debris in lumen; 
(4) similar to (3), but almost all tubules have necrotic epithelia. 
Kidney sections were also scored for depletion of hematopoietic tissue, as follows: 
(0) compact arrangement of hematopoietic cells, occurring between most renal tubules; 
(1) loose arrangement of hematopoietic cells, resulting in clusters of renal tubules without 
hematopoietic cells among them; 
(2) multifocal arrangement of hematopoietic cells, with many small patches in 100x field; 
(3) sparse arrangement of hematopoietic cells, with few small patches in 100x field. 
Gill sections were scored for hyperplasia of epithelial cells, as follows: 
(0) a thin layer or double layer of epithelial cells surrounds each secondary lamella; 
(1) small foci of epithelial hyperplasia occur between few secondary lamellae, on few 
primary gill filaments, causing fusion of adjacent secondary lamellae in these foci; 
(2) foci of hyperplasia occur on moderate number of secondary lamellae, mostly at the ends 
of the primary filament; 
(3) foci of hyperplasia occur between many secondary lamellae, from base to end of the 
primary filament; 
(4) epithelial hyperplasia is diffuse, resulting in adhesion of almost all secondary lamellae. 
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Plasma chemistry In a separate experiment, 3 scup were treated by intraperitoneal injection 
with com oil and 4 were treated with 0.1 mg/kg TCB in com oil. Blood samples were 
drawn from all fish on day 12 through the caudal peduncle vein , using sterile syringes pre-
treated with lithium heparin (10 mg/rnl solution). Samples were centrifuged on low speed 
to separate cells from plasma, and plasma was stored at -20"C until analysis. Plasma 
chemistry was performed at the New York State Diagnostic Laboratory, Cornell University 
College of Veterinary Medicine, using a standard screening panel at 37"C. 
Photographs 35 rnm color slides (EPY 64 Tungsten Ektachrome) were taken of H&E-
stained microscope slides and scanned into Adobe Photoshop software (v. 2.5.1 for 
Macintosh) using a Kodak RFS 2035 slide scanner. Images were scaled and labeled using 
Adobe Photoshop, and were printed on a Kodak XL photographic printer. No image 
enhancement, contrast adjustment, or color adjustment was used to modify the figures . 
TCB residues Content of 3,3',4,4'-tetrachlorobiphenyl was quantified in pooled samples, 
consisting of liver or muscle sections from all fish within a treatment group. Subcutaneous 
muscle tissue was sampled from the side of body, mid-way between the head and tail, just 
below the lateral line. Tissue extraction followed AOAC Method 983.21 (Helrich, 1990). 
Samples were mixed with sodium sulfate and pet ether, homogenized, and serially 
extracted with pet ether. Extracts were cleaned up on a Florisil column and concentrated 
under nitrogen. Extracts were analyzed for TCB by gas chromatography with electron 
capture detection (GC/ECD) using an HP 5890 Series II GC/ECD. Confirmation of the 
TCB was performed by gas chromatography with mass spectrometry (GC/MS) using an 
HP 5890/5970 GC/MS by monitoring molecular ions I 10, 150, 184, 220, 222, 290, 292, 
and 294. The fragmentation pattern of each sample was compared to the TCB standard and 
TCB was quantified with rnlz 292. Measured concentrations of TCB were corrected for 
extraction efficiency using the recovery of 4,4'-dibromooctafluorobiphenyl (DBOFB) 
which was spiked into each sample prior to extraction, and were quantified relative to the 
internal standard 2,4,5,6-tetrachloro-m-xylene (TCMX). Recoveries of DBOFB ranged 
from 60 to 96% with an average of 76%. The average recovery of TCB matrix spikes was 
110%. The precision of duplicate analyses was within 3%. Data were obtained as TCB 
content per g tissue wet weight. Sample dry weight and sample lipid weight were 
measured for a few representative tissue samples. 
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Results 
Cumulative mortality 
None of the fish treated with eith<?r vehicle or with 0.1 mg/kg TCB died over the course of 
the experiment. Among the fish treated with 5.0 mg/kg TCB, the rate of mortality 
increased with time following injection (Fig I). Thus, between days 0 and 4 none of the 
treated fish died; between days 4 and 5 only one fish died out of a total of 20 that were 
treated with this dose and not yet sampled; between days 5 and 12, three fish died out of 
the 14 remaining; and between days 12 and 16 one-third of the remaining fish (2/6) died. 
The increase in mortality with time may be attributed to a severe deterioration of kidney and 
gill tissue, and possible loss of function , following treatment with 5.0 mg/kg TCB (see 
below). 
Gross effects of TCB 
For each animal, a morphometric condition index (body weight/ length squared), 
hepatosomatic index (liver weight/ body weight) and gonadosomatic index (gonad weight/ 
body weight) were determined at the time of death. Neither condition index (Fig 2A) nor 
hepatosomatic index (Fig 2B) was significantly altered by either TCB dose, at any time 
point following TCB treatment. Gonadosomatic index was also unaffected by the 
treatments, and the values indicated that animals were not reproductively active at the time 
of the experiment (males: 0.05 ± 0.02; females: 0.52 ± 0.11). 
Gross pathology was noted among the fish treated with 5.0 mg/kg TCB. On days 
12 and 16, most animals treated with this dose had pale gill tissue displaying aneurysm, 
pale-colored livers, and eroded tail fins. Three fish (I on day 12, 2 on day 16) had thin, 
red fluid in the intraperitoneal cavity, and one fish (day 16) had a grossly swollen bladder 
full of retained urine. None of the experimental animals, including those that died 
spontaneously, exhibited signs of peritonitis, suggesting that gross pathology and mortality 
were due to TCB itself and not to improper injection. 
Liver histopathology 
A marked basophilia of hepatocytes, indicative of proliferation of endoplasmic reticulum 
and of a loss of lipid and glycogen reserves, developed in all TCB-treated fish over the 
time-course of the experiment. This was scored with a subjective index of severity, as 
described in Methods, and scores for each treatment group are plotted for comparison (Fig 
3A). In untreated and control (vehicle-treated) fish, hepatocytes were strongly vacuolated, 
probably resulting from heavy accumulation of lipid and glycogen, which are artifactually 
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Figure 1. Cumulative mortality in treated fish. X-axis is the number of days subsequent to 
TCB injection. Plotted on they-axis is the percent survival of treated fish during each 
sampling "interval" (i.e. the spaces of time between sampling points). Indicated in 
parenthesis is the number of fish that died during a sampling interval, divided by the 
number of treated fish alive at the beginning of the interval. 
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Figure 2. Condition index (A) and hepatosomatic index (B) in treated fish . Condition 
index was measured as body weight divided by the square of body length, hepatosomatic 
index was measured as liver weight divided by body weight. X-axis is number of days 
subsequent to TCB injection, y-axis is index. Each point represents the mean and standard 
deviation (n-1) of measurements on four or five fish per treatment group. Plot symbols 
are: square, com oil control, open circle, 0.1 mglkg TCB, closed circle, 5.0 mg/kg TCB . 
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Figure 3. Histopathology in treated fish, based on subjective scores of severity as 
described in Methods. (A) degree of basophilia in hepatocytes, (B) severity of damage to 
renal tubules, (C) loss of hematopoietic tissue in kidney, (D) extent of epithelial hyperplasia 
in gill. X-axis is number of days subsequent to TCB injection, y-axis is score. Each point 
represents the mean and standard deviation (n-1) of the scores for four or five fi sh per 
treatment group. Plot symbols are: square, corn oil control, open circle, 0.1 mglkg TCB, 
closed circle, 5.0 mglkg TCB. 
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Figure 4. H&E stained slides of liver and spleen. (A) Liver of fish treated with com oil 
and sampled on day 12 (lOOOx). Note small nuclei and light cytoplasm. (B) Liver of fish 
treated with 0.1 mg/kg TCB and sampled on day 12 (1000x). Note larger nuclei, diffuse 
stain in cytoplasm, and cytoplasmic vacuoles (v). (C) Spleen of fish treated with com oil 
and sampled on day 12 (200x). Melanomacrophage aggregate is indicated (m). (D) 
Spleen of fish treated with 5.0 mglkg TCB and sampled on day 12 (200x). 
Melanomacrophage aggregates are indicated (m). 
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removed during tissue processing. This results in a predominantly light-colored cytoplasm 
under H&E stain (Fig 4A). From day one until day five after TCB treatment, a diffuse 
coloring developed in the cytoplasm of hepatocytes from fish treated with either dose, and 
by day 12, an extreme basophilia typified hepatocytes from fi sh treated with the high dose 
(Fig 4B). Round cytoplasmic vacuoles, 3-4 Jlm in diameter, were seen in many TCB 
treated fish (Fig 4B), which may represent low levels of lipid and glycogen remaining in 
liver. Irregularly shaped vacuoles were al so seen in hepatocytes of TCB treated fish , 
giving a foamy appearance to the cytoplasm (Fig 4B). The latter vacuoles may be the result 
of swelling of endoplasmic reticulum or other organelles. 
Some TCB treated fish had enlarged, regular nuclei (Fig 4B, as compared to 4A), 
indicating activity. No changes were detected in hepatic macrophages. 
Spleen histopathology 
All fish treated with TCB had an increased number of melanomacrophage aggregates in the 
spleen (Table 1 ). Whereas control fish had sparsely di stributed melanomacrophage 
aggregates which were general ly round in shape (Fig 4C), TCB treated fish had a larger 
number of smaller, more irregularly shaped aggregates (Fig 4D). TCB treatment thus 
brought about an increased number of individual aggregates, but may not have brought 
about an increased number of melanomacrophage cell s per unit area. In fish treated with 
the high dose, we also observed a more "open" architecture to the spleen (Fig 4D), with 
extensive acellular space, suggestive of edema. 
TABLE! 
Number of Melanomacrophage Aggregates in Spleen of TCB-Treated and Control Fish 
day corn oil I control 0 . 1 mg/kg TCB 5.0 mg/kg TCB 
(n = 4) (n = 5) (n = 5) 
0 38 ± 12 
12 39 ± 8 77 ± 8 109 ± 26 
16/1 8 29 ± 14 50± 16 95 ±43 
For each fish, the number of aggregates was counted in three random fields at lOOx, and 
averaged. Values presented are mean ± standard deviation for four or five fish in each 
treatment group. "Day 0" fish were untreated, TCB-treated fish were killed on days 12 and 
16, and corn oil treated-fish were killed on days 12 and 18. 
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Kidney histopathology 
TCB treatment induced a marked necrosis of renal tubules (Fig 3B), which was scored in 
each fish with a subjective index of severity, as described in Methods. In untreated and 
vehicle-treated fish, renal tubules were characterized by an even layer of cuboidal cells and 
a small lumen, clusters of hematopoietic cells were found throughout the tissue and 
surrounding most tubules, and macrophages occurred in discrete, round-shaped aggregates 
(Fig SA). Following TCB treatment there was a dilation of the renal tubule lumen (day 1-
2), followed by a squamous metaplasia, or flattening, of tubule epithelia (Fig 5B; day 5), 
which implies necrosis and shedding of renal epithelial cells. Also seen in this figure are 
cross-lumenal tags connecting epithelial cells on opposite sides of the tubule, which 
characterized many TCB-treated fish kidneys. By day 12 (Fig 5C), kidneys displayed 
chronic necrosis mixed with regeneration. Degeneration was indicated by foci of 
squamous epithelia, and regeneration was indicated by the presence of large, basophilic, 
cuboidal epithelia in many tubules. Also seen in this figure is mineralized, intralumenal 
debris , which was typical for kidneys of fish treated with 5.0 mg/kg and sampled on day 
12. Such condensed debris may be associated with tubule dilation and obstruction. 
Vacuolation within tubule epithelia was seen on day 12, suggesting fluid accumulation in 
the cells. 
A loss of hematopoietic tissue accompanied kidney tubule degeneration. This was 
also scored over time with a subjective index, as described in Methods (Fig 3C). The 
quantity of renal hematopoietic tissue ranged from a continuous network (Fig SA; control), 
to a multifocal distribution (Fig 5B; day 5), to a sparse distribution (Fig 5C; day 12). A 
similar depletion of kidney hematopoietic tissue was induced by TCDD in rainbow trout, 
perch, and lake trout sac fry (Spitsbergen et al., 1988a; Spitsbergen et al., 1988b; 
Spitsbergen et al., 1991). By day 12, kidneys were characterized by extensive acellular 
space between tubules and within foci of hematopoietic tissue, suggesting edema (Fig 5C). 
Melanomacrophage centers in kidney tended to disaggregate in TCB-treated fish, changing 
from discrete, round structures (control) into less-round, more granular structures (Fig 5B; 
day 5), and in some cases dispersing (day 12). Renal pathology occurred at both TCB 
doses, although it was generally more severe at the high dose (Fig 3B and 3C). By day 
16, kidneys of all fish treated with the low dose showed little pathology and resembled the 
kidneys of control fish. 
Gill histopathology 
Treatment with either dose of TCB was associated with a hyperplasia of epithelial cells 
between the secondary lamellae; this was more extensive at the high dose. The extent of 
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Figure 5. H&E stained slides of kidney and gill . (A) Kidney of fish treated with com oil 
and sampled on day 12 ( 400x). Section showing renal tubules (T in lumen), hematopoietic 
cells surrounding tubules. (B) Kidney of fish treated with 5.0 mglkg TCB and sampled 
on day 5 (400x). Section showing dilated renal tubules with squamous epithelia (Tin 
lumen), melanomacrophage aggregate in lower left, foci of hematopoietic cells. (C) 
Kidney of fish treated with 5.0 mg/k.g TCB and sampled on day 12 ( 400x). Section 
showing necrotic renal tubules (T in lumen) with intralumenal debris, small patch of 
hematopoietic cells in lower right. (D) Gill of fish treated with com oil and sampled on 
day 12 (400x). Section showing secondary gill lamellae on one primary filament. (E) Gill 
of fish treated with 0.1 mg/k.g TCB and sampled on day 12 (400x). Note hyperplasia of 
epithelial cells along primary lamella, causing adhesion at base of secondary lamellae (* 
indicates the outer edge of hyperplasia). (F) Gill of fish treated with 5.0 mg/k.g TCB and 
sampled on day 12 (400x). Arrows indicate the base and tip of each secondary lamella. 
Note hyperplasia of epithelial cells causing severe, diffuse adhesion of secondary lamellae 
(* indicates the outer edge of hyperplasia). 
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Figure 6. Scup tail fin. (A) Vehicle-treated scup showing no fin erosion (top), and TCB-
treated scup showing erosion of tail fin (bottom). (B) Superficial epithelial tissue from tail 
fin of fish displaying gross signs of fin erosion, treated with 5.0 mg/kg TCB and sampled 
on day 16 (400x). Section showing necrotic and swollen epithelia (arrows on some 
examples). (C) Calcified bone tissue from tip of tail fin, from same fish shown in B 
(1 OOx). Note the absence of cartilage and epithelia surrounding the ray, erosion along the 
border and within the matrix of the ray (arrows). (D) Tail fin of fish treated with corn oil 
and sampled on day 18 (1 OOx). Shown is segmented bone tissue (at center) surrounded by 
layers of cartilage. 
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revealed several alterations. Many superficial epithelia were necrotic, swollen, or 
vacuolated (Fig 6B). Both epithelial and cartilaginous tissue were eroded away at the tips 
of the fin, leaving exposed bone tissue (Fig 6C). In areas of bone that were thus exposed, 
irregular erosions occurred along the border and within the calcified bone matrix (Fig 6C). 
Many of these eroded spaces contained cell debris and possible inflammatory cells, which 
were also found in the epithelia. In tail fin of the vehicle-treated fish sampled on day 18, 
no epithelial necrosis was noted, nor did we see a loss of soft tissues around bone, or an 
erosion of bony tissues (Fig 6D). 
Histology of other tissues 
In most organs examined, vascular endothelium appeared to be histologically normal. TCB 
induced no apparent histological damage in most tissues of mesenchymal origin (muscle, 
heart), nor in gonad or intestinal mucosa. 
Plasma chemistry 
In a separate experiment, fish were treated with either vehicle or 0.1 mg/kg TCB, and 
plasma samples were drawn twelve days after treatment for chemical analysis (Table 2). 
The only parameter that was apparently affected by TCB treatment was aspartate 
aminotransferase (AST), which was elevated above control levels in two of the four TCB-
treated fish. Elevation in AST has been associated with hepatic disease in fish (Casillas et 
al., 1982). All other components analyzed in TCB-treated fish fell within the range of 
concentrations seen in vehicle-treated fish. 
Residue analysis 
TCB content was measured in pooled samples of liver and muscle tissue from each group 
of scup in the time-course study (Fig 7; Table 3). The concentration of TCB in muscle 
tissue reached a high peak in fish sampled one day after injection with either dose, and this 
dropped sharply by day 5 (0.1 mglkg dose) or by day 2 (5.0 mg/kg dose). In fish treated 
with 0.1 mglkg, the TCB content in liver reached a maximum concentration of 0.015 !lgl g 
liver dry weight on day 5. In fish treated with 5.0 mglkg, the TCB content in liver did not 
reach a maximum until day 12, at which time the concentration was 2.2 llg TCB/ g liver 
dry weight. At both doses, hepatic TCB content on day 16 was substantially lower than 
the hepatic peak concentration, indicating that the bulk of the dose was depurated over the 
time-course of the experiment. Analysis of bile residues indicated that this depuration was 
due to both metabolism and to the loss of parent compound (White et al., in preparation). 
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Plasma chemistry 
In a separate experiment, fish were treated with either vehicle or 0.1 mg/kg TCB, and 
plasma samples were drawn twelve days after treatment for chemical analysis (Table 2). 
The only parameter that was apparently affected by TCB treatment was aspartate 
aminotransferase (AST), which was elevated above control levels in two of the four TCB-
treated fish. Elevation in AST has been associated with hepatic disease in fish (Casillas et 
al., 1982). All other components analyzed in TCB-treated fish fell within the range of 
concentrations seen in vehicle-treated fish. 
Residue analysis 
TCB content was measured in pooled samples of liver and muscle tissue from each group 
of scup in the time-course study (Fig 7; Table 3). The concentration of TCB in muscle 
tissue reached a high peak in fish sampled one day after injection with either dose, and this 
dropped sharply by day 5 (0.1 mg/kg dose) or by day 2 (5.0 mglkg dose). In fish treated 
with 0.1 mg/kg, the TCB content in liver reached a maximum concentration of 0.015 Jlg/ g 
liver dry weight on day 5. In fish treated with 5.0 mg/kg, the TCB content in liver did not 
reach a maximum until day 12, at which time the concentration was 2.2 Jlg TCB/ g liver 
dry weight. At both doses, hepatic TCB content on day 16 was substantially lower than 
the hepatic peak concentration, indicating that the bulk of the dose was depurated over the 
tirrie-course of the experiment. Analysis of bile residues indicated that this depuration was 
due to both metabolism and to the loss of parent compound (White et al., in preparation). 
Administered TCB apparently distributed to muscle tissue first, and to liver later, at 
both doses. This is consistent with prior studies in our laboratory (Harris et al., 
unpublished data), in which fish were treated orally with 3,3',4,4',5,5'-
hexachlorobiphenyl (HCB). In that study, HCB concentration was relatively high in 
muscle tissue and low in liver at an early sampling point (day 2), followed by a reduced 
concentration in muscle with redistribution of HCB to other tissues including liver at a later 
sampling point (day 6). 
TCB concentration in muscle tissue was greater than that in liver tissue in almost 
every treatment group, when expressed as Jlg TCB/ g tissue dry weight (Table 3, top). 
Average lipid weights in the samples were 3.4% lipid in liver and 11.7% lipid in muscle. 
Thus, the much greater lipid content in muscle could account for the greater TCB 
concentration in this tissue, as PCBs tend to partition into lipid (Chiou, 1985). When TCB 
concentrations were expressed as Jlg TCB/ g tissue lipid weight (Table _3, bottom), liver 
concentrations exceeded muscle concentrations at several time points (Fig 7). 
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TABLE2 
Plasma Chemistry in Vehicle-Treated and TCB-Treated (0.1 mglkg) Fish 
vehicle (n=3) TCB (n=4) 
average st dev average st dev 
sodium a 151 7 159 8 
potassium a 5.6 0.5 4.9 0.8 
cWoride a 149 6 153 7 
C02 a 6 2 7 1 
calcium b 9.6 0.4 10.5 0.7 
phosphorus b 6.7 1.6 6.4 0.7 
total protein c 1.7 0.3 1.8 0.4 
albumin c 0.3 0.1 0.3 0.0 
globulin c 1.4 0.3 1.5 0.3 
urea b 8.0 3.6 4.8 1.3 
creatinine b 0.2 0.1 0.2 0.1 
glucose b 77 15 99 14 
cholesterol b 112 52 125 50 
ALTd 3 2 3 
ASTd 44 17 89 51 
Alk Phos d 6 8 12 2 
GGTd 1 2 
bilirubin b 0.6 0.3 0 .5 0.4 
uric acid b 0.1 0.0 0.1 0.1 
Blood was drawn from the caudal peduncle vein, 12 days after intraperitoneal treatment 
with either com oil or TCB in com oil, and plasma was separated from cells. Plasma 
components were analyzed with a standard screening panel at 37"C. 
Units: a mEq!L; b mgldL; c g/dL; d U/L. 
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; Alk 
Phos, alkaline phosphatase; GGT, gamma glutamyl transferase. 
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TABLE3 
TCB Concentration in Pooled Tissue Samples of TCB-Treated Scup 
0.1 mg/kg 5.0 mg/kg 
day liver muscle liver muscle 
11g/g dry weight 11g/g dry weight 
0 0.0000 0.000 0.000 0 .00 
0.0003 0.412 0 .302 8.41 
2 0.0023 0.171 0.411 1.09 
5 0.0147 0.038 0.638 0.90 
12 0.0056 0.020 2.191 1.25 
16 0.0059 0.012 0.404 2.29 
11g/g lipid weight 11g/g lipid weight 
0 0.000 0.000 0.00 0.00 
0.002 0.926 2.22 18.90 
2 0.017 0.384 3.02 2.45 
5 0.108 0.085 4.69 2.02 
12 0.041 0.045 16.11 2.81 
16 0.043 0.027 2.97 5.14 
Fish were treated with TCB by a single intraperitoneal injection on day 0, and sampled at 
the time points indicated. TCB concentration was measured by GC/ECD as described in 
Methods, in pooled samples consisting of equally-sized tissue sections from all fish within 
a treatment group (n = 4 or 5 fish per sample). TCB concentration is expressed in j..lg TCB/ 
g tissue dry weight (top) or j..lg TCB/ g tissue lipid weight (bottom). Concentrations per 
lipid weight were calculated by converting dry weight to wet weight (dry= 25% of wet for 
liver, dry= 26.3% of wet for muscle), then dividing by percent lipid in wet tissue (3.4% 
lipid in liver, 11 .7% lipid in muscle). 
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Figure 7. GC/MS analyses ofTCB content in pooled liver and muscle samples from fish 
treated with 0.1 mg/kg TCB (A), and with 5.0 mg/kg TCB (B). X-axis is number of days 
subsequent to TCB injection. Y -axis is TCB concentration in ~g TCB/ g tissue lipid 
I 
weight. Each point is a measurement on a single sample, consisting of pooled liver or 
muscle sections from all 4 or 5 fish in each treatment group. Plot symbols are: closed 
circle, liver sample, open circle, muscle sample. 
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Discussion 
In the present study we demonstrate that the Ah-receptor agonist 3,3',4,4'-TCB 
induces cellular alterations in several organs of the marine fish scup. TCB primarily targets 
epithelial tissues (hepatocytes, renal tubules, gill epithelia) and lymphoid tissues (renal 
hematopoietic cells, spleen) in scup. Similarly, epithelial and lymphoid tissues were found 
to be primary targets of histopathology induced by the Ah-receptor agonist TCDD in 
rainbow trout and perch (Spitsbergen et al., 1988a; Spitsbergen et al., 1988b; van der 
Weiden et al., 1992). Studies in mammals indicate that TCDD and the structurally related 
halogenated biphenyls cause alterations in the proliferation and differentiation of epithelial 
cells (e.g. chloracne), and cause histopathology in lymphoid organs (e.g. thymic atrophy) 
(Goldstein and Safe, 1989). Structure-activity studies in mammals suggest that these 
effects on epithelial and lymphoid tissues may be associated with ligand binding to the Ah 
receptor (Goldstein and Safe, 1989). Ah receptor has been identified in scup and other 
teleost fish (Hahn et al., 1994), thus some of the tissue damage found in the present study 
and others may be related to, or mediated by, TCB binding to this receptor. 
Liver We attribute the TCB-induced basophilia of hepatocytes in the present study 
to a proliferation of endoplasmic reticulum in liver, and to a loss of lipid and glycogen 
stores. TCDD treatment has previously been associated with decreased hepatocyte 
glycogen in rainbow trout, perch, and lake trout sac fry (Spitsbergen et al. , 1988a; 
Spitsbergen et al., 1988b; Spitsbergen et al., 1991). Treatment with a high dose of Aroclor 
has been found to elicit an increased content of smooth endoplasmic reticulum in channel 
catfish hepatocytes, which was directly correlated with increases in hepatic microsomal 
monooxygenase (P450) activity (Klaunig et al., 1979). Similarly, TCB treatment induced 
the hepatic content of cytochrome P450 in these scup (chapter 2), concurrently with the 
apparent increases in hepatic endoplasmic reticulum content. Such proliferation of 
endoplasmic reticulum may be prerequisite to the induction of microsomal cytochromes 
P450, which are integral membrane proteins in the endoplasmic reticulum. 
Spleen We report a consistently greater number of melanomacrophage centers in 
spleen of TCB-treated fish as compared to vehicle-treated fish (Table 1 ). Factors known to 
increase melanomacrophage aggregates include chronic disease, chemical exposure, 
infectious disease, old age, and starvation (Ferguson, 1989). In such cases, the 
melanomacrophage centers act to sequester particulate material, including cellular 
breakdown products (Ferguson, 1989). Hence, we speculate that this histological 
alteration served a protective, or "clean-up", function in TCB-exposed fish. 
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Kidney TCB treatment caused a severe degeneration of renal tubules in scup 
exposed to either dose. By day 12 foci of regeneration were evident, but epithelial necrosis 
was ongoing. We found no reports of similar symptoms in fish treated with PCBs or 
dioxins, however, Rao and Banerji (1990) report a very similar degeneration of proximal 
and distal tubules in the kidney of rat fed Aroclor. The renal tubular epithelium is a major 
route for the excretion of foreign compounds in fish (Ferguson, 1989), thus severe tubular 
damage may be expected to lead to impaired excretory capacity. Plasma chemistry (Table 
2), conducted on a separate group of fish treated with either vehicle or 0.1 mg/kg TCB, 
indicated that TCB treatment caused no significant change in plasma content of electrolytes 
or nitrogenous waste products. Thus excretory capacity, indicative of both kidney and gil1 
function, was apparently not compromised in a group of fish administered 0.1 mg/kg TCB. 
Gill TCB induced hyperplasia of gill epithelia in half of the fish treated with 0.1 
mg/kg and all of the fish treated with 5.0 mg/kg, on days 12 and 16 after treatment. At the 
high dose some fish displayed diffuse hyperplasia, causing fusion of secondary lamellae on 
most of the primary gil1 filaments, and thus drastically reducing the gill surface area. There 
was no evidence of gill hyperplasia in vehicle-treated fish, with the exception of a single 
animal sampled on day 12, that received a score of I (see Methods). Epithelial hyperplasia 
is believed to be a general stress response and is induced in fish gill by a wide variety of 
toxicants and parasites (Evans, 1987). Gill epithelia play a critical role in gas exchange, 
maintenance of acid/base balance, ionic regulation, and excretion of nitrogenous waste 
(Ferguson, 1989). Epithelial hyperplasia could reduce the effective surface area available 
for these functions, and could increase the diffusional distances from water to blood 
(within the gill pillar endothelia). For example, the induction of epithelial hyperplasia by 
chlorine exposure was seen to correlate with reduced oxygen uptake efficiency in trout 
(Black and McCarthy, 1990). 
Thus a greatly reduced epithelial surface area, and greatly increased diffusional 
distances, in gills of scup treated with 5.0 mg/kg TCB could have elicited a range of 
effects, from inhibited respiration to impaired waste excretion. Unlike the kidney 
pathology in the present study, which was very similar at the two TCB doses until day 12, 
gill pathology was consistently more extensive in fish treated with the high TCB dose. We 
therefore speculate that impaired gill function may have been a major contributing factor in 
the death of fish treated with 5.0 mg/kg TCB. Necropsies were conducted on gills of two 
fish that died spontaneously, and these two animals received scores of 3 and 4, 
respectively , for epithelial hyperplasia (see Methods), confirming that the moribund fish 
had severe gill lesions. 
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Tail fin Fin erosion in fish is associated with a wide variety of environmental 
stressors, including lipophilic organic compounds, heavy metals, waste water, crude oil, 
pathogens (reviewed in Sindermann, 1979), and nutrient depletion. Fin erosion has long 
been known to be associated with environmental PCB contamination (McDermott-Ehrlich 
et al. , 1977; Sherwood and Mearns, 1977), and has been induced in numerous studies by 
prolonged exposure to TCDD (among the earliest, Miller et al., 1973; Hawkes and Norris, 
1977)). Literature reports of histopathology associated with fin erosion describe 
principally epithelial lesions. Among the earlier reports, Murchelano (1975) described 
epidermal hyperplasia, dermal fibrosis, hyperemia, and hemorrhage, without an 
inflammatory response, in winter flounder from a contaminated environment. Wellings et 
al. (1976) reported epidermal hyperplasia, dermal fibrosis, focal necrosis of epidermis, an 
inflammatory response, and in some cases an apparent resorption of the bony fin rays, in 
flounder and sole from a contaminated environment. In the present study we describe 
epithelial lesions and inflammation, as have been noted by other investigators, and we also 
report an unusual lesion in bone tissue associated with fin erosion. The lesions in bone 
were likely secondary to those in epithelia, as they only occurred in areas of the fin where 
the protective soft tissues were eroded away. 
The mechanisms by which PCB and dioxin induce fin erosion are not fully known. 
These compounds may be acting as immune suppressants, rendering superficial tissues of 
treated fish more susceptible to attack by water-borne pathogens. However, it cannot be 
ruled out that PCBs or dioxins may exert a direct effect on epithelial or bone cells, or that 
Ah receptor binding of these compounds may mediate these tissue alterations. 
TCB residues Among the fish treated with 0.1 mg/kg TCB, lesions and cellular 
alterations were less severe in the group sampled on day 16 than in the group sampled on 
day 12. On day 16, the kidneys displayed no tubule necrosis and had abundant 
hematopoietic tissue, the number of macrophage aggregates in spleen was closer to control 
levels, the mean score for liver basophilia was lower than that on day 12, and the mean 
score for gill hyperplasia was also lower than that on day 12. TCB residue analysis on 
pooled liver samples indicated that TCB content was maximal on day 5 in fish treated with 
0.1 mg/kg, and was maximal on day 12 in fish treated with 5.0 mglkg (Fig 6). Depuration 
of TCB was apparent by day 12 in fish treated with 0.1 mg/kg, and by day 16 in fish 
treated with 5.0 mg/kg. It is possible that in fish treated with the low TCB dose, repair of 
tissue lesions occurred from day 5 (the apparent onset of depuration) to day 16 (the final 
sampling point), suggesting that tissues are capable of returning toward normal 
morphology within a short time after of toxicant elimination. Most lesions appeared to be 
persistent in fish treated with 5.0 mg/kg TCB, consistent with the high levels of TCB 
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remaining in tissues on day 16, even after the bulk of the dose had been depurated (Table 
3). 
In conclusion, we report that treatment of a marine teleost with 3,3',4,4'-TCB is 
associated with lesions in several epithelial tissues, including hepatocytes, renal tubules, 
gill epithelia, and superficial epithelia of tail fin. We also report a depletion of lymphoid 
tissues, and either an increase or a rearrangement of melanomacrophage cells in kidney and 
spleen. Most of the histological alterations in liver, spleen, kidney, and gill were elicited 
by both 0.1 mglkg TCB and 5.0 mglkg TCB, and we provide suggestive evidence that fish 
treated with the lower dose may have achieved full recovery from many of the alterations 
following TCB depuration. Histopathology in epithelial and lymphoid tissues may be 
downstream consequences of TCB binding to the cytosolic Ah receptor, and may also be 
related to microsomal interactions between TCB and CYP1A1, including the possible in 
situ production of reactive TCB metabolites and reactive oxygen species. 
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CHAPTER FIVE 
In vitro Metabolism of Polychlorinated Biphenyl (PCB) 
Congeners by the Marine Fish Scup (Stenotomus chrysops): 
Relationship to Cytochrome P450 Expression 
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Abstract 
Marine fish are exposed to high concentrations of polychlorinated biphenyl (PCB) 
contaminants in coastal areas worldwide. However, there is little direct information 
concerning the mechanisms and capacity for PCB metabolism by teleost species. We 
analyzed and compared in vitro metabolism of the tetrachlorobiphenyl (TCB) congeners 
3,3',4,4'-TCB (IUPAC #77) and 2,2' ,5,5'-TCB (IUPAC #52) in the marine fish scup 
(Stenotomus chrysops). Metabolism rates were quantified using a radiometric assay, in 
which production of aqueous-soluble TCB derivatives was measured. Hepatic rnicrosomes 
from feral scup metabolized 3,3',4,4'-TCB and 2,2',5,5'-TCB at approximate rates of 
0 .13 and 2.06 pmol/min/mg microsomal protein, respectively. 3,3',4,4'-TCB turnover 
was inhibitable by cytochrome c, CO, and a-naphthoflavone, indicating that it was a P450 
catalyzed activity. Liquid chromatography of reaction products on XAD resin resolved one 
water-soluble metabolite peak and two methanol-soluble metabolite peaks from each 
congener. Treatment of depurated fish with the CYPIA inducers ~-naphthoflavone, 3-
methylcholanthrene, and 2,3,7,8-tetrachlorodibenzofuran caused moderate increases in the 
rate of metabolism of 3,3',4,4'-TCB, correlated with increases in microsomal CYPIAI 
content. Fish treated with CYPlA inducers also had slightly increased rates of 2,2',5,5'-
TCB metabolism. However, among the treatment groups there was a strong positive 
correlation between rate of metabolism of 2,2',5,5'-TCB and microsomal content of the 
putative teleost CYP2B. Feral fish had significantly greater rates of metabolism of 
2,2',5,5'-TCB than did depurated or depurated/treated fish , which corresponded to an 
elevated content of microsomal CYP2B. In competitive inhibition studies, neither TCB 
congener inhibited the metabolism of the other one, suggesting two separate principal 
catalysts. 3,3',4,4'-TCB strongly inhibited both EROD and MROD activity while 
2,2',5,5'-TCB inhibited neither one; neither congener inhibited PROD activity. We 
conclude that scup have the capacity to transform PCBs to aqueous-soluble derivatives in 
vitro, which suggests in vivo production of excretion products. Induction and inhibition 
studies suggest that scup CYPIAI is a principal catalyst for the metabolism of 3,3',4,4'-
TCB, while a putative scup CYP2B homologue is a principal catalyst for the metabolism of 
2,2',5,5'-TCB in scup liver microsomes, as is the case in rat liver microsomes. The 
metabolism of 2,2',5,5'-TCB is more rapid than that of 3,3',4,4'-TCB, which lacks 
adjacent, unsubstituted meta-para positions. However, in vitro rates with either congener 
are quite slow. The basis for slow turnover of substrates that bind well to the active site is 
unknown. 
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Introduction 
Polychlorinated biphenyls (PCB) are ubiquitous contaminants in the marine 
environment (Tanabe, 1988; Fowler, 1990), having been discharged into coastal waters 
during several decades of industrial use. Due to their chemical stability and 
hydrophobicity, PCBs have tended to concentrate in marine sediments (Tanabe, 1988; 
Fowler, 1990) and have entered the food chains of teleost fish. The fates of lipophilic 
organic compounds in fish include long-term retention in fatty tissues, elimination of parent 
compound via the gills, urine, or bile, elimination in gametes at spawning, and 
biotransformation to metabolites. There is a large body of work concerning PCB uptake 
and elimination in fish, but little is known about metabolism of PCBs by fish. In the 
earliest studies, some investigators found no evidence for in vivo metabolism of PCB 
congeners in fish (Hutzinger et al. , 1972; Narbonne, 1979). Others detected metabolites at 
very low levels in bile or in whole organisms (Metcalf et al., 1975; Sanborn et al. , 1975; 
Melancon and Lech, 1976; Hinz and Matsumura, 1977; Herbst et al. , 1978; Varanasi et al. , 
1987). These early studies dealt primarily with non-coplanar congeners such as 2,2',5,5'-
TCB ; those studies that did investigate coplanar PCB congeners found no metabolism of 
4-MCB and 4,4'-DCB; (Hutzinger et al., 1972; Herbst et al., 1978). More recently , some 
investigators have inferred PCB metabolism in fish, having observed selective loss of 
certain congeners in analysis of PCB residues in tissue (Niimi and Oliver, 1983; Boon et 
al. , 1989; Brown, 1992; de Boer et al., 1993). There is no direct information concerning 
the specific catalysts involved in PCB metabolism in fish, their rates of metabolic activity, 
and their regulation. Such information is important to our understanding of factors that 
may affect PCB congener metabolism, and thus determine the effects of PCBs, in fish. 
In mammals, the oxidative metabolism of PCBs is catalyzed primarily by 
cytochromes P450, which play a role in both detoxification and activation of substrates. In 
detoxification, P450-generated metabolites may be further metabolized by secondary 
enzymes to nontoxic, aqueous-soluble products that are readily excreted. Alternatively, 
oxygenated metabolites may be unstable and reactive, and may form covalent attachments 
with biomolecules. The formation of both innocuous and active metabolites can depend 
upon the level of expression and activity of specific cytochromes P450, and of secondary 
metabolizing enzymes, in target tissues. 
Prior work in mammals indicates that structure-activity relationships govern the 
metabolism of PCBs by cytochromes P450, with chlorine position determining which 
P450 enzyme carries out the transformation. In rat liver, hydrocarbon-inducible CYPIA 
forms metabolize congeners with halogenated substituents at one or both para positions, 
133 
Cl Cl 
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3, 3', 4, 4'-TCB 
Congener 77 
Cl 2, 2', 5, 5'-TCB Cl 
Congener 52 
Figure 1. Polychlorinated biphenyl congeners used in the study: 3,3',4,4'-TCB (IUPAC 
#77); 2,2',5,5'-TCB (IUPAC #52). 
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and with adjacent unsubstituted ortho-meta carbons, while phenobarbital-inducible CYP2B 
forms (CYP2B 1, CYP2B2) metabolize congeners with adjacent, unsubstituted meta-para 
positions (Kaminsky et al., 1981 ; Kennedy et al., 1981; Shimada and Sawabe, 1983; Mills 
et al., 1985; Ishida et al., 1991). In addition, it was observed that PCB congeners with 
two or more ortho substituents are more rapidly metabolized by rat CYP2B than by 
CYP1A, while congeners lacking ortho substituents are more rapidly metabolized by rat 
CYP 1 A than by CYP2B. 
There is currently no direct information concerning the role of cytochromes P450 in 
PCB metabolism in fish. One may deduce from the literature the involvement of CYP1A-
like and CYP2B-like activity, based on the relative abundance of PCB congeners found in 
fish tissue (Niimi and Oliver, 1983; Boon et al. , 1989; Brown, 1992; de Boer et al., 1993). 
Here we report on the metabolism of two tetrachlorobiphenyl (TCB) congeners by hepatic 
microsomes of the marine fish scup (Stenotomus chrysops): 3,3',4,4'-TCB (IUPAC 
·#77), a rat CYP1A substrate and an Ah receptor agonist, and 2,2',5,5'-TCB (IUPAC # 
52), a substrate and inducer of the phenobarbital-inducible rat CYP2B forms (Fig I). We 
find that scup metabolize both congeners to aqueous-soluble products in vitro. We present 
evidence to indicate that TCB metabolism in fish is accomplished by cytochrome P450, and 
that metabolism of the two congeners is by different P450s. Metabolism of 3,3',4,4'-TCB 
is catalyzed by the scup CYPIA1 homologue and metabolism of 2,2',5,5'-TCB appears to 
be catalyzed by a scup CYP2B-like protein, thus following the same substrate SARs that 
have been observed in rat. 
Materials and Methods 
Chemicals 3,3',4,4'-TCB [U-14q (52.1 mCilmmol) was purchased from Pathfinder (St. 
Louis, MO). Analysis by GCIECD and GC/MS revealed no hydrophobic contaminant 
peaks(> 99% pure); small polar contaminants were completely removed by dissolving the 
TCB in hexane and extracting twice with NaOH. 2,2',5,5'-TCB [U-14q (14.2 
mCilmrnol) was purchased from Sigma (St. Louis, MO). This product was determined to 
be> 98% pure by HPLC analysis, conducted on an ODS-2 column by the manufacturer. 
Unlabeled 3,3',4,4'-TCB was obtained from Pathfinder (St. Louis, MO). Purity of the 
TCB was > 99% by GCIECD and GC/MS analysis. Unlabeled 2,2',5,5'-TCB was 
obtained from Ultrascientific (North Kingstown, Rl). Manufacturer analysis by GCIFID 
indicated> 99% purity. Ethoxyresorufin, methoxyresorufin, and pentoxyresorufin were 
from Molecular Probes (Eugene, OR). All other chemicals used were of the highest grade 
available from commercial suppliers. 
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Animals Scup (Stenotomus chrysops) were caught by angling in Tarpaulin Cove and 
Buzzards Bay, Massachusetts. Some individuals were killed immediately upon capture, 
and livers were stored in liquid nitrogen until rnicrosomes were prepared. Prior studies in 
our laboratory suggest that enzyme degradation does not occur to any appreciable degree in 
scup tissues stored at liquid nitrogen temperatures (unpublished observations). Livers 
from these individuals were pooled for microsome preparation (approximately 20 to 70 fish 
per pool) and used for quantification of parameters in "feral" fish. Other individuals were 
held in laboratory aquaria for one year to allow depuration of environmental residues. 
Depurated fish were treated by intraperitoneal injection with either com oil ("control" fish), 
~-naphthoflavone (BNF; 20 mglkg), 3-methylcholanthrene (MC; 20 mg/kg), or 2,3,7,8-
tetrachlorodibenzofuran (TCDF; 3 Jl.g/kg), and killed five days later by cervical transection. 
All treatments were not carried out at the same time, thus com oil-treated fish are not strictly 
"controls" for each of the treatments. Nonetheless, extensive work in our laboratory has 
shown that depurated, com oil-treated scup express cytochrome P450 parameters at 
predictably low levels. Livers from all injected fish were removed immediately upon 
killing, and rnicrosomes were prepared by differential centrifugation, as previously 
described (Hahn and Stegeman, 1994). Microsomal protein content was measured with the 
bicinchoninic acid method (Smith et al., 1985), using bovine serum albumin as a standard. 
Hepatic microsomes from rat were obtained from Dr. Mark Melancon (U.S. Fish 
and Wildlife Service, Laurel, MD). Fisher-344 rats were treated by intraperitoneal injection 
with either com oil (control, day 1), 3-methylcholanthrene in com oil (MC, 20 mglkg, day 
1 ), or phenobarbital in saline (PB, 80 mg/kg, days 1, 2, 3). Animals were killed on day 
four by decapitation, and microsomes were prepared by differential centrifugation 
(Melancon et al., 1990). 
Characterization of monooxygenase systems The content of microsomal cytochrome P450 
was determined using dithionite difference spectra of CO-treated samples, as previously 
described (Stegeman and Binder, 1979), with an extinction coefficient of 91 mM-1 cm-1 
(Omura and Sato, 1964). Ethoxyresorufin 0-deethylase (EROD) activity was quantified at 
32oC with a fluorometric kinetic assay, using a Cytofluor 2300 fluorescence plate reader 
(Millipore), as described previously (Hahn et al., 1993). 
Immunoblot analysis was performed as previously described (Kloepper-Sams et 
al., 1987; Stegeman et al., 1991). Primary antibodies used were (1) monoclonal antibody 
1-12-3, raised against scup cytochrome P450E (CYP1 A 1) (Park et al., 1986), and (2) 
polyclonal antibody 7-94, raised against scup cytochrome P450B (Gray, 1988). 
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Irnmunochemical cross-reactivity with rat CYP2B I suggests that scup P450B is a CYP2B 
form (Stegeman et al., 1990a; Stegeman et al., 1990b ). Secondary antibodies used were 
(1) alkaline phosphatase linked goat-anti-mouse IgG, and (2) alkaline phosphatase linked 
goat-anti-rabbit IgG. Content of each enzyme in hepatic microsomes was quantified by 
densitometric scanning of antibody-reactive bands with a video imaging system 
(Masterscan, Scanalytics, division of CSPI, Billerica, MA), and comparison to P450E and 
P450B standards. 
TCB/P450 binding spectrum Hepatic microsomes from feral scup were diluted to a 
concentration of 1 mg/ml in a Tris buffer (see below), and divided evenly between two 
cuvettes. 3,3',4,4'-TCB was dissolved in DMSO to a concentration of 0.5 mM, and added 
to the microsomal suspension in the sample cuvette at concentrations ranging from 1 J!M to 
10 JlM (final concentration of0.2% to 2% DMSO). Equivalent volumes ofDMSO were 
added to the reference cuvette. A uv/visible difference spectrum of the microsome/TCB 
suspension was obtained by scanning over a wavelength range of 350 nm to 500 nm on a 
Shimadzu UV-260 spectrophotometer. 
TCB metabolism assay The assay of Schnellman et al. (1983) was used, with 
modifications, to assess metabolism of 3,3',4,4'-TCB and 2,2',5 ,5'-TCB. Incubations 
were performed at 3o·c under air in a shaking incubator. This temperature was determined 
to be optimal for CYP1A1 activity in scup hepatic microsomes (Stegeman et al., 1979). 
Incubations were 0.5 ml and contained 1 mg/ml microsomal protein (unless stated 
otherwise), 50 mM Tris, pH 7.6, 0.1 mM EDTA, and 211M or 5 ).tM (nominal 
concentration) 14c-labeled TCB that had been dissolved in acetone (acetone concentration 
in the incubations was approximately 1% to 3% ). Substrate saturation profiles were 
obtained to determine that the 2 11M TCB and 5 JlM concentrations were optimal in scup; 
both concentrations gave the same rate of metabolism in vitro. For assays conducted with 
rat liver microsomes, incubations were performed at 3TC using 5 JlM 14C-labeled TCB 
(6% acetone in the incubation). After a 2 minute pre-incubation, reactions were initiated by 
the addition of 1 mM NADPH and run for 60 minutes (unless stated otherwise). Reactions 
were terminated by the addition of 0.75 ml 0.5 N NaOH, and heated at 7o·c for 10 
minutes to aid in microsome solubilization (Schnellman et al., 1983). To remove parent 
TCB, the samples were extracted two to three times with 2.5 ml aliquots of n-hexane : 
100% ethanol ( 19:1 ). 500 Jll of the aqueous/NaOH sample was then neutralized with HCl 
and combined with 6 ml Scintiverse ll (Fisher Scientific), and aqueous radioactivity was 
quantified by measuring 14c with liquid scintillation counting on a Beckman LS5000TD 
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counter. The rate of production of aqueous-soluble metabolites was determined by 
subtracting the aqueous radioactivity in control incubations, containing either boiled 
microsomes or no microsomes (both controls gave similar results) , and dividing by specific 
activity of the substrate to convert dpm (disintegrations per minute) to pmol PCB 
metabolites. The limits of resolution of the assay were approximately 20 dpm, giving 
approximate detection limits of 0.03 pmollminlmg microsomal protein for 3,3',4,4'-TCB 
metabolites, and 0.1 pmol/minlmg for 2,2',5,5'-TCB metabolites. Duplicate, and in some 
cases triplicate, assays were performed on each sample. 
Some metabolism assays were conducted in controlled atmospheres rather than 
under air, according to Binder ( 1982) with modifications. In these reactions, microsomes, 
buffer, and substrate were combined and the mixture was bubbled gently with either N2 or 
CO for 60 seconds. Tubes were immediately sealed with air-tight serum stoppers. The gas 
phase in the tube above the reaction mixture, either N2 or C0:02 (80:20), was then 
prepared as follows. The sealed volume of each tube was connected to a manifold with 
capillary tubing, and a syringe needle attached to the capillary tubing was passed through 
the serum stopper. The tube-syringe units were sequentially evacuated and then gassed 
with either N2 or CO. After several cycles, ending with the gassing, the tubes were 
disconnected from the manifold. In the CO tubes, the total volume of gas was adjusted to 8 
ml with a syringe, and 2 ml of 02 was injected through the serum stopper. Reactions were 
initiated by injection of NADPH through the serum stoppers with a syringe, and run as 
above. 
XAD column chromatography Aqueous-soluble metabolites of 14c-labeled TCBs were 
generated by hepatic microsomes of feral scup (3 ,3',4,4'-TCB and 2,2',5 ,5'-TCB), Me-
treated rat (3,3',4,4'-TCB), and control rat (2,2',5,5'-TCB), as above. Incubations were 
extracted with hexane/ethanol as above, and the remaining aqueous/NaOH sample was 
applied to the column. XAD columns were prepared by pouring 5 em of dry XAD-2 
(coarse) resin (Amberlite polystyrene beads, Sigma) into a glass pasteur pipette, with a 
glass wool plug at the bottom. The column was pre-washed with several milliliters each of 
water, methanol, acetone, and water again, before sample application. Sample was applied 
and the column was sequentially washed with several milliliters each of water, methanol, 
and acetone (which elutes parent compound). Each 1 ml fraction was collected and dried in 
a 6o·c oven to reduce solvent volume. 5 rnl of Scintiverse II was added to each sample, 
and metabolites were quantified by liquid scintillation counting as above. 
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Inhibition of TCB metabolism TCB metabolism assays were conducted as above, with 
several modifications. In some assays 1 mM NADH was substituted for NADPH in the 
assay buffer. Horse heart cytochrome c (Sigma) was dissolved in assay buffer and added 
to some assays at 100 fl.M. a-naphthoflavone (ANF) dissolved in methanol was added to 
assays at 1 ~M, 10 f.!M, and 100 ~M (10 Jll methanol per 500 Jll assay); control and blank 
assays for comparison included 10 ~1 methanol alone. Some assays were conducted with a 
single 14c-labeled TCB congener as the substrate, and with the other TCB congener added 
as an unlabeled "competitor". These assays included 2 flM 14c-labeled substrate 
(dissolved in 6 ~1 acetone) and 4JlM cold competitor (dissolved in 4 ~1 acetone). To blank 
and control assays (those not containing cold competitor), 4 ~1 acetone was added to 
balance the solvent volumes. 
Inhibition of alkoxyresorufin 0-dealkylase activities Ethoxyresorufin 0-deethylase 
(EROD) activity, methoxyresorufin 0-demethylase (MROD) activity, and pentoxyresorufin 
0-depentylase (PROD) activity were assayed by measuring the appearance of resorufin, 
using a Cytofluor 2300 fluorescence plate reader, as above. Substrate concentrations in the 
assays were 2jlM ER, 2 flM MR, and 5 JlM PR (optimal concentrations). Microsomal 
protein concentrations in the assays were 0.16 jlg/jll for EROD ( 1 Jll microsomes per 
assay) , 0.31 ~g/jll for MROD (2Jll microsomes per assay), and 1.6jlg/jll for PROD (10 
Jll microsomes per assay), to optimize detection. Each TCB congener was dissolved in 
acetone and added at concentrations of 0.25 JlM, 0.5 JlM, 0.75 JlM, and 1.0 JlM 0111 
acetone in 200 ~I assay). Control assays (without TCB) included 1 Jll acetone alone. 
Microsomes, buffer, substrate, and TCB were pre-incubated at 3o·c for 5 minutes in a 
shaking water bath, and reactions were initiated by the addition of 1.1 jlg/jll NADPH (final 
concentration in assay). 
Polyclonal antibody inhibition studies Metabolism of both TCB congeners was assayed in 
the presence of potentially inhibitory polyclonal antibodies. Assay conditions were as 
above, but incubations contained 5 ~M TCB in a total volume of 250 ~1. Antibodies used 
were polyclonal 119p ("anti-CYP1A1 "), which is a rabbit-anti-scup IgG raised against 
scup CYP1A1 (Kloepper-Sams et al., 1987); polyclonal 7-94 ("anti-CYP2B"), which is a 
rabbit-anti-scup IgG raised against scup P450B (Gray, 1988), the putative scup CYP2B 
(Stegeman et al., 1990a; Stegeman et al., 1990b); and c-93, which is the IgG fraction of 
non-immune rabbit serum, as a control. Prior studies have shown that polyclonal 119p 
binds to purified scup CYP1Al in immunoblots and inhibits hepatic EROD activity and 
benzo[a]pyrene metabolism, whereas it does not bind to purified scup P450B in 
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immunoblots and does not inhibit hepatic aminopyrine N-demethylase activity (Kloepper-
Sams et al., 1987) or hepatic testosterone 6~-hydroxylase activity (unpublished 
observation). Unpublished studies in our laboratory have shown that polyclonal 7-94 
binds to purified scup P450B in immunoblots but not to purified scup CYP 1 A 1. Original 
antibody solutions were concentrated by centrifugation in Centricon 30 microconcentrators 
(Amicon, W.R. Grace and Co. , Danvers, MA), and resuspended in 50 mM Tris, 0.1 mM 
EDTA, pH 7.6, at a concentration of 50 mg/ml. Protein content was measured in the 
original antibody solution and in the Centricon filtrate fractions by monitoring absorbance 
at 280 nm, to assure that only a very small fraction of antibody was lost during the 
preparation. Antibodies and serum were used in TCB metabolism assays at 15, 30, and 60 
Jlg/pmol P450. The 250 Jll assay contained 90 pmol total cytochrome P450 in 250 Jlg 
microsomal protein, thus antibodies were added at 1350 Jlg, 2700 Jlg, and 5400 Jlg, 
respectively. Microsomes, buffer, and antibody were combined in test tubes (116 Jll total 
volume) and pre-incubated for one hour on ice. Reactions were initiated by the addition of 
TCB, NADPH, and the remaining buffer volume needed, and carried out as above. 
The same polyclonal antibodies were added to EROD activity assays. Antibodies 
and serum were used at 30 Jlg/pmol P450 and 60 Jlg/pmol P450. The 200 Jll assay 
contained 11.3 pmol total cytochrome P450 in 31.5 Jlg microsomal protein, thus antibodies 
were added at 339 Jlg and 678 Jlg, respectively. Microsomes and antibody were pre-
incubated in a small volume of buffer, for one hour on ice, prior to the addition of 
ethoxyresorufin substrate in additional buffer. Reactions were initiated by the addition of 
NADPH, and run as above. 
Statistics Significant differences between scup treatment groups (Table 1) were evaluated 
with a one-factor ANOV A test, using Statview SE+ Graphics, v.1.03 (Abacus Concepts) 
for Macintosh. 
Results 
TCB metabolism 
Hepatic microsomes from freshly caught animals metabolized both 3,3',4,4'-TCB and 
2,2',5,5'-TCB to aqueous-soluble metabolites in vitro, in a manner that was linear with 
incubation time and that increased with increasing content of microsomal protein (Fig 2). 
The apparent turnover of 3,3',4,4'-TCB to aqueous-soluble products was dependent on 
native protein and on NADPH cofactor (Fig 3), consistent with an enzyme-catalyzed 
reaction. NADH supported TCB metabolism at rates 60% less than with NADPH (Fig 3). 
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Figure 2. Metabolism of TCB congeners in hepatic microsomes of feral scup. Rates of 
TCB metabolism were assessed radiometrically, in I rnl incubations containing I mg/rnl 
microsomal protein (A, B) and conducted for one hour (C). Each point is the mean of 
triplicate assays on a single, pooled microsomal sample. (A) Metabolism of 3,3',4,4'-TCB 
(pmollmg) versus time of incubation (min). (B) Metabolism of 2,2',5,5'-TCB (pmollmg) 
versus time of incubation (min). (C) Metabolism of 3,3',4,4'-TCB (pmollhour) versus 
content of microsomal protein in the I rnl incubation (mg). 
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Figure 3. Inhibition of3,3',4,4'-TCB metabolism in hepatic microsomes of feral scup. 
The farthest left bar represents the rate of metabolism in a complete incubation ( 100% ), 
assayed radiometrically as in Methods (actual rates were as listed in Table 1). Subsequent 
bars indicate % complete activity in assays containing: no microsomes, boiled 
microsomes, no NADPH, NADH substituted for NADPH, 100 J.!M cytochrome c, 100 J.!M 
ANF, 10 J.!M ANF, 1 J.!M ANF, CO gas (80% atmosphere), and N2 gas (near 100% 
atmosphere) . Assays were conducted as described in Methods. The aqueous radioactivity 
in assays containing boiled microsomes was equal to that in assays conducted with no 
microsomes; these were used as subtractive blank assays and assigned a rate of zero. 
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Addition of 100 ~M cytochrome c, which competes with P450 for electrons from NADPH 
cytochrome P450 reductase, reduced the activity rate by 52% (Fig 3). Addition of ANF, a 
competitive inhibitor of CYP1A 1 in scup (Klotz et al., 1984), reduced the rate of TCB 
metabolism in a concentration-dependent manner, with no detectable activity at 100 ~ 
ANF (Fig 3). Addition of CO (80% atmosphere), which binds reversibly to the ferrous 
cytochrome P450 heme, reduced the rate of TCB metabolism by 42% (Fig 3). These data 
indicate that the primary metabolism of 3,3',4,4'-TCB in scup liver microsomes is 
catalyzed largely by cytochrome(s) P450. 
In contrast, an N2 gas atmosphere, which should limit the availability of 02 for 
P450 catalysis, only inhibited TCB metabolism by 7% (Fig 3). Because the rate of 
metabolism of 3,3',4,4'-TCB is so slow (approximately 0.2 pmol/min/mg, maximum), 
very little 02 is required to maintain this activity in vitro. If one assumes a conservative 
catalytic efficiency of 10% (i.e. one turnover of TCB for every 10 turnovers of 02 by 
P450), then only 120 pmol (1 o-1 0 moles) of 02 would be required to support this activity 
in one mg of microsomal protein for one hour. The 10 ml volume of head space in the 
assay tube prior to evacuation and gassing (see Methods) contains approximately w-4 
moles 02, based on the conversion factor of 0.209 liters 02 in one liter of air. It is not 
surprising that the methods used could not reduce the 02 concentration in the assay tube 
from w-4 moles to< w-10 moles; thus loss of activity in a (mostly) N2 atmosphere was 
not seen. 
Binding spectrum 
To further verify that the metabolism of 3,3',4,4'-TCB in scup hepatic microsomes 
involved a direct interaction with P450, binding spectra were obtained (Fig 4). The 
combination of TCB and microsomes produced a classic type I binding spectrum, with a 
peak at 390 nm and a trough at 420 nm, indicative of the low spin to high spin transition of 
the ferric P450 associated with substrate binding to the active site. Due to the very small 
absorbance changes measured, we were unable to accurately determine a spectral 
dissociation constant from these data. 
Metabolite characterization 
Metabolites of 14c-3,3',4,4'-TCB and 14c-2,2',5,5'-TCB were generated in scup liver 
microsomes and separated with liquid chromatography on XAD resin. Microsomal 
incubations with 3,3',4,4'-TCB were carried out for 60 minutes, then parent compound 
was extracted with hexane:ethanol, and the remaining aqueous fraction was applied to the 
column. Three major peaks of 14c eluted from the column: one in the first two ml of 
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Figure 4. TCB I cytochrome P450 binding spectrum. 10 JlM 3,3',4,4'-TCB was added to 
a 1 mg/rnl suspension of hepatic rnicrosomes from feral scup, and uv/visible difference 
spectrum was obtained. Plotted is absorbance (y) versus wavelength (x). TCB displays a 
typical type I binding spectrum, with a peak at 390 nm and a trough at 420 nm. 
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water, one in the first two ml of methanol, and one in the eleventh ml of methanol (Fig 5A 
and 5B). Very similar profiles were obtained with incubations using scup liver 
microsomes and microsomes from MC-treated rat (Fig 5), suggesting a similar formation 
of three classes of metabolites with different degrees of aqueous-solubility. When parent 
TCB alone was added to the column, it adhered to the matrix during water and methanol 
washes, and all radioactivity eluted in the first three acetone fractions (Fig 5C). We thus 
conclude that the water and methanol peaks are hydroxylated TCB derivatives generated 
during in vitro metabolism of 14C-labeled TCB. 
Metabolites of 2,2',5,5'-TCB also eluted from XAD columns with water and 
methanol washes, following incubation in scup liver rnicrosomes (Fig 6) or control rat liver 
microsomes (not shown). When parent 2,2',5,5'-TCB alone was added to the column, a 
major peak eluted in the first three acetone fractions. As with 3,3',4,4'-TCB, some 
microsomal incubations with 2,2',5,5'-TCB had small peaks eluting in acetone (Fig 6), 
which disappeared when the incubations were extracted once more with hexane:ethanol 
prior to application on the column. We thus attribute the latter peak to parent TCB. The 
ratio of water-soluble to methanol-soluble metabolites of 2,2',5,5'-TCB (measured as total, 
blank-subtracted, dpm of peak fractions eluting from XAD) increased with time of 
incubation (Fig 6). Thus, the proportion of metabolite radioactivity eluting in water washes 
increased from 38% (20 minutes) to 49% (40 minutes) to 57% (60 minutes) . The 
proportion of total metabolites eluting in methanol decreased accordingly, as did the 
number of peaks eluting in methanol (Fig 6). We thus conclude that the metabolites eluting 
with water may be, at least in part, the product of further biotransformation of the 
metabolites eluting with methanol. The former peak could include dihydroxy TCBs and/or 
dihydrodiol TCBs, formed when mono-oxygenated products are attacked by cytochrome 
P450 and epoxide hydrolase, respectively. 
Induction of TCB metabolism 
Rates of in vitro metabolism of 3,3',4,4'-TCB and 2,2',5,5'-TCB were determined in liver 
microsomes from control scup (depurated and treated with com oil), feral scup, and scup 
treated with various CYP1A inducers (Table 1). Levels of hepatic microsomal P450, 
immunodetectable CYP1A1 content, and rates of CYP1A1 -catalyzed EROD activity were 
elevated in all groups as compared to control fish (Table 1 ). Irnrnunodetectable content of 
the putative scup CYP2B was significantly greater in feral fish than in all other groups of 
fish analyzed, suggesting environmental exposure to compound(s) that elevate CYP2B 
(Table 1; see Discussion). The rate of metabolism of 3,3',4,4'-TCB in all groups of fish 
treated with CYP1A inducers tended to be greater than the rate in controls, although this 
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Figure 5. XAD column profiles of 3,3',4,4'-TCB metabolites produced in feral scup 
hepatic microsomes (A), and in MC-treated rat hepatic microsomes (B), and profile of 
3,3',4,4'-TCB (C). Metabolites were generated and separated on the column as described 
in Methods. Bars represent the radioactivity contained in each I rnl fraction, eluted from 
the column as it was washed with I ml aliquots of water, methanol, and acetone. The first 
three (A, B) or first one (C) fractions are H20 column blanks; the next fraction was eluted 
as sample was applied to the column. 
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Figure 6. XAD column profiles of 2,2' ,5,5'-TCB metabolites produced in feral scup 
hepatic microsomes. Data were obtained as described in Fig 5. Incubations were 
conducted for 20 minutes (A), 40 minutes (B), or 60 minutes (C). Indicated above the 
water and methanol fractions is the percentage of total recovered metabolites that eluted in 
water and methanol, respectively. Water- and methanol-metabolites were quantified by 
summing the radioactivity in the peak fractions , after subtracting background radioactivity 
from each fraction. The peaks eluting with acetone are parent TCB (see Results section). 
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TABLEt 
Microsomal Enzyme Contents and Activities in Depurated, Feral, and Treated Scup 
control feral BNF MC TCDF 
(n = 3) (n = 5 Eools) (n = 3) (n = 3) (n = 3) 
cytochrome P450 0.130 ± 0.024 0.446 ± 0.185 * 0.179 ± 0.036 0.449 ± 0.108 * 0.682 ± 0.206 *** 
(nmol/mg) 
EROD 0.105 ± 0.064 0.715 ± 0.391 1.410 ± 0.084 4.054 ± 2.461 ** 5.011 ± 1.764 ** 
(nmoVmin/mg) 
CYPlA 0.4 ± 0.7 67±40 47 ±7 219±58 ** 288 ± 119 *** 
(pmol P450FJmg) 
CYP2B 6±7### 122 ±51 *** 11±3## 30 ± 13 ## 68 ± 23 * # 
(Emol P450B/mg) 
3,3',4,4'-TCB-OH 0.09 ± 0.10 0.13 ± 0.07 0.23 ± 0.11 * 0.21 ± 0.02 0.23 ± 0.02 * 
(pmoVmin/mg) 
2,2',5,5'-TCB-OH 0.2 ± 0.1 ### 2.1±0.4*** 1.3 ± 0.1 *** ## 0.9 ± 0.2 ** ### 1.2 ± 0.3 *** ## 
(EmoVminlmg) 
Assays were conducted as described in Methods. Individual fish were depurated of environmental residues and treated with 
either com oil (control) or with the CYP1A inducers BNF, MC, or TCDF. Feral samples were prepared from pooled livers of 
freshly-caught animals, 20-70 fish per sample. (Three feral scup pools were assessed for rate of metabolism of 3,3',4,4'-TCB, 
two BNF samples were assessed for CYP2B content, all other sample sizes are as indicated.) Values are means± SD (n-1). 
Sample groups are significantly greater than control at a level: * p<0.05, ** p<O.O I, *** p<O.OOI, or sample groups are 
significantly less than feral at a level: # p<0.05, ## p<O.O 1, ### p<O.OO 1, based on a one-factor ANOV A test. 
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was significant only in fish treated with BNF or TCDF. The rate of metabolism of 
2,2',5,5'-TCB by feral fish was significantly elevated over rates in all groups of depurated 
fish (Table I). The average rate of metabolism of 3,3',4,4'-TCB in feral scup microsomes 
(0.13 pmol/min/mg microsomal protein) was one-fifteenth that of2,2' ,5,5'-TCB (2.1 
pmollmin/mg), and in control scup the rates differed by two-fold. 
A strong positive correlation was seen between rate of metabolism of 2,2',5,5'-
TCB and immunodetectable content of the putative scup CYP2B (r2 = 0.670; Fig 7). A 
weak positive correlation was seen between rate of metabolism of 3,3',4,4'-TCB and 
immunodetectable CYP1AI content in each fish (r2 = O.IOI; Fig 7). No correlation was 
seen for 2,2',5,5'-TCB metabolism versus CYP1AI content, nor for 3,3',4,4'-TCB 
metabolism versus CYP2B content (Fig 7). We hypothesized that the weakness of the 
correlation between rate of 3,3',4,4'-TCB metabolism and microsomal CYPIA1 content 
was related to the fact that the rates of this activity were so slow. The variability in inter-
individual response to a given chemical treatment (the range or standard deviation) was as 
great as the response itself (the mean activity rate in each treatment group). Thus, patterns 
of response were visible only when group means were plotted, rather than individual 
values. Upon plotting means (Fig 8), correlations became stronger for 2,2',5,5'-TCB 
metabolism versus CYP2B content (r2 = 0.690), and for 3,3',4,4'-TCB metabolism 
versus CYP I A I content (r2 = 0.45I ). Again, no correlations were seen for the reverse 
plots (Fig 8). These data are consistent with scup CYPIAI being a principal catalyst for 
the in vitro metabolism of the coplanar congener 3,3',4,4'-TCB, and the putative CYP2B a 
principal catalyst for the in vitro metabolism of the di-ortho-substituted congener 2,2',5,5'-
TCB. 
Inhibition of TCB metabolism by TCBs 
To further identify the catalysts responsible for metabolism of the two TCB congeners in 
vitro, one 14c-labeled TCB congener was used as substrate, and the other congener added 
as an unlabeled "competitor". The addition of cold 2,2',5,5'-TCB caused a moderate 
elevation in the rate of metabolism of 14c-labeled 3,3' ,4,4'-TCB (Table 2). The addition 
of cold 3,3',4,4'-TCB caused a very slight drop in the rate of metabolism of 14c-labeled 
2,2',5,5'-TCB. These results indicate that 2,2',5,5'-TCB does not inhibit the metabolism 
of 3,3',4,4'-TCB, while 3,3',4,4'-TCB may bind with a relatively weak affinity to the 
catalyst for 2,2',5,5'-TCB metabolism. The data imply the presence of two separate 
enzymes, one principally responsible for the in vitro metabolism of 3,3',4,4'-TCB and the 
other principally responsible for the in vitro metabolism of 2,2',5,5'-TCB. 
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Figure 7. Rate of metabolism of TCB congeners in vitro versus immunodetectable P450 in 
scup hepatic microsomes. Data points are for individual livers (control, BNF, MC, TCDF) 
or for pooled samples (feral), and are the same data used for Table 1. TCB metabolism 
was assayed radiometrically, and is expressed as pmollminlmg microsomal protein. 
Content of cytochromes P450 was determined by Western blotting. (A) 2,2',5,5'-TCB 
metabolism versus CYP2B content. (B) 3,3',4,4'-TCB metabolism versus CYP1Al 
content. (C) 2,2',5,5'-TCB metabolism versus CYPlAI content. (D) 3,3',4,4'-TCB 
metabolism versus CYP2B content. Three feral pools were assessed for rate of metabolism 
of 3,3',4,4'-TCB, and five were assessed for rate of metabolism of 2,2',5,5'-TCB. 
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cytochromes P450 in hepatic rnicrosomes from control scup, feral scup, and scup treated 
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measurements for each treatment group, and are taken from Table I. All data were 
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TABLE2 
Rate of Metabolism of 14c_ TCB Congeners in Hepatic Microsomes from Feral Scup: 
Addition of a "Competing" TCB Congener 
substrate competitor dpma pmol/min/mg b 
14C-3,3',4,4'-TCB control 367.3 0.14 
cold 2,2',5,5'-TCB 474.0 0.24 
blank 209.0 
14c-2,2' ,5,5'-TCB control 572.6 1.5 
cold 3,3',4,4',-TCB 482.4 1.2 
blank 132.0 
Microsomes were incubated with 14c-TCB "substrate" at 2lJ.M, and cold TCB 
"competitor" at 4 lJ.M. Control assays contained no competitor, blank assays contained no 
microsomes and were used as a subtractive blank for 14c extraction efficiency. 
a Disintegrations per minute from 14c, measured in extracted aqueous phase of metabolism 
assay. Each value is a mean of duplicate assays. 
b Rates were calculated by subtracting the blanks, then dividing by specific activity of the 
substrate to convert dpm to pmol. Rates are given in pmol aqueous-soluble metabolites 
produced/ minute incubation/ mg microsomal protein. 
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Inhibition of alkoxyresorufin 0-dealkylase activities 
The two TCB congeners were employed at a range of concentrations to assess their ability 
to inhibit various alkoxyresorufin 0-dealkylase activities (Fig 9). 1 ~M 3,3',4,4'-TCB 
inhibited EROD activity by approximately 56% and MROD activity by approximately 70%. 
In contrast, 1 ~M 2,2',5,5'-TCB inhibited neither of these activities. PROD activity was 
not inhibited by either congener at any concentration tested (Fig 9C). 
Inhibition of TCB metabolism by antibodies 
EROD activity, catalyzed principally by CYP1Al in scup (Klotz et al., 1983), was used as 
a control to test for polyclonal antibody specificity. The anti-scup CYP1Al polyclonal 
antibody, when added at 60 ~g/pmol P450, inhibited EROD activity by 41% with respect 
to non-immune serum controls (Fig I OA). In contrast, 60 ~g/pmol of the anti-scup 
CYP2B polyclonal antibody inhibited EROD activity by only 13% with respect to non-
immune serum controls. Thus the antibodies showed some degree of specificity for EROD 
inhibition. 
The metabolism of 2,2',5,5'-TCB was inhibited almost completely by 60 ~g/pmol 
of the anti-CYP2B antibody, whereas the anti-CYP1 A 1 antibody did not inhibit this activity 
at all, as compared to non-immune serum controls (Fig 1 OB). The rate of metabolism of 
3,3',4,4'-TCB was reduced to near zero by 60 ~g/pmol of either anti-CYP2B or non-
immune serum (Fig I OC), suggesting that this activity is susceptible to strong inhibition by 
nonspecific interactions. The anti-CYPIAI antibody caused a dramatic increase in the rate 
of metabolism of 3,3',4,4'-TCB, particularly at low titres (Fig lOC; see Discussion). 
Discussion 
We have quantified rates of metabolism of two TCB congeners in hepatic 
rnicrosomes from the marine fish scup, providing the first direct demonstration of 
cytochrome P450 involvement in PCB metabolism by teleost fish. The metabolism of 
3,3',4,4'-TCB was inhibitable by cytochrome c, ANF, and CO gas, indicating that it is a 
P450-catalyzed activity. Aqueous-soluble products were detected following microsomal 
incubation with either 3,3 ',4,4'-TCB or 2,2',5,5'-TCB, suggesting the capacity for in vivo 
biotransformation. Microsomal metabolism of 2,2',5,5'-TCB was more rapid than that of 
3,3',4,4'-TCB, consistent with prior work in mammals suggesting that PCB congeners 
with adjacent, unsubstituted meta-para positions are more susceptible to enzymatic attack 
(Matthews and Tuey, 1980; Boon et al. , 1989; Borlakoglu and Wilkins, 1993). 
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Figure 9. Inhibition of alkoxyresorufin 0-dealkylase activities by TCB congeners. Plotted 
is rate of activity (y) versus TCB concentration in the incubation (x), for (A) EROD, (B) 
MROD, (C) PROD. Activities were measured in hepatic microsomes from feral scup, 
using a fluorometric assay as described in Methods. Each TCB congener was added in 
acetone at concentrations of 0, 0.25, 0.5, 0.75, and 1.0 ~M. Each point is a mean of 
duplicate assays, and all results were reproducible in duplicate experiments. 
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Figure 10. Polyclonal antibody inhibition of metabolic activities in hepatic microsomes 
from feral scup. Plotted is rate of activity (y) versus antibody titre in the incubation (x), for 
(A) EROD activity, (B) 2,2',5,5'-TCB metabolism, and (C) 3,3',4,4'-TCB metabolism. 
EROD activity was assayed fluorometrically and TCB metabolism radiometrically, as in 
Methods. Antibodies used were 119p, raised against scup CYPIA1 ; 7-94, raised against 
scup CYP2B; and c-93, which is non-immune rabbit serum. Rate of activity in controls 
containing no serum is indicated by the point at x = 0. Each point is a mean of duplicate 
assays, and results were reproducible in duplicate experiments. 
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Structure/activity relationships in TCB metabolism 
Induction responses, correlation analyses, and inhibition studies all indicate that PCB 
metabolism in teleost fish follows the same substrate SARs that have been observed in rat. 
Specifically, it appears that the coplanar congener 3,3',4,4'-TCB is metabolized principally 
by the scup CYPIAI homologue, while the di-ortho-substituted congener 2,2',5,5'-TCB 
is metabolized principally by scup P450B. Imrnunochemical cross-reactivity with rat 
CYP2B 1 suggests that P450B is likely a CYP2B homologue (Stegeman et al., 1990a; 
Stegeman et al. , 1990b). Elevated rates of metabolism of 3,3',4,4'-TCB were seen in scup 
that had been treated with CYP1A inducers, with a positive correlation among treatment 
groups between CYP1A1 content and rate of metabolism of 3,3',4,4'-TCB. Similarly, 
there was a strong positive correlation among treatment groups between content of the 
putative CYP2B and rate of metabolism of 2,2',5,5'-TCB. 
Although the metabolism of 3,3',4,4'-TCB was strongly inhibited by ANF (Fig 3), 
the metabolism of2,2',5 ,5'-TCB was inhibited to nearly the same extent by each ANF 
concentration (data not shown). ANF was formerly believed to be a specific inhibitor of 
CYP1A enzymes, but recent evidence (Chang et al. , 1994) indicates that it inhibits other 
human cytochromes P450 as well , including an enzyme of the CYP2B subfamily. 
Therefore, we interpret the ANF inhibition of TCB metabolism to suggest a role for 
cytochrome P450, and not for any specific P450 form. 
The anti-scup CYP2B polyclonal antibody strongly inhibited the metabolism of 
2,2',5,5'-TCB, while the anti-scup CYPIAI polyclonal antibody did not, further 
suggesting a role for CYP2B in this activity. The metabolism of 3,3',4,4'-TCB was not 
amenable to antibody inhibition studies, due to the very low rates in scup hepatic 
microsomes. This activity was inhibited almost completely by both anti-scup CYP2B and 
by non-immune serum, suggesting extreme sensitivity to inhibition by nonspecific 
interactions. The anti-scup CYP1A1 polyclonal antibody caused a slight elevation in the 
rate of metabolism of 2,2',5,5'-TCB (60%), and a strong elevation in the rate of 
metabolism of 3,3',4,4'-TCB (250%), when added at 15 ~g/pmol. Such elevations in 
activity are commonly reported in the use of polyclonal antibodies, and are attributed to 
nonspecific binding. In the case of this antibody, the modest inhibition of EROD activity 
( 41 % ), and the nonspecific stimulation of TCB metabolism, suggest that it is not an 
effective inhibitory antibody. Nonetheless, the strong stimulation of 3,3',4,4'-TCB 
metabolism by this antibody provides further suggestion that this may be a CYP1A1-
catalyzed activity, with the stimulation owing to anti-CYPIAI I CYP1A1 binding in such a 
way as to stabilize the catalyst and enhance the rate of 3,3',4,4'-TCB metabolism. 
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Inhibition studies using alkoxyresorufin substrates further shed light on the TCB 
substrate SARs. Studies with rat have shown that EROD activity is catalyzed principally 
by CYP1Al, MROD activity principally by CYPIA2, and PROD activity largely by 
CYP2B 112B2 (Burke et al., 1985). Scup express what appears to be a single CYPl A 
protein in liver microsomes, which bears sequence similarity to both mammalian CYPIA1 
and CYPIA2, but is apparently more closely related to CYPIA I (Morrison et al. , 
submitted). Scup CYP1Al is the principal catalyst for EROD activity in hepatic 
microsomes (Klotz et al., 1983) and is likely also a catalyst for MROD activity. We found 
that 3,3',4,4'-TCB strongly inhibited both EROD and MROD activities, whereas 
2,2',5,5'-TCB did not (Fig 9), suggesting that 3,3',4,4'-TCB binds to the scup CYP1A1 
active site and 2,2',5,5'-TCB does not. This is consistent with prior work (Gooch et al ., 
1989) showing that 3,3',4,4'-TCB is a competitive inhibitor of EROD activity in scup 
hepatic microsomes with Ki = 0.3 ~M. and that 2,2',5,5'-TCB and 2,2',4,4'-TCB do not 
inhibit EROD activity. In a more recent study using lower protein concentrations and more 
sensitive measurement techniques, a Ki as low as 0.02 ~M was determined for EROD 
inhibition by 3,3',4,4'-TCB (Hahn, unpublished observation). This inhibition is 
consistent with CYPIA1 being a catalyst for the metabolism of 3,3',4,4'-TCB, whereas 
the lack of such inhibition by 2,2',5,5'-TCB suggests that it is not a CYP1Al substrate. 
PROD activity is catalyzed largely by CYP2B forms in rat liver microsomes (Burke et al. , 
1985), although the principal catalyst for this activity has not been identified in fish. The 
very low rate of PROD activity catalyzed by scup hepatic microsomes was not inhibited by 
either TCB congener, possibly suggesting that a P450 form other than CYP1Al or CYP2B 
contributes to this activity. 
Induction of 3.3' .4.4'-TCB metabolism 
Although CYPlAl content and EROD activity were highly induced by treatment offish 
with Ah receptor agonists, the metabolism of 3,3',4,4'-TCB was relatively refractory to 
induction. Thus, scup treated with MC had 40-fold greater rates of EROD activity than 
corn-oil treated scup, but only 2-fold greater rates of TCB metabolism. Similarly, a 
microsomal sample from an MC-treated rat was found to have a 70-fold higher rate of 
EROD activity, but only a 6-fold higher rate ofTCB metabolism, than did a microsomal 
sample from a com-oil treated rat (unpublished observation). 3,3',4,4'-TCB has been 
found to bind tightly to scup CYP1Al in hepatic microsomes, evidenced by EROD 
inhibition (see above Discussion), and co-precipitation using polyclonal antibodies raised 
against scup CYP1A1 (Joy et al., unpublished observation). The reason for such slow 
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metabolism of a substrate which binds tightly and specifically to the scup CYP1A1 active 
site is unclear. 
The slow metabolism in vitro may be due, in part, to the substrate concentration 
used: metabolism assays were generally carried out at 2 J.1M 3,3',4,4'-TCB, which was 
determined to be optimal in kinetic studies, and which is commonly used in mammalian 
metabolism studies. However, the Ki for CYPlAl inhibition by TCB was estimated to be 
from 0.3 J.LM down to 0.02 J.LM in scup (see above). Thus, substrate concentration in the 
assay was 7 to 100 times higher than the concentration that elicits half-maximal inhibition 
of EROD activity. It is possible that substrate inhibition was partially responsible for the 
low rates of TCB metabolism in vitro. The assay was not routinely carried out at lower 
substrate concentrations, however, because assays containing 0.2 J.LM TCB had rates of 
metabolism that were barely detectable (data not shown). 
In a separate study (chapter 2), we present evidence to indicate that TCB elicits 
catalysis-dependent inactivation of scup CYP 1 A 1 in vitro. The inactivation likely involves 
partial uncoupling of the P450 catalytic cycle, and consequent generation of reactive 
oxygen species, during TCB occupation of the CYP1A1 active site (chapter 2). Thus, the 
active pool of microsomal CYP1A1 is gradually inactivated during incubation with TCB 
and NADPH cofactor, which likely contributes to the slow rates of TCB metabolism in 
vitro. The slow, uncoupled metabolism of TCB may be due to steric hindrance, with the 
bulky chlorine substituents preventing facile oxygenation of the substrate. This would 
explain the apparent paradox presented by the tight binding of TCB in the CYP I A 1 active 
site, yet the very slow rate of CYPIA1 metabolism of TCB. 
Teleost CYP2B 
The elevated level of the putative scup CYP2B homologue in hepatic microsomes from 
feral scup is a novel finding. To date there is no conClusive evidence that chemicals can 
elicit CYP2B induction in fish . Several investigators have exposed fish to mammalian 
CYP2B inducers, and failed to see elevation in enzyme activities that are catalyzed by 
mammalian CYP2B enzymes (Addison et al. , 1977; Eisele et al., 1984; Addison et al., 
1987; Ankley et al., 1987; Goks~yr et al., 1987; Elskus and Stegeman, 1989; Haasch et 
al., 1994). A few investigators have treated fish with mammalian CYP2B inducers, and 
have reported increases in CYP2B-like activities (Gutman and Kidron, 1971; Bums, 1976; 
Forlin and Lidman, 1978; Bach and Snegaroff, 1989; Jensen et al., 1991). However, in 
the latter studies the reported increases in activity were either very slight (Gutman and 
Kidron, 1971, p-chloro-N-methylaniline N-demethylase; Jensen et al., 1991, aldrin 
epoxidase), or were not necessarily CYP2B-like activities (Forlin and Lidman, 1978, p-
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nitroanisole 0-demethylase; Bach and Snegaroff, 1989, 7-ethoxycoumarin 0-deethylase). 
In one study (Burns, 1976) there was a reported elevation in aldrin epoxidase activity in 
treated fish, but this activity actually declined when expressed per nmol cytochrome P450, 
indicating that there was no selective increase in CYP2B-like activity. Thus, none of these 
papers provides convincing evidence for actual induction of a CYP2B-like activity, and in 
no case was there reported an elevation in a fish protein homologous to mammalian 
CYP2B. 
Against this background of results, the much greater content of immunodetectable 
P450B, the putative scup CYP2B homologue, in feral scup than in depurated scup 
suggests that some environmental residue or combination of residues may have brought 
about elevated levels of CYP2B. The feral fish had elevated rates of 2,2',5,5'-TCB 
metabolism, a CYP2B-like activity, in terms of both specific activity (activity per mg) and 
estimated turnover number (activity per nmol P450), suggesting elevation (if not actual 
induction) by exogenous chemicals. Exogenous chemical inducers would likely have been 
lost during the one-year depuration period, resulting in lowered levels of CYP2B in all 
groups of depurated/treated scup in our study. The nature of such compounds, and 
whether they resemble mammalian PB-Iike inducers, is not known and will require further 
study. In all groups offish treated with CYP1A-like inducers, there was a slight elevation 
in CYP2B content (Table 1), suggesting that similar compounds in the environment could 
contribute to CYP2B elevation in feral fish. However, the ratio of microsomal CYP2B 
content to CYP1Al content was far higher in the feral fish (1.8) than in the fish treated with 
CYPIA inducers (0.1 - 0.2), indicating P450 regulation by different factors. Alternatively, 
the elevated CYP2B content in feral fish may involve as yet undefined physiological or 
hormonal regulation of this enzyme. 
Implications of TCB metabolism 
The rates of TCB metabolism in scup are far lower than rates of metabolism of polycyclic 
aromatic hydrocarbons in the same species. For example, Stegeman et al. ( 1981) report a 
rate of metabolism of benzo[a]pyrene of 250 pmol/minlmg microsomal protein in hepatic 
rnicrosomes from feral scup, and 964 pmol/minlmg in hepatic microsomes from Me-
treated scup. One might deduce from in vitro data that metabolism is a relatively slow route 
of removal of PCBs, as compared to other xenobiotics, from the tissues of fish. Yet, we 
have detected appreciable quantities of hydroxylated metabolites of 3,3',4,4'-TCB in bile 
and liver of TCB-treated fish, including 2-0H-, 4-0H-, 5-0H-, 6-0H-TCB, and two di-
hydroxy products (White et al., in preparation). Several investigators have presented PCB 
residue data suggesting that metabolism may enhance PCB elimination from fish . Brown 
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(Brown, 1992) conducted an analysis of PCB residues in tissues of 32 teleost species, and 
based on relative depletion of PCB congeners, inferred CYPI A-like PCB metabolism in 18 
species and CYP2B-like PCB metabolism in 4 different species. Some investigators have 
noted selective loss from fish tissues of 3,3',4,4'-TCB and 3,3',4,4',5-PeCB (Niirni and 
Oliver, 1983; de Boer et al., 1993), which suggests CYP1A-like activity. Other 
investigators have noted selective loss from fish tissues of 2,2',5,5'-TCB and several other 
congeners with adjacent, unsubstituted meta-para positions (Boon et al., 1989), which 
suggests CYP2B-like activity. Thus, even low rates of metabolism could contribute to 
PCB disposition over time. 
PCB metabolism, even at relatively slow rates, could result in the production of 
toxic or reactive PCB derivatives. Mono-hydroxy metabolites of ortho-chlorinated PCBs, 
including 2,2',5,5'-TCB, have estrogenic properties in mouse (Korach et al. , 1988). A 
metabolite of 3,3',4,4'-TCB was found to interfere with vitamin A disposition in mouse 
and rat (Brouwer and van den Berg, 1986). Several studies have indicated the metabolic 
production of unstable PCB intermediates, which alky1ate cellular macromolecules (Hesse 
et al., 1978; Shimada and Sato, 1978; Hargraves and Allen, 1979; Morales and Matthews, 
1979; Shimada and Sato, 1980). The presence of PCB metabolites in tissues may thus 
render fish susceptible to a range of deleterious effects. 
In conclusion, we provide evidence indicating that the marine fish scup can 
metabolize both 3,3 ',4,4'-TCB and 2,2',5,5'-TCB to aqueous-soluble derivatives in vitro, 
and that such metabolism is accomplished by CYP1A1 and the putative CYP2B, 
respectively. These results imply that PCB metabolism in teleosts may generally follow the 
same substrate SARs that have been suggested for rat. Such metabolism may provide a 
route for PCB detoxification and elimination in vivo, but may lead to the production of 
toxic or reactive products. Knowledge of the catalysts involved in metabolism is crucial to 
understanding the factors that may up-regulate or down-regulate the turnover of xenobiotics 
in exposed organisms. 
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CHAPTER SIX 
In vitro Metabolism of Polychlorinated Biphenyl (PCB) Congeners by 
Beluga Whale (Delphinapterus leucas) and Pilot Whale (Globicephala melaena): 
Relationship to Cytochrome P450 Expression 
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Abstract 
Marine mammals throughout the world are exposed to PCB contamination, but there is no 
direct information concerning the mechanisms and capacity for PCB metabolism in these 
species. We measured rates of metabolism in vitro of two tetrachlorobiphenyl (TCB) 
congeners, 3,3',4,4'-TCB (TIJPAC #77) and 2,2',5,5'-TCB (TIJPAC #52), in beluga 
whale and pilot whale, as related to content of selected cytochrome P450 forms. Total 
cytochromes P450 and b5 were each present at approximately 0.2 nmol/mg microsomal 
protein in livers of both cetacean species. TCB metabolism was assessed by incubating 
hepatic microsomes with 14c-labeled TCB, followed by liquid/liquid extraction and 
scintillation counting of the aqueous-soluble material . Liver microsomes from male and 
female beluga metabolized 3,3',4,4'-TCB at rates of approximately 21 and 5 pmol/minlmg 
microsomal protein, respectively, rates that were comparable to those seen in rats treated 
with CYPlA inducers. Pilot whale hepatic microsomes had very little capacity to transform 
this congener, with rates ranging from not detectable to 0.3 pmol/min/mg. These sex and 
species differences in rates of TCB metabolism were generally consistent with content of 
immunodetectable CYPlA equivalents. CYP1A content was eleven-fold greater in liver 
microsomes from male beluga than from female beluga, and was close to the limits of 
detection in hepatic microsomes of many pilot whales. Inhibition studies with a.-
naphthoflavone and ethoxyresorufin in beluga liver microsomes indicated that CYPlA is 
likely a major catalyst, but possibly not the sole catalyst, of 3,3',4,4'-TCB metabolism in 
this species. Microsomal metabolism of 2,2',5,5'-TCB was detectable at similar rates in 
the two species (0.3 - 1.1 pmol/minlmg), substantially lower than rates reported by some 
investigators in control rat liver microsomes. Both cetacean species expressed microsomal 
proteins cross-reactive with polyclonal antibodies raised against rabbit CYP2B4 and dog 
CYP2B 10, but not rat CYP2B 1/2. Whether the turnover of 2,2',5,5 '-TCB is catalyzed by 
the cetacean CYP2B-like protein(s) is an open question, as the structure and function of the 
cross-reactive proteins is still unclear. This study demonstrates that PCBs are metabolized 
to aqueous-soluble products in cetacean liver, and coupled with residue data from other 
studies, our data indicate that PCB metabolism plays a role in shaping the patterns of PCB 
residues found in cetacean tissue. 
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Introduction 
Marine mammals are exposed to lipophilic, anthropogenic contaminants throughout 
the world oceans. Polychlorinated biphenyls (PCB) and other chlorinated organics have 
been found in the tissues of many cetacean species, including beluga and pilot whales 
(Tanabe et al., 1987; Muir et al., 1988; Muir et al., 1990; Norstrom et al., 1990; Schantz et 
al., 1993). These odontocete (toothed whale) species may be particularly susceptible to 
bioaccumulation and retention of lipophilic organic contaminants, due to their large lipid 
reservoirs and to their place at the top of oceanic food webs. Despite the high degree of 
exposure, there is very little direct infonnation concerning the capacity of marine mammals 
to metabolize chlorinated organics. 
PCBs are ubiquitous contaminants in marine ecosystems (Tanabe, 1988; Fowler, 
1990) and are characterized by chemical stability and hydrophobicity, which lead to their 
persistence in marine sediments and food webs. The coplanar PCB congeners that possess 
meta and para but no ortho-substituents are Ah-receptor agonists, and elicit a suite of toxic 
responses in laboratory mammals similar to those elicited by 2,3,7,8-tetrachlorodibenzo-p-
dioxin (reviewed in Goldstein and Safe, 1989). Some ortho-substituted, non-coplanar 
PCB congeners have been reported to cause DNA damage (e.g. Stadnicki et al., 1979) and 
to elicit neurotoxic effects (Shain et al., 1991; Kodavanti et al., 1993) in laboratory 
mammals. Studies of PCB toxicity in marine mammals are necessarily more limited. 
Investigations have indicated that dietary PCB is linked to reproductive failure (Reijnders, 
1986), vitamin A deficiency, and thyroid honnone deficiency (Brouwer et al., 1989) in 
common seals. 
In addition to toxicity mediated by PCB parent compounds, the process of PCB 
metabolism may be deleterious as well. PCB congeners and mixtures can be metabolically 
activated to unstable intennediates which alkylate cellular macromolecules (Hesse et al., 
1978; Shimada and Sato, 1978; Hargraves and Allen, 1979; Morales and Matthews, 1979; 
Shimada and Sate, 1980). Some hydroxylated PCB metabolites have inherent toxicity as 
well. Mono-hydroxy metabolites of ortho-chlorinated PCBs, including 2,2',5,5'-TCB, 
have estrogenic properties in the mouse (Korach et al., 1988). A metabolite of 3,3',4,4'-
TCB was found to interfere with vitamin A disposition in mouse and rat (Brouwer and van 
den Berg, 1986). In spite of the production of reactive intennediates and metabolites, 
many studies have found that PCB metabolism is a principal pathway for both 
detoxification (Yoshimura et al., 1987; Klassen Wehler et al., 1990) and for elimination 
(reviewed in Birnbaum, 1985) in vertebrates. 
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In rodents, the oxidative metabolism of PCBs is catalyzed primarily by 
cytochromes P450, which play a role in both the detoxification and the activation of 
substrates. Studies have indicated that structure-activity relationships govern the 
metabolism of PCBs by cytochromes P450, with chlorine position determining which 
P450 enzyme carries out the transformation. In rat liver, CYPIA forms effectively 
metabolize congeners with halogenated substituents at one or both para positions, and with 
adjacent unsubstituted ortho-meta carbons, while PB-inducible CYP2B forms preferentially 
metabolize congeners with adjacent, unsubstituted meta-para positions (Kaminsky et al. , 
1981 ; Kennedy et al., 1981; Shimada and Saw abe, 1983; Mills et al., 1985; Ishida et al., 
1991). These studies also indicate that congeners with two or more ortho substituents are 
more rapidly metabolized by rat CYP2B than by CYP 1 A, whereas congeners with no ortho 
substituents are more rapidly metabolized by rat CYP1A than by CYP2B. 
The hepatic cytochrome P450 system has been studied in few cetacean species, 
namely beluga whale (White et al. , 1994 ), minke whale (GoksS!Syr et al. , 1986; GoksS!Syr et 
al., 1988), short-finned pilot whale, killer whale, and striped dolphin (Watanabe et al. , 
1989). There have been no direct studies of PCB metabolism in cetaceans. Several 
investigators have inferred rates and catalysts involved in cetacean PCB metabolism, based 
on PCB residues detected in tissues (Tanabe et al. , 1988; Duinker et al., 1989; Norstrom et 
al., 1992). For example, based on the relative enrichment of meta-para unsubstituted PCB 
congeners in cetacean tissue, it has been suggested that monooxygenase activities 
characteristic of CYP2B are reduced in cetaceans as compared to terrestrial mammals 
(Tanabe et al., 1988; Norstrom et al., 1992). 
In this study we provide the first direct evidence of chlorobiphenyl metabolism in 
cetaceans. We describe in vitro metabolism of two tetrachlorobiphenyl (TCB) congeners 
by hepatic microsomes from beluga whale and pilot whale: 3,3' ,4,4'-TCB (IUPAC #77), 
a rat CYP1A substrate and an Ah receptor agonist, and 2,2',5,5'-TCB (IUPAC #52), a 
substrate of PB-inducible rat CYP2B forms. The results demonstrate that these beluga had 
a relatively substantial capacity to metabolize 3,3',4,4'-TCB, whereas the pilot whales 
analyzed had a very limited capacity for such metabolism. The relative rates of this activity 
were consistent with the relative contents of microsomal CYP1A, which were low in most 
of the pilot whales but appeared to be induced in some of the beluga. Both species 
metabolized 2,2',5,5'-TCB at low but detectable rates, and immunoblots showed the 
expression of CYP2B-like proteins in both species. These CYP2B-like proteins may be 
involved in the metabolism of 2,2',5,5'-TCB in cetaceans, but this remains speculative, as 
their structure and function are not yet described. 
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Materials and Methods 
Chemicals 3,3',4,4'-TCB [U-14q (52.1 mCilmmol) was purchased from Pathfinder (St. 
Louis, MO). Analysis by GC/ECD and GC/MS revealed no hydrophobic contaminant 
peaks(> 99% pure); small polar contaminants were completely removed by dissolving the 
TCB in hexane and extracting twice with NaOH. 2,2',5,5'-TCB [U~ 14q (14.2 
mCi/mmol) was purchased from Sigma (St. Louis, MO). This product was determined to 
be> 98% pure by HPLC analysis, conducted on an ODS-2 column by the manufacturer. 
Unlabeled 3,3',4,4'-TCB was obtained from Pathfinder (St. Louis, MO). Purity of the 
TCB was> 99% by GC/ECD and GC/MS analysis. Unlabeled 2,2',5,5'-TCB was 
obtained from Ultrascientific (North Kingstown, RI). Manufacturer analysis by GCIFID 
indicated> 99% purity. Ethoxyresorufin was from Molecular Probes (Eugene, OR). All 
other chemicals used were of the highest grade available from commercial suppliers. 
Antibodies used are described below. 
Tissues Beluga whales (Delphinapterus leucas) from the Husky Lakes of the Tuktoyuktuk 
peninsula, on the MacKenzie River delta (Canadian Arctic), were hunted by local Inuit in a 
subsistence harvest in November 1989. Collection and preparation of these samples have 
been described elsewhere (White et al., 1994). The six beluga samples used in TCB 
metabolism studies were selected to represent the full range of cytochrome P450 content in 
this population. These included three females with relatively low (female-typical) P450 and 
CYP1A, and three males with relatively high (male-typical) P450 and CYP1A. 
Pilot whales (Globicephala melaena) were found stranded on Cape Cod, 
Massachusetts, during December 1990 and September-October 1991 . Some animals died 
naturally, while others were euthanized with pentobarbital by authorized personnel of the 
New England Aquarium. Liver samples were removed at times ranging from 5 minutes to 
several hours after death, and immediately frozen in liquid nitrogen. Samples from nine 
pilot whales were selected for TCB metabolism studies. These included the 6 animals with 
the shortest time interval between euthanasia and sample freezing (5 to 45 minutes), and 
thus with the lowest chance of having enzyme degradation in the samples. These were all 
from the 1991 stranding. Also assayed were 3 animals with relatively high CYP 1 A 
content, all from 1990. The latter samples were collected approximately 2 to 3 hours 
subsequent to death or euthanasia. Hepatic microsomes were prepared by differential 
centrifugation as previously described (White et al., 1994), and microsomal protein content 
was measured with the bicinchoninic acid method (Smith et al ., 1985), using bovine serum 
albumin as a standard. 
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Hepatic microsomes from rat were provided by Dr. Mark Melancon (U.S. Fish and 
Wildlife Service, Laurel, MD). Fisher-344 rats were treated by intraperitoneal injection 
with either com oil (control, day I), 3-methylcholanthrene in corn oil (MC, 20 mglkg, day 
I), or phenobarbital in saline (PB, 80 mg/k.g, days I, 2, 3). Animals were killed on day 
four by decapitation, and microsomes were prepared by differential centrifugation 
(Melancon et al., I990). 
Microsome characterization The content of microsomal P450 was determined using 
dithionite difference spectra of CO-treated samples (Stegeman and Binder, I979), with an 
extinction coefficient of 9I mM-I cm-1 (Omura and Sato, 1964). Ethoxyresorufin 0-
deethylase (EROD) activity in beluga was quantified at 3TC using the spectrophotometric 
kinetic assay of Klotz et al. ( I984 ). EROD activity in pilot whale samples was measured 
similarly, but rates in many samples were below the limits of detection of the 
spectrophotometric assay. EROD rates in pilot whale were thus quantified at 32·c with a 
fluorometric kinetic assay, using a Cytofluor 2300 fluorescence plate reader (Millipore), as 
described previously (Hahn et al., I993). The fluorometric rates are reported here. 
Imrnunoblot (Western blot) analysis was performed as previously described 
(Kloepper-Sams et al., 1987; Stegeman et al., 1991 ). Primary antibodies used were as 
follows: monoclonal antibody 1-I2-3, raised against cytochrome P450E from the marine 
fish scup (a CYP1A1 homologue) (Park et al., 1986); polyclonal antibody 7-94, raised 
against scup cytochrome P450B (Gray, 1988), which is likely a CYP2B form (Stegeman et 
al., 1990a; Stegeman et al., I990b); anti-P450PB4, a polyclonal antibody against rat 
CYP2B I, provided by Dr. David Waxman (Dana-Farber Cancer Institute, Boston, MA) 
(Frey et al., 1985); anti-P450LM2, a goat polyclonal antibody against raised against PB-
inducible rabbit CYP2B4, obtained from Oxford Biomedical Research, Inc. (Oxford, MI); 
and anti-PBD2, a polyclonal antibody raised against PB-inducible dog CYP2B 10, provided 
by Dr. James Halpert (University of Arizona) (Duignan et al., 1987). Antibodies raised 
against scup P450B and rat CYP2B I show reciprocal cross-reactivity, each recognizing the 
same protein bands in both rat microsomes and in scup microsomes (White et al., I994). 
MAb 1-12-3 has been shown to strongly cross-react with mammalian CYPlAl but not 
CYPIA2 (Park et al., I986; K.loepper-Sams et al., 1987). Secondary antibodies used were 
alkaline phosphatase linked goat-anti-mouse IgG, goat-anti-rabbit IgG, and rabbit-anti-goat 
IgG. Blots of pilot whale samples with MAb I-12-3 were probed and developed using the 
Enhanced Chemiluminescent Detection kit of Schleicher and Schuell (Keene, NH), 
according to manufacturer's instructions. 
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Content of the P450E homologue (P450 1 A) in beluga and pilot whale microsomes 
was quantified by densitometric scanning of MAb 1-12-3-reactive bands with a video 
imaging system (Masterscan, Scanalytics, division of CSPI, Billerica, MA), and 
comparison to P450E standards. Because the strength with which MAb 1-12-3 recognizes 
P450E homologues may differ between species, CYP 1 A levels deduced from immunoblots 
represent relative rather than absolute values for each species. 
TCB metabolism assay The assay of Schnellman et al . (1983) was used, with 
modifications, to measure metabolism of 3,3',4,4'-TCB and 2,2',5,5'-TCB. Incubations 
were performed at 37•c under air in a shaking incubator. Incubations were 0.5 m1 (unless 
specified otherwise) and contained 1 mg/ml microsomal protein, 50 mM Tris, pH 7 .6, 0.1 
mM EDTA, and 5 J..LM 14C-labeled TCB dissolved in acetone (acetone concentration in the 
incubations was approximately 3%). The TCB concentration used in the assay was similar 
to concentrations that have been used in studies of TCB metabolism in rat hepatic 
microsomes (e.g. Ghiasuddin et al., 1976; Mills et al., 1985). After a 2-minute pre-
incubation, reactions were initiated by the addition of 1 mM NADPH and run for 30 
minutes. Reactions were terminated by the addition of0.75 ml of0.5 N NaOH, and heated 
at 7o·c for 10 minutes to aid in microsome solubilization (Schnellman et al., 1983). To 
remove parent TCB, the samples were extracted two to three times with 2.5-ml aliquots of 
n-hexane : 100% ethanol (19: 1 ). 500 J..Ll of the aqueous/NaOH phase was then neutralized 
with HCl and combined with 6 ml Scintiverse TI (Fisher Scientific), and I4c in this phase 
was measured with liquid scintillation counting on a Beckman LS5000TD counter. Rate of 
production of aqueous-soluble metabolites was calculated by subtracting the aqueous 
radioactivity in blank incubations containing either boiled microsomes or no microsomes 
(both blanks gave similar results), and converting to pmol of PCB equivalents. The limits 
of resolution of the assay were approximately 20 dpm, giving approximate detection limits 
of 0.03 pmol/minlmg for 3,3',4,4'-TCB metabolism, and 0.1 pmol/min/mg for 2,2',5,5'-
TCB metabolism. Duplicate assays were performed on each sample. The amount of 
substrate converted to aqueous metabolites was 12% for male beluga with 3,3',4,4'-TCB, 
3% for female beluga with 3,3',4,4'-TCB, and< 1% for all other assays . It is thus 
reasonable to assume that substrate depletion did not occur, and that the assay conditions 
used (30 minutes, 1 mg/ml) gave results that were within the linear range for these 
activities. 
Studies were conducted to assure that any residual pentobarbital in pilot whale 
microsomes was not inhibitory to metabolism of 2,2',5,5'-TCB. Microsomes were pre-
incubated at 37•c for 10 minutes in a Tris buffer (see above) with NADPH cofactor, to 
171 
allow for pentobarbital metabolism. 14c-labeled TCB was then added to initiate the TCB 
metabolism assay, which was conducted as described above. The rates of TCB 
metabolism in these incubations were nearly identical to the rates of duplicate tubes that 
were not pre-incubated. 
Inhibition studies TCB metabolism assays were conducted with beluga hepatic 
microsomes, as above, in the presence of the CYP1A inhibitor a-naphthoflavone (ANF). 
Microsomes and buffer were combined, ANF added first, then TCB substrate, and 
reactions were initiated with NADPH. ANF was dissolved in methanol and added at final 
concentrations of 1 ~. 10 ~.and 100 J..LM ANF (5 J..Ll added to 250 Jll reaction volume). 
Methanol alone (5 J..Ll) was added to control and blank incubations. Each assay was 
performed in duplicate. 
Fluorometric, kinetic EROD assays were conducted with beluga hepatic 
microsomes, as described above, in the presence of potential inhibitors. Microsomes, 
buffer, and ER substrate were combined, ANF or TCB inhibitor added, and reactions were 
initiated with NADPH. ANF was dissolved in methanol and added at final concentrations 
of 1 J..LM, 10 J..LM, and 100 J.LM (4 J..Ll added to 200 Jll reaction volume); 4 J..Ll methanol alone 
was added to control incubations. The two TCB congeners were each dissolved in acetone 
and added at final concentrations of 1.0 J..LM, 0.75 J..LM, 0.5 J.LM, and 0.25 J..LM (1 J..Ll added 
to 200 J..Ll reaction volume); 1 Jll acetone alone was added to control incubations. Each 
assay was performed in duplicate. Protein concentration in the EROD assay was 0.2 
mg/ml, and substrate concentration was 2 J..LM ER. 
XAD column chromatography Aqueous-soluble metabolites of 14C-labeled 3,3',4,4'-TCB 
were generated in beluga hepatic microsomes as above. Incubations were extracted with 
hexane/ethanol as above, and the remaining aqueous/NaOH sample was applied to an XAD 
column. Columns were prepared by pouring 5 em of dry XAD-2 (coarse) resin (Amberlite 
polystyrene beads, Sigma) into a glass pasteur pipette, with a glass wool plug at the 
bottom. The column was pre-washed with several milliliters each of water, methanol, 
acetone, and water again, before sample application. Sample was applied and the column 
was sequentially washed with several milliliters each of water, methanol, and acetone. 
Each 1 ml fraction was collected and dried in a 6o·c oven to reduce solvent volume. 5 ml 
of Scintiverse II was added to each sample, and metabolites were quantified by liquid 
scintillation counting as above. When parent TCB alone was mixed with assay buffer and 
added to a column, all radioactivity eluted with acetone washes. 
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Statistics Significant differences between sample groups were evaluated with a one-factor 
ANOVA test, using Statview SE+ Graphics, v.1 .03 (Abacus Concepts) for Macintosh. 
Results 
Microsomal monooxygenase systems 
The content of microsomal cytochromes P450 and b5 determined for 18 pilot whales are 
listed in Table 1, and compared to our previously published results for beluga whale. 
Values for pilot whales are separated into two groups, which were stranded in separate 
years. The beluga were presumably all of a single social group. Average values for P450 
and b5 ranged from 0.2 - 0.3 nmollmg microsomal protein, in all groups. Three male and 
three female beluga selected for TCB metabolism studies had average P450 content of 
0.325 and 0.182 nmol/mg, respectively (Table 2). This sexual dimorphism in enzyme 
content was typical for the beluga population (White et al. , 1994). Nine pilot whale 
samples were selected for TCB metabolism studies, with average P450 contents of 0.314 
and 0.211 nmol/mg in the 1990 and 1991 subgroups, respectively (Table 2). 
Monooxygenase components and activities were not sexually differentiated in the pilot 
whale populations examined, so mixed-sex averages are presented. 
Immunoblot analysis with the CYP1A1-specific monoclonal antibody 1-12-3 
revealed a single cross-reactive protein in each pilot whale liver sample (Fig 1). Beluga 
liver microsomes were previously shown to have a single 1-12-3 cross-reacting protein 
(White et al., 1994). Until sequence data is available, we will refer to these 
immunoreactive proteins as members of the P450 I A subfamily, or CYP 1 A homologues. 
Average specific content of the cetacean CYPIA homologue was similar in beluga and 
1990 pilot whale, whereas average content in 1991 pilot whale was significantly less than 
that in beluga (Table 1). EROD activity, catalyzed predominantly by CYP1A in mammals, 
varied widely within each species: 24 - 750 pmol/minlmg in beluga, 3 - 520 pmollminlmg 
in pilot whale. As with CYP1A, average EROD rates for 1990 pilot whale and for beluga 
were similar, whereas rates in the 1991 pilot whale group were significantly less than those 
in beluga (Table 1 ). 
Within each species, there was a strong positive correlation between EROD activity 
and immunodetectable CYP1A content (pilot: Fig 2; beluga: White et al., 1994), consistent 
with the cetacean CYP1A homologue being a principal catalyst for microsomal EROD 
activity. Among the animals selected for TCB metabolism studies, the male beluga had 11-
fold greater CYP1A content and 15-fold higher EROD rates than did the selected females. 
The 1990 pilot whale sub-group selected for analysis had 30-fold greater CYPIA content 
173 
TABLE 1 
Microsomal Monooxygenase Components and Activities in Pilot and Beluga Liver Samples 
Pilot whale, 1990 Pilot whale, 1991 Beluga whale a 
(n =4) (n = 14) (n = 13) 
Cytochrome P450 0.275 ± 0.142 0.207 ± 0.079 0.274 ± 0.089 
(nmollmg) 
Cytochrome b5 0.210 ± 0.045 0.219 ± 0.062 0.222 ± 0.034 
(nmollmg) 
EROD activity 239 ± 211 33 ± 62 * 291 ± 261 
(pmollrnin/mg) 
CYP1A 17 ± 9 3±7* 37 ± 28 
(pmol P450E/mg) b 
All values are expressed as sample means± standard deviations based on (n-1 ). 
* Values in 1991 pilot whale are significantly less than those in beluga at p S 0.01, based 
on a one-factor ANOVA test. 
a Data reported by White et al., 1994. 
b The strength of cross-reaction with MAb 1-12-3 may be species-specific, thus 
immunochernical comparisons across-species are not strictly quantitative. 
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TABLE2 
TCB Metabolism Rates and P450 Parameters in Selected Cetacean Samples 
Beluga whale, male a Beluga whale, female a Pilot whale, 1990 b Pilot whale, 1991 b 
(n = 3) (n = 3) (n = 3) (n =6) 
Cyt P450 (nmol/mg) 0.325 ± 0.046 0.182 ± 0.070 0.314 ± 0.146 0.211 ± 0.031 
EROD (pmol/min/mg) 563 ±55 * 38 ± 22 306 ± 199 7±5 
CYP I A (Emol/mg) c 67.0 ± 6.7 * 5.9 ± 2.1 19.4 ± 8.4 0.6 ± 0.7 
3,3',4,4'-TCB-OH 
(pmol/min/mg) 21.48 ± 1.59 # 4.88 ± 0.36 0.24 ± 0.06 0.04 ± 0.07 
(pmol/min/nmol P450) 66.64 ± 7.39 # 29.06 ± 8.68 0.92 ± 0.45 0.18 ± 0.35 
(pmollmin/nmol CYP I A) 321.9 ± 25.5 870.8 ± 212.1 14.7 ± 7 .5 50.8 ± 73.3 
2,2',5,5'-TCB-OH 
(pmol/min/mg) 1.14 ±0. 10 :j: 0.32 ± 0.10 0.40 ± 0.07 
(pmol/min/nmol P450) 3.54±0.51 :j: 1.80 ± 0.18 1.96 ± 0.49 
All values are expressed as mean ± standard deviation based on (n-1 ). Sample groups are statistically different from each other at 
p::::; 0.01, as follows: * male beluga> 1990 pilot> female beluga= 1991 pilot;# male beluga> female beluga> 1990 pilot= 
199 1 pilot; :j: male beluga> female beluga= pilot, based on a one-factor ANOV A test. 
a Cytochrome P450, CYP1A, and EROD data for the beluga are taken from White et al., 1994. 
b Data for pilot whales are mixed-sex averages, as no sex differences were seen. 
c CYP1A is expressed as pmol of P450E equivalents/mg. 
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Figure 1. Imrnunoblot of hepatic microsomes from pilot whale with MAb l- 12-3, raised 
against scup P450E (CYPlAJ). Proteins were separated by SDS-PAGE and transferred to 
nitrocellulose by electroblotting. The membrane was incubated in 1" and 2" antibodies as in 
Methods, and CYP I A was visualized by alkaline-phosphatase color development. Lanes 
are as foJlows: I and 2, 1990 samples; 3, 4 , and 5, 1991 samples; 6, scup hepatic 
rnicrosomes; 7, molecular weight standards. 
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Figure 2. Correlation between hepatic microsomal EROD activity, assayed 
fluorometrically, and immunodetectable CYP I A content in I7 pilot whales. Content of the 
CYPIA homologue was measured as described in Figure I and Methods. 
R2 = 0 .787. 
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and 40-fold higher EROD rates than did the 1991 sub-group; neither CYP1A content nor 
EROD activity was sexually differentiated in the pilot whales (Table 2). 
Immunodetection of cytochrome P4502B 
Hepatic microsomes from both species were immunoblotted with polyclonal antibodies 
specific for cytochromes P4502B. Neither anti-rat CYP2B 1 nor anti-scup P450B cross-
reacted with cetacean microsomes. However, anti-rabbit CYP2B4 recognized a protein 
band in the molecular weight region of cytochromes P450 in pilot whale (Fig 3A) and 
beluga whale (White et al., 1994). Anti-dog CYP2Bl0 also recognized protein(s) in the 
P450 region, in hepatic.microsomes from both cetacean species (Figs 3B and 3C). The 
major band(s) detected in the cetacean samples by both the rabbit and the dog antibodies 
appear to be protein(s) of slightly lower electrophoretic molecular weight than those of the 
immunogens, and slightly lower than that of the major protein detected in liver microsomes 
from phenobarbital-treated rat (Fig 3). The content of the detected protein(s) did not appear 
to vary markedly between species or between sexes. We tentatively conclude that the 
cross-reactive proteins represent members of the CYP2 family in cetacean liver. 
TCB metabolism 
The rate of metabolism of 3,3',4,4'-TCB was five times greater in liver microsomes from 
male beluga than from female, when expressed per milligram of microsomal protein (Table 
2). This sex difference remained significant when activity was expressed per nmol total 
cytochrome P450, however, females had a greater capacity to metabolize this congener per 
nmol CYPlA (Table 2). These metabolic rates are comparable to those that have been 
reported in liver microsomes from rats treated with CYP1A inducers (see Discussion). In 
contrast, hepatic microsomes from pilot whales of both sexes had very limited capacity to 
metabolize 3,3',4,4'-TCB (Table 2) . Rates in the samples from 1991 were near the limits 
of detection of the assay, and rates in the samples from 1990 were only slightly greater. In 
both species, rates of 3,3',4,4'-TCB metabolism were positively correlated with relative 
content of immunodetectable CYPlA and with rates of EROD activity (Fig 4), consistent 
with cetacean CYPIA being a principal catalyst for the metabolism of 3,3',4,4'-TCB in 
vitro. 
Rates of metabolism of 2,2',5,5'-TCB were similar in the two whale species (Table 
2), and were slow by comparison to rates that have been reported in rat liver microsomes 
(see Discussion). The pilot whales metabolized this congener at rates that were two to ten 
times faster than the rate of metabolism of 3,3',4,4'-TCB. The belugas metabolized this 
congener at less than one-tenth the rate of metabolism of 3,3',4,4'-TCB. Rates of 
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Figure 3. SDS-PAGE immunoblots of cetacean liver microsomes with anti-CYP2B 
polyclonal antibodies. (A) Pilot whale microsomes with anti-P450LM2, raised against 
rabbit CYP2B4. (B) Pilot whale microsomes with anti-PBD2, raised against dog 
CYP2B10. (C) Beluga whale microsomes with anti-PBD2, raised against dog CYP2B10. 
Lane 1, PB-treated rat liver rnicrosomes; lanes 2-7, pilot or beluga whale (70 ~g protein/ 
lane); lane 8, purified rabbit P450LM2 (A) or purified dog CYP2B 10 (B,C). 
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Figure 4. Rate of metabolism of 3,3',4,4'-TCB versus immunodetectable CYPIA content 
(A) and versus EROD activity (B) in liver microsomes from beluga whale and pilot whale. 
Squares are beluga, circles are pilot whale. TCB metabolism was assayed radiometrically 
as described in Methods, and is expressed as pmol/minlmg (beluga) or 10 x pmol/rnin/mg 
(pilot). CYPlA content was determined immunochemically as in Figure 1, and EROD 
activity was assayed either spectrophotometrically or fluorometrically , as outlined in 
Methods. (A) r2 = 0.990, beluga, and r2 = 0.756, pilot. (B) r2 = 0.998, beluga, and r2 = 
0.526, pilot. 
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2,2',5,5'-TCB metabolism in male beluga were slightly, but significantly, greater than 
those in female (Table 2). 
Inhibition studies 
To further define the role of CYP1A in cetacean TCB metabolism, we examined the 
capacity of the two TCB congeners to inhibit EROD activity in beluga liver microsomes. 
EROD is catalyzed principally by CYP1A in mammals, including beluga whale (White et 
al., 1994). The Ki for inhibition of EROD activity in rat liver microsomes has been found 
to be 0.015 ~M for 3,3',4,4'-TCB and 0.54 ~M for 2,2',5,5'-TCB (DeMatteis et al., 
1989). In beluga, however, the TCB congeners were far less inhibitory toward EROD 
activity. Concentrations of 0.25- 1.0 ~M 3,3',4,4'-TCB inhibited EROD activity by 10% 
- 16%, while similar concentrations of 2,2',5,5'-TCB did not inhibit EROD activity at all 
(Fig 5). In contrast, ANF, which is known to be a strong inhibitor of mammalian CYP1A 
in vitro (Testa and Jenner, 1981 ), inhibited beluga EROD activity by 97% at 1.0 ~M (Fig 
5). 
Concentrations of ANF up to 100 ~M had limited capacity to inhibit the metabolism 
of either TCB congener in beluga hepatic microsomes (Fig 6). Metabolism of 3,3',4,4'-
TCB was inhibited by 36-47%, and metabolism of 2,2',5,5'-TCB by 0-15%. By contrast, 
100 ~M ANF inhibited beluga EROD activity completely (Fig 6), and inhibited 
benzo[a]pyrene metabolism by 60-100% in beluga liver micro somes (White et al., 1994 ). 
Metabolite characterization 
Metabolites of 3,3',4,4'-TCB generated in vitro by beluga liver microsomes were separated 
with liquid chromatography on XAD resin (Fig 7 A). Incubations carried out with several 
beluga samples were extracted once with hexane:ethanol ( 19: 1) to remove most of the 
parent compound, and then pooled for metabolite analysis. Following sample application, 
peaks of radioactivity eluted from the column with the first 2 ml of water, the first 4 ml of 
methanol, and the first 4 ml of acetone. The acetone peak did not appear when metabolism 
assays were extracted once more with hexane:ethanol prior to application on the column 
(not shown). When parent TCB alone was added to the column, it adhered to the matrix 
during water and methanol washes and only eluted with acetone (Fig 7B). We therefore 
attribute the acetone peak in figure 7A to unmetabolized parent TCB. The peaks that elute 
with water and methanol contain specifically-labeled compounds of a more polar nature 
than TCB itself, which we conclude to be hydroxylated TCB derivatives generated during 
in vitro metabolism of 14c-labeled TCB. The presence of two discrete metabolite peaks 
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Figure 5. Inhibition of EROD activity in beluga liver microsomes by TCB and ANF. 
EROD activity was assayed fluorometrically , using a pooled sample of two male belugas. 
Potentially inhibitory compounds were added at concentrations of 0.25 - 1.0 ~. ER 
substrate was used at 2 ~. and protein concentration was 0.2 mg/rnl, as detailed in 
Methods. Each point is a mean of two measurements. 
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Figure 6. Inhibition of enzyme activities in beluga liver microsomes by ANF. TCB 
metabolism assays were conducted radiometrically, using a pooled sample of two male 
belugas (1 mg microsomal protein/ ml assay). EROD activity was measured 
fluorometrically on the same sample (at 0.2 mg/ml) as described in Methods. ANF was 
dissolved in methanol and added to assays at final concentrations of 1 ~M, 10 ~. and 100 
~M. Each point is a mean of two measurements. 
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Figure 7. XAD column profiles of 3,3',4,4'-TCB metabolites produced in microsomes 
from a male beluga whale (A), and of 3,3',4,4'-TCB parent compound (B). Metabolites 
were generated and separated on the column as described in Methods. Bars represent the 
radioactivity contained in each 1 rnl fraction, eluted from the column as it was washed with 
1 rnl aliquots of water, methanol, and acetone. The first three (A) or first one (B) fractions 
are H20 column blanks, the next fraction was eluted as sample was applied to the column. 
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suggests the formation of two classes of TCB metabolites, with different degrees of 
aqueous solubility. 
Discussion 
Cetaceans throughout the world have been found to contain chlorobiphenyls and 
other polyhalogenated aromatic hydrocarbons in their tissues. Inferences have been made 
regarding disposition of these compounds, based on relative concentrations found in 
cetacean and other environmental samples. However, there is no quantitative information 
on the capacity of these animals to transform and eliminate such compounds. In the case of 
protected species like marine mammals, the study of in vitro pollutant metabolism is one of 
the few tools available to assess this capacity. We have quantified the rates of metabolism 
of two tetrachlorobiphenyl congeners by hepatic microsomes from beluga whale and pilot 
whale. The rates of metabolism of 3,3',4,4'-TCB in beluga samples were comparable to 
those reported in induced rat liver (see below), whereas the rates of this activity in pilot 
whale samples were comparatively slow. We report a moderate rate of metabolism of 
2,2',5,5'-TCB in both cetacean species. The production of polar TCB derivatives in vitro 
suggests the capacity for biotransformation of TCBs in vivo, which would allow for 
detoxification and elimination, but may also lead to the production of toxic or reactive 
metabolites. 
Monooxygenase systems 
The values reported here for pilot whale cytochromes P450 and b5 and for EROD activity 
are similar to those reported for other cetacean species, specifically beluga whale (White et 
al., 1994 ), minke whale (Goks¢yr et al., 1986; Goks¢yr et al., 1988), and short-finned 
pilot whale, striped dolphin, and killer whale (Watanabe et al., 1989). The strong positive 
correlation between CYP1A content and EROD activity (Fig 2) suggests that a CYP1A 
form is the principal catalyst of this activity in pilot whale, as is generally the case in 
mammals. We speculate that expression of CYPlA in pilot whale may be related to body 
burden of Ah receptor agonists, as it is in beluga (White et al., 1994). The pilot whales 
stranded in December 1990 had significantly greater CYP1A content and EROD activity 
than did the indi victuals stranded in September -October, 1991. Because of the small 
sample size and the large spread in values, this inter-group difference may be due to 
statistical sampling error (i.e. chance differences, when randomly sampling from two 
similar populations). However, the inter-group difference also suggests that the two 
populations had different exposure histories. Pilot whales from the western North Atlantic 
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have been found to accumulate appreciable concentrations of DDTs, PCBs, chlordanes, 
and other chlorinated organics (Muir et al., 1988), some of which are potential CYPIA 
inducers. Exposure to such compounds would depend both upon geographic range, and 
on contaminant residues in prey populations. The two groups of pilot whales in this study 
were stranded on different months and in separate years, suggesting that differential 
exposure (particularly differential recent exposure) was possible. 
3.3',4,4'-TCB metabolism 
The rates of metabolism of 3,3',4,4'-TCB in male beluga hepatic microsomes were similar 
to rates reported in hepatic microsomes from rats treated with CYP1A inducers: 18 and 50 
pmoVmin/mg in MC-treated rats (Mills et al. , 1985; Ishida et al., 1991 ), and 22 
pmoVmin/mg in rats treated with Aroclor 1254 (Borlakoglu and Wilkins, 1993). In an 
earlier study (White et al., 1994) we provided evidence indicating that hepatic CYP1A in 
these beluga was induced by exposure to environmental contaminants, including coplanar 
PCBs. Such induction may explain the elevated rates of TCB metabolism in these beluga. 
The strong sex difference in rate of 3,3',4,4'-TCB metabolism is consistent with sex 
differences in CYPIA content and in blubber concentration of coplanar PCBs in this 
population (White et al., 1994). It should be noted, however, that these "high" rates of 
TCB metabolism are still one order of magnitude slower than the rates of metabolism of 
benzo[a]pyrene in hepatic microsomes of the same individuals (White et al., 1994). 
The pilot whale samples selected for TCB metabolism analysis had very limited 
capacity to transform 3,3',4,4'-TCB, in comparison to rat and beluga. Despite apparently 
elevated CYP1A content and EROD activity in the individuals stranded in 1990, the rates of 
metabolism of 3,3',4,4'-TCB in this group were only slightly higher than rates in the 1991 
group. The low rates in the 1990 group may be related to sample deterioration, as these 
animals were not dissected until some hours after death (see Methods). However, we 
doubt that to be the case, since rates of EROD activity were relatively high in the 1990 
samples. It is possible that the two cetacean species simply possess different capacities for 
this activity, which may involve differences in CYPIA or differences in the contributions 
of non-CYP1A catalysts to this activity (see below). Similar levels of CYP1A expression 
do not bring about similar rates of 3,3',4,4'-TCB metabolism in the two cetacean species: 
rate of TCB metabolism per nmol CYP1A was far lower in the pilot whales (Table 2), 
despite the fact that rate of EROD activity per nmol CYP I A was similar between the two 
species. 
Our data suggest that CYP1A is a principal catalyst for the metabolism 3,3',4,4'-
TCB in cetaceans, as has been shown in rats (Shimada and Saw abe, 1983; Mills et al., 
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1985; Ishida et al., 1991). The rate of metabolism of 3,3',4,4'-TCB by each cetacean 
species was positively correlated with imrnunodetectable CYPIA content and with rate of 
CYP1A-mediated EROD activity (Fig 4), indicating that CYPlA contributes to this activity 
in cetaceans. Inhibition studies with beluga liver microsomes (Figs 5 and 6) further 
indicate a role for CYPIA in the metabolism of 3,3',4,4'-TCB. In the first inhibition 
study, EROD activity was inhibited almost 100% by 1 j..lM ANF, 16% by 1 j..lM 3,3',4,4'-
TCB, and 0% by 1 j..lM 2,2',5,5'-TCB. This result suggests that 3,3',4,4'-TCB has some 
ability to bind to and inhibit the beluga EROD catalyst (CYP1A), although such binding 
appears weak by comparison to ER or ANF binding. 3,3',4,4'-TCB appears to be a 
weaker EROD inhibitor in hepatic microsomes of beluga than in hepatic rnicrosomes of 
other species studied. The Ki for EROD inhibition by 3,3',4,4'-TCB has been determined 
to be I5 nM in rat, 15 nM in chick embryo (De Matteis et al., 1989), and 20 nM in the 
marine fish scup (Hahn, unpublished observation). Although we did not determine a Ki 
for beluga, it would appear to be in excess of I j..lM 3,3'4,4'-TCB. This result may 
suggest a cetacean CYP1A of slightly different structure, reflecting the divergent evolution 
of marine mammals. This question will ultimately be addressed by sequencing the beluga 
CYP I A gene and comparing to sequences of animals from other classes and orders. 
In the second inhibition study, ANF inhibited EROD activity by almost 100%, 
3,3',4,4'-TCB metabolism by up to 47%, and 2,2',5,5'-TCB metabolism by 0-15%. 
ANF is a strong inhibitor of CYP1A catalytic activity in mammals, but recent evidence 
indicates that it is not entirely specific for inhibition of CYP1A forms (Chang et al., 1994). 
Therefore, an approximately 50% inhibition of cetacean 3,3',4,4'-TCB metabolism by 
ANF suggests that as much as 50% of this activity is catalyzed by CYPIA. In contrast to 
these data, Ishida and co-workers (Ishida et al., 199I) found that the metabolism of 
3,3',4,4'-TCB in hepatic rnicrosomes from MC-treated rat was inhibited 78% by 10 j..lM 
ANF, and 86% by 100 j..lM ANF. Our data may be interpreted in two ways: (1) more than 
one catalyst contributes to the metabolism of 3,3',4,4'-TCB in beluga liver rnicrosomes, or 
(2) beluga CYPIA displays binding and catalytic properties toward ANF, TCB, and ER, 
which differ significantly from CYPIA in other species studied. 
2.2'.5,5'-TCB metabolism 
Distinct from the species difference in capacity for metabolism of 3,3',4,4'-TCB, the 
capacity to metabolize 2,2',5,5'-TCB was approximately equal in the beluga and pilot 
whale samples. Thus the enzyme(s) responsible for 2,2',5,5'-TCB metabolism appear to 
be regulated independently of the principal enzyme(s) that catalyze 3,3',4,4'-TCB 
metabolism in these species. CYPIA appears to play little or no role in this activity , 
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indicated by the finding that 2,2',5,5'-TCB does not inhibit EROD activity and by the 
finding that ANF does not strongly inhibit 2,2',5,5'-TCB metabolism. 
The rates that we measured for 2,2',5,5'-TCB metabolism in cetacean liver 
microsomes are lower than some that have been found in control rat liver microsomes: 2.3 
pmollmin/mg (our laboratory), and 10 pmollmin/mg (Ishida et al., 1991). Other 
investigators, however, have reported no detectable activity in control rat liver microsomes 
(Ghiasuddin et al., 1976; Mills et al., 1985). In hepatic microsomes from PB-treated rat, 
rates ranging from 4 (Ghiasuddin et al., 1976) to 66 (Mills et al., 1985) to 1450 
pmol/min/mg (Ishida et al., 1991) have been reported. 
Studies with rodents indicate that PB-inducible CYP2B enzymes are principal 
catalysts for the metabolism of non-coplanar PCB congeners, including 2,2',5,5'-TCB 
(Shimada et al., 1981; Mills et al., 1985; Ishida et al., 1991 ). However, the expression 
and activity of CYP2B forms in cetacean liver is still open to question. Catalytic data, 
including PROD activity in beluga (White eta!., 1994), aldrin epoxidase activity in short-
finned pilot whale, striped dolphin, and killer whale (Watanabe et al., 1989), and 
metabolism of 2,2',5,5'-TCB in pilot whale and beluga (this study) suggest that CYP2B-
like activities are slight in cetaceans. Similarly, inferences based on PCB residue data from 
cetaceans suggest very low CYP2B-like activity. Tanabe et al. (Tanabe et al., 1988) found 
selective enrichment of meta-para unsubstituted PCB congeners in DaB's porpoise and 
striped dolphin, and Norstrom et al. (Norstrom eta!., 1992) found selective enrichment of 
these congeners in Arctic beluga, suggesting comparatively slow metabolism and 
depuration of those congeners that are CYP2B substrates in rat. 
Despite the catalytic data, immunochemical results indicate the presence of a 
possible CYP2B homologue in liver microsomes of pilot whale and beluga whale. This 
protein (or proteins) has an electrophoretic migration near that of cytochromes P450 and is 
immunochemically related to rabbit CYP2B4 and dog CYP2B I 0. However, the lack of 
cross-reaction with antibodies specific to rat CYP2B l/2B2 raises questions about the 
identity of the cetacean protein(s). It is not yet clear whether these proteins bear structural 
or functional similarity to CYP2B forms in other mammals. It remains an interesting 
possibility that the cetacean protein(s) detected are catalysts of 2,2',5,5'-TCB metabolism 
in these species. 
PCB residues 
Our in vitro data complement PCB residue data in providing a direct demonstration of 
selective PCB metabolism and elimination by cetaceans. Several studies have noted 
selective retention in cetacean blubber of those PCBs resembling CYP2B-like substrates 
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(i.e. meta-para unsubstituted congeners), with selective elimination from blubber of those 
PCBs resembling CYP1A-like substrates (Tanabe et al., 1988; Duinker et al. , 1989; 
Norstrom et al., 1992). We report very slow rates of metabolism in beluga liver 
microsomes of 2,2'5,5'-TCB, a meta-para unsubstituted congener that resembles those 
congeners that tend to accumulate in cetacean blubber. We report a much higher rate of 
metabolism in beluga liver microsomes of 3,3' ,4,4'-TCB, a CYP1A-like substrate that 
belongs to the group of congeners that are selectively eliminated from cetacean tissue. 
There are several routes by which PCBs may be eliminated from mammalian tissue, 
including metabolism, loss of parent compound to urine and feces, and transfer through 
lactation and pregnancy. The rates of PCB elimination via non-metabolic routes are 
generally either not congener-specific, or are dependent upon congener lipophilicity and 
thus on chlorine number. For example, PCB elimination by Dall's porpoise during 
parturition and lactation was greater for the lower chlorinated congeners than for the higher 
(Subramanian et al., 1988), half-lives for PCB elimination from exposed humans were 
shorter for tetra- and penta- than for hexa- and hepatchlorobiphenyls (Ryan et al., 1993), 
and rates of PCB depuration from fish have generally been found to increase with 
decreasing chlorine number and with decreasing octanol/water partition coefficient (Niimi 
and Oliver, 1983; Jones et al., 1989). A differential elimination of two congeners with the 
same chlorine number (e.g. 2,2',5 ,5'-TCB and 3,3',4,4'-TCB) is likely to be mediated by 
differential rates of metabolism in vivo. Our in vitro data support a model in which rates of 
metabolism, and consequent elimination, govern the relative concentrations of some PCB 
congeners in cetacean tissue. 
In summary, we have provided the first direct demonstration of polychlorinated 
biphenyl metabolism in marine mammals. Catalytic and immunochemical data suggest that 
PCB metabolism in these cetacean species may follow similar structure-activity 
relationships as those found in rat, with CYPIA being involved in coplanar PCB 
metabolism and CYP2B involved in noncoplanar PCB metabolism. Our data suggest that 
CYPIA induction (seen in these beluga) may enhance the metabolism of the toxic, coplanar 
PCB congeners by cetaceans, but that metabolism of the noncoplanar congeners is limited. 
Furthermore, these in vitro results, coupled with residue data, provide evidence for the 
importance of PCB metabolism to cetaceans that are exposed to these environmental 
pollutants. This study provides a framework for further investigation of the capacity of 
marine mammals to biotransform lipophilic organic contaminants, and of the effects of 
contaminants and their metabolites on marine mammals. 
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CHAPTER SEVEN 
Catalytic and Immunochemical Characterization of Hepatic Microsomal 
Cytochromes P450 in Beluga Whale (Delphinapterus leucas) 
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Understanding the effects of environmental contaminants on 
cetaceans and other marine mammals will require information 
on the biochemistry of xenobiotic metabolism in these species. 
We characterized the hepatic microsomal cytochrome P450 
system in beluga whales (Delphinapterus leucas) from the Cana-
dian Arctic. The content of native P450 averaged 0.203 and 
0.319 nmollmg microsomal protein, cytochrome b5 content 
averaged 0.199 and 0.236 nmol/mg, and rates of NADPH-cy-
tochrome c reductase were 79 and 76 nmollmin/mg, for females 
and males respectively. Ethoxyresorufin 0-deethylase (EROD), 
pentoxyresorufin 0 -depentylase (PROD), and benzota)pyrene 
(BP) hydroxylase {AHH) activities were significantly greater in 
males than in females, and were highly correlated with one an-
other (r 2 between 0.853 and 0.912). HPLC analysis of in vitro 
BP metabolites revealed benzo-ring (7,8- and 9,10-) dihydro-
diols, consistent with activation of this compound, as well as 
4,5-dihydrodiol, 3-0H-, 7-0H-, and 9-0H-BP and I ,6- and 3,6-
quinones. Estradiol 2-hydroxylase activity did not differ be-
tween sexes, and rates did not correlate with those of the other 
activities. Antibodies against scup P4SOB (an apparent teleost 
CYP2B) and rat CYP2B I did not recognize proteins in beluga 
liver microsomes, but there was a protein detected by antibodies 
to PB-induciblc rabbit CYP2B4. Antibodies to ethanol and ke-
tone-inducible rat CYP2E1 reacted with two proteins in beluga 
liver microsomes. Antibodies specific to hydrocarbon-inducible 
CYP1A1 and/or CYPIA2 forms showed a single protein band, 
apparently more closely related to CYPIAI. The content of 
CYPIA was fivefold greater in male than in female beluga. 
CYPI A content was highly correlated with EROD, PROD, and 
AHH activities, suggesting that this P450 form is a primary 
catalyst for these reactions in beluga. CYPIA content and activ-
ity were highly correlated with the concentrations in blubber of 
non-ortho and mono-ortho PCB congeners, compounds that in-
duce CYPI A in other mammals. These results indicate that a 
CYP lA is a catalyst for the metabolism of aromatic hydrocar-
bon pollutants in the beluga whale, and strongly suggest that 
this protein is induced in these organisms by environmental con-
taminants, including PCBs. The results support the measure-
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ment of CYP1A expression as a biomarker of exposure to in-
ducers in marine mammals. The full functional and evolution-
ary relationships of beluga CYP1A and of beluga proteins 
immunologically related to other P450 forms are uncertain. 
0 199• Aeadt:mic: Pru. ... lnc. 
Many marine mammals accumulate appreciable concen-
trations of organic pollutants, including polycyclic aro-
matic hydrocarbons (PAH),l chlorinated pesticides, poly-
chlorinated biphenyls (PCB), and other halogenated aro-
matic hydrocarbons (Ono eta/., 1987; Aguilar and Borrell, 
1988; Muir eta/., 1988; Duinker eta/ .. 1989; Hellou el a/., 
1991 ; Woodley et a! .. 1991 ). Their large lipid reservoirs 
may strongly contribute to retention of lipophilic xenobio-
tics, and thus to contaminant accumulation. It is speculated 
that such contaminants exert effects on marine mammals 
at the bioch emical, organism a!, and perhaps even the popu-
lation levels, but few studies have addressed these effects in 
a detailed way (Engelhardt, 1982; Reijnders, 1986). The 
odontocetes (toothed whales) may be a particularly vulnera-
ble group, as they are top predators in oceanic ecosystems 
and appear to bioaccumulate pollutants from their prey or-
ganisms. 
Among the odontocetes, the beluga whale (Delphinap-
terus leucas) is a species of particular interest and concern. 
The population of beluga inhabiting the St. Lawrence Es-
tuary is one of the most heavily contaminated groups of 
'This research was supponed in pan by NIH Grants ES04220 (J .J.S.) 
and ES05479 (M.E.H .), by EPA Gr.mt R817988, by the WHOI/ MIT Joint 
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Presented in pan at the 1992 Annual Meeting of the Society of Environ-
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' Abbreviations used: EROD, ethoxyresorufin 0-deethylase; PROD, 
pentoxyresorufin 0-depcntylase; BP, benzo[a]pyreoe; AHH, atyl bydrc>-
carbon hydroxylase; HPLC, high-performance liquid cbromatogrdphy; 
PB, phenobarbital; PCB, polychlorinated biphenyl; PAH, polycyclic aro-
matic hydrocarbon; E,-20H, estradiol 2-hydroxylase; ANF, alpha naph-
thoflavone; MAb, monoclonal antibody; MO. monooxygenase; DHD, di-
bydrodiol. 
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marine mammals known (Masse et a/., 1986; Martineau et 
at., 1987; Muir eta/., 1990), having high concentrations of 
PCB, DDT, and other organochlorine pesticides. Such con-
tamination has been suggested as a causative factor in the 
failure of this population to recover from the hunting-re-
lated population decline earlier in this century (Martineau 
eta/., 1987, 1988). At present there is no information on the 
biochemistry of xenobiotic metabolism and its role in de-
termining the susceptibility or resistance to pollutants in 
this species. A biochemical and molecular characterization 
of microsomal enzymes could provide a better understand-
ing of the effects of environmental pollutants on beluga, 
and on cetaceans in general. 
Cytochrome P450 monooxygenases are central to the ox-
idative metabolism of a wide array of endogenous and xen-
obiotic compounds (Nebert and Gonzalez, 1987), includ-
ing many marine pollutants. P450-mediated metabolism 
can result in either the detoxification or the activation of 
xenobiotic substrates, thus determining toxicity. Members 
of the P450 subfamilies CYP I A, CYP2B, and CYP2E (Nel-
son eta/., 1993) are important in metabolism of many pol-
lutants. CYPIA forms are inducible by PAH and by planar, 
polyhalogenated aromatic compounds (e.g., PCBs, chlori-
nated dioxins), which may then be metabolized by these 
enzymes. Proteins in the CYP2B subfamily are inducible in 
terrestrial mammals by barbiturates and by ortho-substi-
tuted (noncoplanar) polyhalogenated biphenyls, which in 
turn may be metabolized by these enzymes. 
A limited number of previous studies have described 
P450 or P450-associated activities in pinnipeds (Engel-
hardt, 1982; Addison and Brodie, 1984; Addison et at. , 
1986; Goks0yr eta/., 1992) and cetaceans (minke whale, 
pilot whale, killer whale, and dolphin) (Goks0yr et a/., 
1986, 1988; Watanabe et a/., 1989). Other studies have in-
ferred P450 characteristics based on patterns of PCB con-
geners detected in cetacean tissues, relative to those found 
in the environment (Tanabe et a/., 1988; Duinker eta/., 
1989; Norstrom et at .. 1992). For example, based on the 
relative persistence of meta-para unsubstituted PCB con-
geners in cetacean tissue, it has been suggested that monoox-
ygenase activities characteristic of CYP2B are reduced in 
cetaceans compared to those in terrestrial mammals (Tan-
abe eta/., 1988; Norstrom eta/. , 1992). Other workers have 
reported aromatic DNA adducts, ostensibly ofPAH, in the 
livers of Arctic beluga (Ray eta! .. 1991 ), suggesting bioacti-
vation of such compounds. In this study we describe the 
hepatic P450 system in beluga from a site in the Canadian 
Arctic distant from known inputs of pollutants. Results of 
our catalytic and immunochemical assays indicate that a 
hepatic microsomal CYP 1 A isoforrn is expressed in beluga 
whale. The content of this protein is correlated with the 
content of chlorobiphenyl residues, indicating that hepatic 
CYP I A has been induced by environmental chemicals in 
these Arctic beluga, and providing a basis of comparison 
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with other cetacean populations, including beluga from the 
contaminated St. Lawrence system. Our results also indi-
cate that expression ofCYP2B-related proteins is uncertain 
in these whales. Cetaceans, which diverged from the ungu-
late line, may provide a valuable point of comparison for 
establishing the fundamental roles and evolution of P450 
enzymes in mammalian species. 
MA TERIA.LS AND METHODS 
c~u,.;cm. All chemicals used were of the highest grade available from 
commercial suppliers and were similar to those used previously in this 
laboratory (Stegeman and Binder, 1979). 7-Ethoxyresorulin was synthe-
siud as previously described (Klotz et al .. 1984). Benzo(a]pyrene was puri-
fied by extraction with 0.1 S N KOH in 85% dimethyl sulfoxide. Estradiol 
was purified by thin-layer chromatography in a solvent system consisting 
of cbloroform:acetnne at a ratio of 7:3. Antibodies used are described 
below. 
Timus. Beluga whales (D. leucas) from the Huslcy Lalces of the 
Tuktoyuktuk peninsula, on the MacKenl.ie River delta (Canadian Arctic), 
were hunted by local Inuit in a subsi5tence harvest in November, 1989. 
Freshly killed individuals were weighed and measured and sexes were de-
termined. On average, these animals weighed 200 kg less than expected for 
beluga of their length (Lockhart ez al., in preparation), suggesting t.hat they 
had not fed for a period prior to capture. Liver samples were removed 
within 30 min of termination. Slices of liver 0.5- to l.(k:m thick (approxi-
mately SO g per animal) were frozen immediately on dry ice and then 
stored at -8o•c until microsomes were prepared. Portions ofliver from 13 
animals were obtained from the Canadian Department of Fisheries and 
Oceans. 
Prep4ratiott of cyrosol1l11d "'icroso~Ms. Pieces offrol.en ~ver were pul-
veriz.ed at liquid nitrogen temperatures with a ceramic mortar and pestle. 
Liver powders were homogenized with a Tefton-glass homogenizer (I 0 
passes) in 9 vol of cold 25 mM MOPS buffer, pH 7 .S, at 2o•c, containing 1 
mM dithiothreitol, I mM EDTA, 5 mM EGTA, 0.02% NaN1 , 20 mM 
Na,Mn04 , 10% (v:v) glycerol, and a mixture of protease inhibitors (20 mM 
tosyl 1.-lysine chloromethyl ketone, S m&/ml leupeptin, 13 mg/ml apro-
tinin, 7 mg{ml pepstatin A, and 0 .1 mM pheoylmetbylsulfonylfluoride). 
This homogenization buffer was designed to yield microsomal fractions 
and cytosolic fractions suitable for Ah receptor assays (Hahn eta/., 1994). 
Homogenates were centrifuged for 10 min at 150g and 10 min at 12,000g. 
The supernate was then centrifuged at IOO,OOOg for 70 min. The superna-
tant fraction (cytosol) was removed and frozen in liquid N2 • The IOO,OOOg 
pellet was resuspended in a buffer that was 0. 1 M Tris, pH 7.6, I mM 
EDTA, I mM DlT, and 20% glycerol, at 2 mVg liver. and froun in liquid 
N,. Protein was measured by the bicinchoninic acid method (Smith eta/ .. 
1985). 
Cytoclrromu P4SO 1111d bS. The content of microsomal c;ytoehrome 
P4SO was determined from dithionite difference Spec! Ill of CO-treated sam-
ples (Stegeman and Binder, 1979), assuming extinction coefficients of 91 
mM-• em·• for P450 and Ill mM· ' em· • for P420 (Omura and Sato, 
1964). There were latJe peaks of absorbance at 420 om in some samples. 
Therefore, samples were treated with ascorbic acid and pheoazine metho-
sulfate (Johannesen and DePierre, 1978) to evaluate hemoglobin content. 
Cytochrome b5 was measured usin& NADH difference spectra, as de-
scribed previously (Stegeman and Binder, 1979). 
Ell'lJIWU IIUIIys. All assays were conducted at 37°C. NADPH cy-
tochrome c (P450) reductase activity was measured by monitoring absor-
bance at SSO nm, as previously described (Stegeman et al., 1979). Estradiol 
2-hydroxylase activity (E,-20Hase) was assayed by 'H,O release from [2-
'H}estradiol (Snowberger and Stegeman, 1987). Ethoxyresorufin 0-deeth· 
ylase (EROD) activiry was quantified using a spectrOphotometric kinetic 
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assay (I<Jotz el a/., 1984). Pentoxyresorufin 0-depcntylasc (PROD) activ-
ity was similarly assayed by measuring resorufln formation, using the spec-
trophotometric assay as described for EROD activity (Klotz el a/ .• 1984). 
PROD activity was also assayed fluorometrically as follows: The 500.,.1 
reaction mixture contained 0.1 M Tris, pH 8, 0 .1 M NaO. 7-pentoxyresoru-
fin at a nominal concentration of 5 I'M (dissolved in dimethyl sulfoxide), 
and 60-100 ,.g of microsomal protein. Reactions were initiated with 10 "' 
NADPH (25 mg/ml), allowed to run for I 5 min at 37•c. and stopped with 
I m l of cold methanol. These were centrifuged at low speed, and resorufin 
fluorescence in the supernatants was determined using an SLM A minco 
SPF-500 spectrofluorometer. Excitation was at 550 nm and fluorescence 
emission was measured at 588 nm, which was the wavelength of maximum 
emission for the resorufin in these samples. Resorufin content was quanti-
fied from a standard curve, generated by measuring the Ouorescencc of 
known amounts of resorufin in the above buffer. 
Benzo[alpyrene (BP) hydroxylase (aryl hydrocarbon hydroxylase; 
AHH) activity was measured with a radiometric assay (Binder and Stege-
man, 1980), and samples were counted in a Beckman LSSOOOTD liquid 
scintillation counter. Inhibition of AHH activity by alpha-naphthoflavone 
(ANF) was determined by adding 10-< M ANF dissolved in methanol to 
the assay tubes (total volume I ,., methanol per 50-,.I assay). 
&n:otaiPyl"'!u mdaboliru. Benzo[a]pyrene metabolites were gener-
ated in vitro from [1H]BP, using reaction mixtures similar to those for 
AHH quantitation. Reaction mixtures of500 ,.r were incubated for 20 min 
at 37"C, stopped with I vol of acetone, and extracted twice with 2 ml ethyl 
acetate, as previously described (Stegeman el al .. 1984). The solvent layer 
was dried under N1 gas and resuspended in methanol. Prior to extraction, 5 
,.g of 6/l-hydroxytestosteronc was added to each sample as an internal 
standard. 
BP metabolite profiles were obtained by high-performance liquid chro-
matography, using a Rain in Dynamax C-18 column (4.6 X 250 mm, 5,.m) 
and a Hewlett-Packard d iode array detector. Metabolites were eluted with 
a water/ methanol/ethanol gradient solution , at a flow rate of I ml/ min, as 
foll ows: stan at45'A. water, 37'A. methanol, 18% ethanol; 15-min transition 
to 35% water, 44% methanol, 2 1% ethanol: 25-min transition to 25% 
water, 50% methanol, 25% ethanol; immediate change to 67% methanol, 
33% ethanol: hold 20 min. Metabolites were identified by comparison of 
retention times and uv; visible absorption spectra with those of authentic 
standards. Metabolites were quantified by collecting fractions eluting from 
the column and measuring radioactivity in a Beckman LS5000TD scintil-
lation counter. 
/mmuMblotting. lmmunoblot ("Western" blot) analysis was per-
formed as described previously (I<Joepper-Sams el ul .. 1987; Stegeman 1!1 
ul .. 199 1 ). Primary antibodies used were as follows: monoclonal antibody 
1-12-3, raised against scup cytochrome P450E (CYPI AI) (Park e1 a/ .. 
1986): a polyclonal antibody raised against mouse CYP IAI but recogniz-
ing both CYPIA I and CYPIA2 forms, provided by Dr. Peter Sinclair 
(Veterans Administration Medical Center, White River Junction, VT); a 
polyclonal antibody against scup cytochrome P450 B (Gray, 1988), which 
is likely a CYP2B form (Stegeman el a! .. 1990); anti-P450PB4, a polyclo-
nal antibody against rat CYP2B I, provided by Dr. David Waxman (Dana-
Farber Cancer Institute, Boston. MA) (Frey et al .. 1985); MAb 4-29-5 p4, a 
monoclonal antibody against rat CYP2B I, provided by Dr. Harry Gelboin 
(NIH , Bethesda, MD)( Park e1 a/ .. 1984); anti-P450LM2. a goat polyclonal 
antibody against rabbit CYP2B4, obtained from Oxford Biomedical Re-
search, Inc. (Oxford, Ml); anti-dog CYP2B I I, provided by Dr. James Hal-
pen (Universi ty nf Arizona) (Duignan tl a/.. 1987); anti-P450RLM6, a 
polyclonal antibody to rat CYP2El , provided by Dr. John Schenlc.man 
(University of Connecticut Health Center. Fannington. CT) (Favreau el 
a/., 1987); and a polyclonal antibody against rat CYP2El obtained from 
OXYGENE Dallas (Dallas, TX). Secondary antibodies used were alkaline 
phosphatase linked goat-anti-mouse lgG, goat-anti-rabbit lgG, and rabbit-
anti-goat lgG. Content of the P450E homologue (CYPI A) in beluga mi-
crosomes was quantified by densitometric scanning of MAl> 1-12-3-reac-
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FIG . I. Dithionite difference spectrum of beluga liver microsomes. 
Data were obtained by measuring the di thionite difference spectrum of 
CO-treated microsomes as described under Materials and Methods. Micro-
somal protein concentrations in the assay were 0.6 to 1.0 mg/ml. y axis, 
absorption; x axis, wavelength (nm). 
tive bands with a video imaging system, and comparison to P450E stan-
dards. Because the strength with which MAb 1-1 2-3 recognizes P450E 
homologues may differ between species, CYPIA levels deduced from the 
immunoblot represent relative rather than absolute values for this species. 
Statistical tzlllllysu. A pooled, two-tailed I test was used to determine 
significant differences between male and female sample groups. The two-
tailed Smith- Sattenhwaite 1 test was used to compare male and female 
groups in those cases in which the variances for the two groups were very 
d ifferent, which included EROD, PROD, and A HH activities and CYP I A 
content. 
RESULTS 
Microsomal Electron Transport Components 
The dithionite difference spectra of CO-treated beluga 
hepatic microsomes showed a cytochrome P450 peak at 
448 nm for all samples, and an additional peak at approxi-
mately 420 nm (Fig. I). Ascorbic acid and phenazine meth-
osulfate were added to some samples to detennine whether 
the latter peak was due to the presence of oxyhemoglobin 
(Johannesen and DePierre, 1978); the resulting spectra in-
dicated that hemoglobin could account for a minor percent-
age of the peak (data not shown). Thus, it appears that this 
peak primarily represents cytochrome P420. Such apparent 
degradation could occur during storage conditions prior to 
microsome preparation. NADH difference spectra were typ-
ical of cytochrome bS. 
Average values for the hepatic content of native cy-
WHITF. F.T AI.. 
TABL£ I 
Microsomal Electron Transport Compon ents 
in Beluga W h ale Liver 
Component Female (11 = 5) Male (11 a 8) 
Microsomal yield (mg/g liver) 14.5 ± 0.5 15. 1 ± 1.8 
Cytochrome P450 (nmol/ mg) 0.203 .!. 0.063'' 0.319 ± o.on·· 
P450 + P420 (nmol/mg) 0.843 ± 0 .224 0.972 ± 0.291 
Cytochrome b5 (nmOI/mg) 0.199 ± 0.027" 0.236 ± 0.031' 
Reductase (nmolfmin/ mg)• 79 ± 7 76 ± 8 
CYPIA (pmol/mg)• 9.9±7.1 ''' 54.0 ± 22.o••• 
Note. Values are means± SD (n- I). Males and females an: statistically 
d ifferent at a level •p < 0.05, .. P < 0.02 • ... P < 0.00 I, based on a pooled I 
test or a Smith-Sattcrthwaitc 1 test. 
• Reductase refers to NADPH cytochrome c (P450) reductase activity. 
• CYPIA is expressed as pmol P450E equivalents/mg. 
tochrome P450, total cytochrome P450 (P450 + P420), cy-
tochrome b5, and NADPH cytochrome c (P450) reductase 
arc given in Table I. Assuming a P420 extinction coeffi-
cient of Ill DlM- t cm- t, all samples contained a greater 
amount of P420 than P450. However, the precise extinc-
tion coefficient for this species has not been determined, 
and denaturation experiments with sodium dodecyl sulfate 
indicate that it may be considerably higher than I II mM-t 
cm- t for these samples (data not shown). The values there-
fore may overestimate the actual P420 content. Nonethe-
less, the presence of P420 suggests that the catalytic rates 
measured here may not reflect the full capacity of the sam-
ples. 
Values for native P450 content varied from 0.123 to 
0.403 nmol/ mg; the mean value for males was significantly 
higher than that for females (Table I). When combined 
with P420, the estimate of total P450 content approached 
1.0 nmolfmg, and the sex difference was no longer evident. 
Cytochrome b5 content and P450 reductase rates showed 
little variation about the means. A sex difference was seen 
in cytochrome b5 content but not in reductase activity. 
Monooxygenase Actlvities 
Rates ofhepatic microsomal monooxygenase(MO) activ-
ities, EROD, A HH, PROD, and E2-20Hase, were mea-
sured in all samples and average values for males and fe-
males are listed in Table 2. Rates of PROD activity were too 
low to be detected by the spectrophotometric assay, but all 
samples gave quantifiable rates of resorufin formation 
when assayed fluorometrically. However, the rates in some 
samples were still near the limits of detection of the assay. 
To confirm that changes in fluorescence did reflect the ap-
pearance of resorufin, the product of several incubations 
was scanned over a range of wavelengths (Fig. 2). The re-
sulting fluorescence spectra confirmed the presence of reso-
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TABLE 2 
Microsomal Monooxygcnase Activities in Beluga Whale Liver 
Activity Female (n ; 5) Male(n ~ 8) 
EROD (pmol/ min/ mg) 97 ± 84" 413±263'' 
PROD (pmol/ min/ mg) 1.4 1. 0.6 .. 6.7 ± 4.5" 
F.,-2011 (pmol/min/mg) 56.9 :1. IR.o• 88.3 :1" 24.2• 
AJ-11-1 (pmol/min/mg) 74 .!. 41 .. 264±158" 
AHH with 10-' M ANF 
(% activity remaining) 2 1 ± 16% 20 ± 15% 
EROD (pmol/ min/ nmol 1'450) 451 ± 373 .. 1255 :t 691 .. 
PROD (pmol/min/nmol 1'450) 7 ± J•• 20 ± 12 .. 
E1-20H (pmol/min/nmol 1'450) 283±412 288 ± 91 
AHH (pmol/min/ nmol P450) 359 ± 163 .. 804 ± 391*' 
Note. Statistical tests arc as described in the legend to Table I. 
rutin, above background levels, even in samples with the 
lowest PROD activities. 
Rates of all MO activities were significantly greater in 
males than in females, when expressed as activity per mi ll i-
gram of microsomal protein. EROD and PROD activities 
each varied over a 30-fold range, yet for both the average of 
males was approximately four times that of females. AHH 
activity varied over a IS-fold range, with a 3.5-fold differ-
ence between males and females. Addition of 10-• M ANF, 
which is a strong and generally specific inhibitor of mam-
malian CYPIA in vitro (Testa and Jenner, 1981 ), caused a 
53 to I 00% inhibition of A HH activity. There was no differ-
ence in the degree of inhibition seen in male versus female 
FIG. 2. Auorescence spectra of pentoxyresorufin 0-<lepentylase reac-
tion mixtures. Beluga liver microsomes were incubated with pentoxyreso-
rufin as described under Materials and Methods, and the fluorescence 
spectrum was analyzed. Excitation was at 550 nm. Resorufin peak occurs 
at 588 nm. The lower curve is a blank incubation (without NADPH), the 
two middle curves are result~ from female beluga, and the two upper 
curves are from male beluga. Axes represent fluorescence (y) versus wave-
length (x: nm). 
P450 IN RELUGA WHALE 
1 2 3 4 5 6 7 R 9 10 11 12 13 14 
i i 
scup 
P4501Al 
be luga scu p 
P4501Al 
F IG. 3. lmmunoblot ofhc:luga hepatic microsomes wi th MAb 1-12-3. 
Proteins were separated on an SDS- PAGF. gel. transferred to nitrocellu-
lose, and incubated with a nt ibo<.ly raised against scup P450E (CYPIA 1). 
Beluga microsomes were applied at I 00 I'C protein/ lane on a large gel. 
Lanes I and 14 arc scup P450E. Lanes 2, 5, 7, 9, and II arc femal e hc:luga. 
Lanes 3, 4, 6, 8, 10, 12, and 13 arc male beluga. Lanes 3 and 8 a rc small 
males. Lane 10 is a male with low EROD activily and high mic rosomal 
P450. T he lower- molecular-weight band seen in some lanes is likely a 
degradation producl. 
samples, nor was there a ny correlation found between rate 
of AHH activity a nd degree of inhibition by ANF. 
Er20Hase activity per milligram microsomal protein var-
ied over a 3.5-fold range, and the average rate in male sam-
ples was slightly but significantly higher than that in fe-
males. 
Significant sex differences were sti ll evident in rates of 
EROD, PROD, and AHH (Table 2) when activities were 
expressed per nanomole of native P450, an estimate of turn-
over number fo r the population of active P450 forms. Aver-
age E2-20Hase activity per nanomole enzyme was nearly 
identical for male and female samples. 
Immunodetection of Cytochrome ?450/A 
Immunoblot analysis with MAb 1-12-3 revealed one ma-
jor cross-reactive protein band in each beluga sample, with 
an electrophoretic migration suggcsti ng a molecular weight 
slightly less than that of scup CYP I A I (Fig. 3). T his anti-
body, which was raised against scup P450E (CYP I A I), has 
been shown to strongly cross-react with mammalian 
CYP I A I, only weakly with CYP lA2, and not with any 
other microsomal proteins (Park et al.. 1986; Kloepper-
Sams et a! .. 1987). To evaluate possible expression of an 
immunological counterpart to CYPIA2, samples were 
blotted with a polyclonal anti-mouse CYP I A I that recog-
nizes both CYP IAI and CYPIA2 in mice and rats (Peter 
Sinclair, personal communication). Onl y a single band was 
detected for each beluga (Fig. 4); the band was coincident in 
migration with the MAb 1-12-3-reactive band and the in-
tensity of the band in different individuals was similar to 
that achieved with MAb 1-12-3. This may indicate that a 
single CYP I A gene is expressed in beluga. However, a sec-
ond CYP I A form could exist which lacks thccpitopes recog-
nized by the antibodies used, which comigrates with the 
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FIG. 4. SDS-PAGE immunoblot of beluga hepatic microsomes wi th 
monoclonal anti-scup P450E (CYPIAI) (lanes I and 2) and polyclonal 
a nt i-mouse C YP I A I (lan~s 2-7). Beluga protein loading was I 00 ~tcflane. 
as in Fig. 3. Lane I, scup P450E. Lanes 2, 3, 4, male beluga. Lane 5, female 
beluga. Lane 6, small male beluga. Lane 7, liver microsomes (30 11g pro-
tein) from a methylcholanthrene-treated mL Molecular weights of the rat 
and scup enzymes determined by prior SDS-PAGE analysis arc : rat 
CYPIAI , 56 kDa; rat CYP IA2, 52 kDa; Scup CYPIAI, 54 kDa. The 
cross-reactive protein in beluga has an apparent mo lecular weight of about 
53 kDa. 
1-12-3-reactive band, or which is simply not expressed in 
the individuals or the tissue examined here. Given this, and 
lacking sequence data, we refer to the beluga protein as 
CYP IA. 
The content of the beluga CYP lA determined by immu-
noblot showed a highly significant sex difference (Table 1). 
Figure 5 illustrates the relationship of CYP I A content to 
sex and body length among the 13 animals (Fig. 5A), and 
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FIG. 5. Correlations o f C YP I A co ntent to le ngth and to na tive cy-
tochrome P450. (A) Hepatic microsomal CYP IA, measured with MAb 
1-12-3 and expre.<.<ed as pmol P450E equivalents/ mg, versus beluga body 
length. (B) Hepatic microsomal C YP I A versus microsomal cytochrome 
P450, measured spectrophotomelrically a s in Fig. I. Closed circles, fe-
males; open circles, males. 
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the relationship ofCYPI A to native P450 content (Fig. 58). 
The individuals fell into two clusters: larger males had con-
sistently higher hepatic content of CYP I A and P450, while 
content in the females was substantiall y lower. Interest-
ingly, the two smallest males had CYPIA and P450 con-
tents that were more like those in females. All individuals in 
this study were most likely sexually mature adults at the 
time of capture, although the smaller males may have been 
young adults, according to growth curves for beluga from 
the MacKenzie Delta (Stewart and Stewart, 19R9; Doidge, 
1990). 
lmmunodetectable CYPIA accounts for 16.5% (±5.8%) 
of nati ve P450 in male samples, and 4.9% (±3.4%) of native 
P450 in female samples, assuming equal reactivity of be-
luga and scup CYP IA forms with the antibody. However, 
because antibody reactivity may vary among species, the 
values obtained for beluga CYP I A represent relative rather 
than absolute amounts of P450E homologue. 
Cytochrome P450 I A I is generally the primary catalyst of 
EROD and AHH activities in mammals and ftsh. Consis-
tent with this, strong positive correlations were found be-
tween rates ofEROD and AHH, and the content ofCYP 1 A 
in beluga. Relationships between EROD a nd CYPIA were 
characterized by r2 = 0.932; between AHH and CYPIA by 
r 2 = 0.853; between EROD and AHH by r 2 = 0.853 (Fig. 6). 
Interestingly, there was also a strong positive correlation 
between these parameters and PROD activity (PROD and 
CYP IA, r 2 = 0.945; PROD and EROD, r 2 = 0.9 12) (Fig. 
6). Results for one individual were excluded from the analy-
sis ofCYP I A content versus catalytic activity: a male with 
high (male-typical) levels of CYPI A and total P450, but 
with catalytic activities among the lowest of all the sample's 
(Fig. 6). This is inexplicable in terms of sample degradation, 
as indicated by the high spectral P450 level and average 
P450/ P420 ratio for this sample. Low rates of P450 activi-
ties in this individual might be attributable to low NADPH 
cytochrome c (P450) reductase activity. Reductase activity 
in this sample was the second lowest of 13 measured (67 
nmol/min/ mg). 
No correlation was found between beluga CYP I A con-
tent and E.z-20Hase activity, nor between E2-20Hase and 
the other activities. 
lmmunodetection of Other P450 lsozymes 
Western blot analysis was conducted to determine 
whether beluga whales express proteins related to CYP2B 
and CYP2E. For each immunoblot, four samples were cho-
sen: two with relatively high CYPlA content and activity, 
and two with relatively low CYPlA content and acti vity. 
The samples were blotted with three antibodies to 
members of the phenobarbital-inducible mammalian 
CYP2B subfamily, and one antibody to an apparent fish 
CYP2B, scup P450B. (Scup P450B and rat CYP2Bl/ 2 
show strong and exclusive reciprocal cross-reactivity.) T he 
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FIG. 6. Correlations between monooxygenase ac tivity and immuno-
de tccta ble CYP I A in beluga liver microsomes. (A) EROD vs C YP lA. (B) 
AHH vs CYPIA. (C) PROD vs CYP IA. C losed circles are female and 
open circles are male beluga. CYP I A was quantified by immunodctcction 
with MAb 1-1 2-3 and is expressed as pmol P450E equivalents/ mg. En-
zyme assays were conducted as described u nder Material~ and Methods. 
Results with the one male I hat had high (male-typical) levels of CYP I A 
and exceptionally low catalytic activities (see Results) were not included in 
the regression analysis. 
polyclonal anti-scup P450B (Fig. 7A) showed no reaction 
with beluga microsomes in the molecular weight region of 
46- to 52-kDa, where scup and rat CYP2B forms migrate. 
In all seven lanes of this blot, staining is apparent in the 
high-molecular-weight region; this is an artifact which is 
commonly seen when using these polyclonal antibodies, 
and it is concluded to be nonspecific. The beluga samples 
each have a more discrete band just below this nonspecific 
staining area, in the region of approximately 60- to 70-kDa. 
T he identity of this protein is not known and wi ll require 
further investigation. Beluga microsomes did not cross-
react with either the polyclonal (Fig. 78) or the monoclonal 
(Fig. ?C) antibodies against rat CYP2B I. However, a poly-
clonal antibody to rabbit CYP2B4 (Fig. 7C) did recognize a 
distinct protein in each of the four beluga samples exam-
ined. This band had an electrophoretic migration near that 
of rat CYP2B I. Polyclonal anti-dog CY P2B II recognized 
at least two bands in beluga liver microsomes with migra-
tion similar to that of authentic dog 2811 (not shown). 
Thus, beluga appear to express a P450 form with some im-
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FIG. 7. SDS-PAGE immunoblots of beluga liver microsomcs with antibodies against CYP2B forms. Beluga microsomal protein loading was 100 
l'g/lanc in A and Bon a large gel, and 60 l'g/lane inC on a mini-gel. (A) Anti-P450B, a polyclonal Ab raised against scup P450B, a likely CYP2B form: 
lane I, untreated ,;cup liver microsomc:s ( 181'g); lanes 2. 3. and 5 were male and lane4 a female beluga; lane6, untreated rat liver microsomes (30 1'&); lane 
7, phenobarbital-treated rat liver microsomes (30 1'&). (B) Anti-P450PB4, a polyclonal Ab raised against rat CYP2B I: lane I, untreated scup liver 
microsomes ( 18 l'g); lanes 2. 3. and 5 were male and lane 4 a female beluga; lane 6, untreated rat liver microsomes (30 I'&); lane 7. phenobarbital-treated 
rat liver microsomes (30 !'&). (C) MAb 4-29-5p4. raised against rat CYP2BI (lanes 1-5), and anti-P450LM2, a polyclonal Ab raised against rabbit 
CYP2B4 (lanes 6- 10): lanes I and 10 , untreated rat liver microsomes (60 ~<&); Janes 2, 3, 8, and 9 were male and Janes 4, 5, 6, and 7 were female beluga. 
Molecular weights of rat CYP2B t and scup P450R (apparent 28) are 52 a nd 46 kDa, respectively. 
munochemica l similarity to CYP2B forms other than 
CYP2B l/2, but the degree of structural similarity with 
these other form is unknown. 
The samples were blotted with two polyclonal antibodies 
raised against the alcohol and ketone-inducible rat 
CYP2E I. One of these antibodies detected a single cross-
reacting band in the P450 region for each sample, while the 
second antibody recognized two distinct bands in each sam-
ple (Fig. 8). This indicates the possible expression in beluga 
of P450 forms related to rat CYP2E I. 
In Vitro Metabolism of Benzo[a]pyrene 
Benzo[a]pyrene is a model polycyclic aromatic hydrocar-
bon which is known to be oxygenated at several different 
I 
j 
rat 
2 3 4 5 6 7 8 9 10 
j 
beluga rat 
FIG. 8. SDS- PAGE immunoblot of beluga liver microsomes with 
polyclonal anti-rat CYP2E I. Protein loading was 60 !'g./lane on a mini-gel. 
Lanes 1-5, anti-RLM6 (gift of J. Schcnkman); lanes 6-10, anti-P4502E I 
(from Oxygene, Dallas). Lanes I and 10 arc untreated ra t liver microsomes 
(60 !JS protein); Janes 2, 3, 8, and 9 are male beluga; Janes 4. 5, 6, and 7 are 
female beluga. 
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postttons by mammalian P450 enzymes (Wiebe! et a/. , 
1975; Pezzuto eta/., 1978). In vitro BP metabolites formed 
by beluga liver microsomes and analyzed by HPLC showed 
a typical suite of dihydrodiol, quinone, and hydroxy deriva-
tives (Fig. 9). Amounts of the metabolites detected are re-
ported in Table 3, along with percentages of total recovered 
metabolites. In both male and female samples, dihydrocliols 
made up the majority of the metabol ites (approximately 
50%), with the rest composed of mono-hydroxy com-
pounds (23-24%) and quinones (24- 25%). The preference 
25 
20 
IS 
10 
10 
7,1-dlol 
~ 
20 39 
Ti '"• Cm in,) 
•o 
.1' 
OaP- ~ 
FIG. 9. Benzo[a]pyrene metabolite profile from a male beluga. He-
patic microsomes were incubated with [3 H)BP for 20 min and metabolites 
were detected by HPLC, as described under Materials and Methods. Me-
tabolite identities are indicated in the figure and in Tahle 3. 
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TABLE 3 
Profile of Benzo(a)pyrene Metabolites Produced by Liver 
Microsomes of Beluga Whale 
Metabolite" Female (n - 3) (%jb Male (n = 3) (%t 
9.10-Dihydrodiol 16.6 j; 6.6• 21.6 j; 3.2 
4 ,5-Dihydrodiol 24.4 j; 3.6 22.3 ± 4.4 
7,8-Dihydrodiol 9.5 ± 8.3 9.3 ± 1.8 
1,6-Quinone 14.9 j; 1.2 13.0 j; 2.2 
3,6-Quinone 10.5 ± 4 .4 10.9 j; 4.3 
9-0H 8.8 ± 2.4 5.9 j; 1.4 
3-0H and 7-0H 15.3 ± 4.7 17.1 ±7.4 
BP metabolized 
(% of substrate) 3.0 j; 1.7 7.9 ± 2.8 
(pmol/ min/ mg) 16.6 ± 9.9 83.5 ± 24.9 
• Metabolites prepared in 20 min incubations, extracted, and eluted 
from an ODS reverse-phase column as described under Materials and 
Methods, and identified by elution time and by uv-spectra compared to 
standards. 
• All values are listed as percentages of total recovered metabolites, in 
order of elution from the column. 
for hydroxylation at the various positions did not differ be-
tween the sexes: the dominant metabolites in both were the 
4,5-dihydrodiol and the 9,1 0-dihydrodiol. An additional 
metabolite, present at a very low concentration, was de-
tected in some samples. This compound eluted after the 
3,6-quinone and before the 9-hydroxy, which is the region 
where the 6, 12-quinone, the 4,5-epox.ide, and the 6-hydrox-
ymethyl metabolites elute. However, the small quantity of 
the unknown compound precluded identification from its 
absorption spectrum. 
DISCUSSION 
Marine mammals are exposed to pollutant chemicals 
throughout the world oceans, yet there have been few de-
tailed studies of the effects of such exposure. Various cy-
tochrome P450 forms arc induced by exposure to organic 
pollutants and function in the primary metabolism of these 
compounds. Characterization of cetacean P450 systems is 
necessary to fully evaluate the capacity of these animals to 
dispose of foreign compounds, and should provide insight 
into the mechanisms ofxenobiotic impact on whale popula-
tions, information that cannot be obtained experimentally 
in these marine mammals. Moreover, CYP I A induction is 
increasingly recognized as a valid biomarker of exposure of 
animals and humans to foreign chemicals that are Ah-re-
ceptor agonists (Stegeman eta/., 1992). Recent studies have 
disclosed an apparent Ah-receptor in liver of beluga (Hahn 
et a/. , 1992, 1994 ), suggesting that beluga have a mecha-
nism for response to these compounds similar to that in 
other mammals. In this study we describe the characteris-
tics of hepatic microsomal enzymes in beluga, including a 
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strong induction of a CYPIA (possibly a CYPIA I) in the 
liver of these animals, correlated with the content ofPCBs 
in the blubber (see below). 
Monooxygenase Systems 
Microsomal monooxygenase enzymes have been ana-
lyzed in a few other cetacean species, and those results are 
comparable to the data reported here (Table 4). The levels 
of native cytochrome P450, cytochrome b5, NADPH cy-
tochrome c (P450) reductase activity, EROD activity, and 
AHH activity in this study were very similar to those found 
in minke whale from Arctic waters (GokS0yr et a/. , 1986, 
1988). Like beluga, minke whale microsomes had apprecia-
ble levels of MAb 1-12-3 cross-reactive protein, and no 
cross-reaction with antibodies raised against rat CYP2B. 
Total P450 content in beluga is close to the P450 contents 
measured in three other cetacean species, short-finned pilot 
whale, striped dolphin, and killer whale, caught off the 
coast of Japan (Watanabe eta!. , 1989). EROD activity lev-
els measured in the four species fall within an overlapping 
range. 
Based on statistical correlations (Fig. 6), we conclude that 
a beluga CYPIA is the primary catalyst for EROD and 
AHH activities, as in most vertebrates that have been exam-
ined. Interestingly, rates of PROD activity-which were rel-
atively low in these animals-were also strongly correlated 
with CYP I A content. In rat liver, PROD activity is cata-
lyzed primarily but not exclusively by PB-inducible CYP2B 
forms (Burke et a/. , 1985). PROD activity has also been 
found to be induced by hydrocarbon-type inducers in rat 
and mouse (Burke el a/., 1985; Kelley et a /., 1990). Our 
results suggest that the PROD activity in these beluga liver 
microsomes is a CYPIA activity. 
Estradiol 2-hydroxylase activity was assayed in part to 
determine whether sample degradation might interfere 
with interpretations of the data for the MO activities we 
measured. If the positive correlations found among EROD, 
AHH, PROD, and CYP I A were attributable to differential 
degrees of P450 degradation, rather than to differences in 
the catalytic capacities of the individual samples, it would 
be expected that ~-20Hase activity would show a similar 
pattern of positive correlation. As no such correlation was 
found, it can be concluded that (I) sample degradation was 
not responsible for the observed correlations between iso-
zyme content and catalytic activities, and (2) ~-20Hase 
activity is not catalyzed by CYP I A in beluga whales. 
~-20Hase is catalyzed largely by CYPIA2 in rat (Dannan 
eta/., 1986). When beluga microsomes were blotted with an 
anti-mouse CYP I A I polyclonal antibody which recognizes 
both CYP I A I and CYP I A2 in mice and rats, there was no 
evidence of an electrophoretically distinct beluga protein 
immunologically related to CYP1A2 (Fig. 4). Microsomal 
Er20Hase activity is al.so catalyzed to varying degrees by 
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TABLE 4 
Comparison of Liver Microsomal Monooxygenase Components and Activities in Different Species of Adult Cetacean 
Beluga whale Minke whale Pilot whale Striped dolphin Killer whale 
(13) (10)' (33)' (5)' (3)" 
cyt P45CY 0.274 ± 0.089 0.35 ± 0.09 0. J7 1 ± 0 .050 0. 186 ± 0.021 0.21 I ± 0.01\R 
cyt h5' 0.222 ± 0.034 0.25 ± 0.03 n.m. n.m. n.m. 
Reductase' 77 ± 8 76 ± 24 64 ± 13 93 ± 18 35 ± 15 
EROD' 291 ± 261 740 ± 170 42 ± 42 191 ± 15 612 ± 373 
AHH' 19 1 ± 156 220 ± 60 7.8 :t 4.2 7.2 ± 1.6 27.4 ± 6.1 
NO/e. Values are means± SO. Numbers in parentheses arc sample size. n.m., parameter not measured. 
• l>dta reponed by Goksoyr eta/., I 988. 
• Data reponed by Watanabe e1 al .. I 989. 
' nmol/ mg. 
'nmolfmin/ mg. 
'pmol/min/ mg. 
several other P450 forms in rat (Dan nan eta!.. 1986). Thus, 
the E2-20Hase catalyst in beluga liver is presently un-
known. 
Benzo[a)pyrene, a prevalent environmental pollutant 
and a model P450 substrate, is metabolized by beluga liver 
microsomes to a suite of oxygenated products including 
bcnzo-ring and K-region dihydrodiols (DHD}, mono-hy-
droxy compounds, and quinones. CYP I A isoforms are gen-
erally most active in bcnzo-ring metabolism of BP, includ-
ing the formation of the proximal carcinogen BP-7 ,8-dihy-
drodiol. This metabolite can be converted to the highly 
carcinogenic ( + )-(7R,8S)-dioi-(9S, I OR)-epoxide. The suite 
of metabolites formed by beluga liver microsomes is similar 
to that produced by liver microsomes of rat (Pezzuto eta/., 
1978; Wroblewski et a/., 1988). Based on studies of 
CYP I A I forms stably expressed in Chinese hamster V79 
cells, the major BP-DHD produced by rat CYPIAI are 
9.10- and 7,8-DHD as well as the K-region (4,5-) DHD. By 
contrast. CYP I A I from humans is more specific for metab-
olism on the bcnzo-ring of BP, and does not form the 4,5-
DHD (J. Doehmer, personal communication). Fish 
CYP IA proteins also metabolize BP predominantly to 
benzo-ring DHD and form little or no K-region DHD (Ste-
geman e/ a/., 1984). Analysis ofCYPIA from beluga may 
shed light on the structural features associated with regiose-
lectivity for BP metabolism. 
Environmental induction ofCYPJA 
Concentrations of organic chemical pollutants in theCa-
nadian Arctic are in general quite low, and there are no 
industrial or population centers, and thus limited local 
sources of contamination. However, the Arctic is not free 
from anthropogenic pollutants. Polycyclic aromatic hydro-
carbons were found in MacKenzie Delta sediments, and 
DNA adducts, ostensibly of PAH, were detected in the 
livers of beluga from the MacKenzie Delta (Ray et a/., 
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1991 ). PCBs and other organochlorines were detected in 
tissues of beluga, ringed seal, polar bear, and narwhal from 
the Canadian Arctic (Norstrom et a/., 1990; Muir et a!. , 
1992). 
Blubber samples from the same beluga described in this 
study were analyzed for content of individual PCB con-
geners (Metner et a/., in preparation). Among the con-
geners analyzed were nine (IUPAC numbers 37, 81, 77, 
126, 169, I 05, 114, 118, 156) which are known to be toxic 
and/or to strongly induce CYPIA forms in rdts (Goldstein 
and Safe, 1989). These arc trichloro- to hexachlorobiphen-
yls, each possessing two para substituents and either one or 
zero ortho substituents. Among the 13 animals examined, 
we found a strong positive correlation between PCB con-
tent in blubber (expressed as the sum of the nine congeners) 
and CYP I A enzyme content in the liver (Fig. I 0; r 2 = 
0.875). The strong correlation between the content of 
known CYPlA inducers and the content ofCYPIA in liver 
indicates that the CYPIA in beluga was induced by these 
compounds, or by compounds that often covary with PCBs 
in the environment, such as polychlorinated dibenzo-p-
dioxins or polychlorinated dibenzofurans. It is possible that 
PCB stores in fatty tissues were mobilized during a period of 
starvation, just prior to capture, contributing to enzyme 
induction. 
Cytochrome P450 content, relative CYP I A content, and 
all catalytic activities assayed were significantly greater in 
male beluga than in female. Sex differences in monooxygen-
ase activities seen in rat have been linked to hormonal regu-
lation of different P450 isoforms (Waxman et a! .. 1985; 
Dannan eta/., 1986). In fish, CYP I A I has been found to be 
suppressed in reproductively active females by the hor-
mone estradiol (Gray el a/. , 1991 ). However, several studies 
have shown that CYP I A I is not sexually differentiated in 
rats, either untreated (Waxman eta/., 1985; Cresteil et a /., 
1986) or treated with CYP I A I inducers (Warren and Bell-
ward. 1978; Waxman et al .. 1985). 
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FIG. 10. CYPIA content in beluga liver microsomes versus concen-
tration of non-onho and mon<rortho PCBs in blubber samples of the same 
animals. CYP lA was quantified as in Fig. 3. The content of PCB congeners 
(referred to as "toxic" PCBs) was detennined by so~ven t-extrac!ion of 
blubber and analysis by gas chromatography, as descnbed by Muar et a/. 
( 1990). Content is expressed as the sum of nine congeners: IUPAC num-
bers 37, 81 , 77, 126, 169, lOS, 114, 118, 156. The r' was 0.875. Closed 
circles, females; open circles, males. 
A further explanation for the sex difference in CYPJA 
content in the beluga may involve enzyme induction. 
Those animals with the highest levels of hepatic CYPIA 
(six males) also had the greatest blubber concentrations of 
non-ortho and mono-ortho PCBs, whereas those animals 
with lower CYPIA content and related activities (five fe-
males two small males) had much lower PCB content in 
body fat (Fig. I 0). There are numerous reports in the litera-
ture of adult male cetaceans having higher blubber concen-
trations of organochlorines than adult females (Martineau 
eta/., 1987; Aguilar and Borrell, 1988; Subramanian eta/., 
1988; Muir et a/., J 990). Several hypotheses might explain 
the sex difference in PCB content. The lower concentra-
tions found in females may be the result of past lactation 
and/ or pregnancy, both means by which organochlorines 
can be eliminated from female cetaceans (Duinker and Hil-
lebrand, 1979; Subramanian eta/. , 1988). Additionally, it 
has been suggested that differences in diet between male 
and female beluga may contribute to differences in contami-
nant loads (Martineau et a/., 1987). A third explanation 
may be that the larger males are the older members of the 
group and thus would have had an increased time over 
which' to accumulate persistent toxicants. Consistent with 
this latter hypothesis, PCB content in the blubber of Saint 
Lawrence beluga was found to increase exponentially with 
increasing age (Martineau et a/., 1987). 
Cytochrome P4502B 
Samples in this study failed to show cross-reactivity with 
polyclonal antibodies raised against rat CYP2B I. Similarly, 
antibodies against a teleost fish enzyme that is structurally 
related to CYP2BJ (scup P450B) (Stegeman eta/., 1990) 
failed to recognize a protein in beluga liver microsomes 
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with a molecular weight near that of P450. This evidence 
inclicating the lack of expression of a protein related to rat 
CYP2B I/2B2 in beluga is similar to results obtained with 
another cetacean. Antibodies raised against rat CYP2B 
failed to cross-react with minke whale liver microsomes 
(Gokseyr eta/., 1988). The absence of a signal on immuno-
blots may be due either to the lack of a gene encoding a 
protein homologous to CYP2B forms or to low/ no expres-
sion of such a gene in beluga liver. Interestingly, PCB con-
geners known to be inducers ofCYP2B in mammals were 
present in these beluga (Metner et a/., in preparation). 
Catalytic data seem to support the immunochemical 
data indicating little CYP2B-like activity in cetaceans. 
While CYP2B I is the primary catalyst of PROD activity in 
rat liver microsomes (Burke eta/., 1985), PROD activity in 
these beluga was very slight and was strongly correlated 
with immunodetectable CYP!A (Fig. 6), suggesting that 
the PROD activity detected here is catalyzed primarily by 
CYPIA. Similarly, aldrin epoxidase activity was found to 
be very low in short-finned pilot whale, striped dolphin, 
and killer whale, compared to that in rat (Watanabe eta/., 
1989); this activity is catalyzed largely by PB-inducible 
CYP2B forms in rat (Wolff and Guengerich, 1987). The in 
vitro production of a K-region BP metabolite ( 4,5-dihydro-
diol) by beluga (Fig. 9) could reflect CYP2B-Iike activity, 
but in rats this metabolite appears to be formed by CYPIA 
as well as by CYP2B forms (e.g., Pezzuto eta/., 1978). 
PCB residue data from cetaceans also suggest that these 
animals have little CYP2B activity. Tanabe et a/. ( 1988) 
found selective retention of meta-para unsubstituted PCB 
congeners in the tissues ofDall's porpoise and striped dol-
phin, relative to congener concentrations in their food or-
ganisms. Preferential retention of these PCBs, which are 
believed to be metabolized primarily by CYP2B forms, sug-
gests the lack of CYP2B activity in these cetaceans. Like-
wise, Norstrom et a/. (1992) found a higher relative abun-
dance of meta-para unsubstituted PCBs in arctic beluga 
than in charr, polar bear, walrus, and ringed seal taken from 
the same habitat, suggesting a distinct inability of cetaceans 
to metabolize these congeners. Consistent with this, we 
have found that beluga liver microsomes have a very low 
capacity for metabolism o£2,2',5,5'-TCB compared to th~t 
of control rat liver microsomes (White and Stegeman, m 
preparation). 
Given the above, the presence of protein bands cross-
reacting with anti-rabbit CYP2B4 or anti-dog CYP2B II is 
intriguing. CYP2B4 is the major PB-inducible P450 form 
in rabbit liver, and its protein sequence is 77% identical to 
that of rat CYP2BJ , as deduced from eDNA sequences 
(Tarr et a/., 1983; Komori et a/., 1988). The question of 
whether CYP2B genes are present and expressed in ceta-
ceans will be resolved with further catalytic and immuno-
chemical studies, including inhibition assays with polyclo-
nal antibodies against CYP2B, and a search for CYP2B 
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genes. It will be interesting in this regard to compare ceta-
ceans with some of their terrestrial relatives among the un-
gulates, the line from which cetaceans diverged 50-60 mil-
lion years ago. Such comparisons of the carnivorous Odon-
toceti with the herbivorous Bovidae might be particularly 
interesting, possibly shedding light on the role of plant natu-
ral products in diversification within the CYP2B subfamily. 
As with CYP2B, interesting questions concern other 
P450 forms in the cetacea. The detection of proteins react-
ing with antibodies to CYP2EI suggests the expression of 
homologues to the ketone inducible rat form. Rat CYP2EI 
is induced in starvation; thus, the suspected starvation of 
these beluga may have contributed to the appearance of 
CYP2E-like proteins. 
In summary, this study documents the expression and 
activity of cytochrome P450 enzymes in the liver of a ma-
rine mammal species, the beluga whale, thought to be at 
risk of pollution effects in some regions. CYP I A proteins 
have been implicated in organic pollutant metabolism in 
many vertebrate species, and appear to serve a similar func-
tion in beluga whale. We conclude that the CYP I A content 
most likely renects xenobiotic ligand binding to the Ah-re-
ceptor, which suggests that toxicity could be mediated by 
the receptor in these animals. The relationship between 
CYPIA content and PCB content indicates that measure-
ment ofCYP I A is likely to be a useful biomarker for expo-
sure of marine mammals to Ah-receptor agonists. No evi-
dence was found in beluga for an enzyme immunochemi-
cally related to rat CYP2BI/2, possibly indicative of the 
divergent evolution of marine and terrestrial mammals. 
These results offer insight into the mechanisms associated 
with toxic effects in beluga, contribute to the framework for 
further study of the effects ofxenobiotics on marine mam-
mal populations, and may provide a paradigm for evaluat-
ing chemical risks in natural populations of mammals. 
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CHAPTER EIGHT 
Summary and Conclusions 
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Teleost studies 
3,3' ,4,4'-TCB is known to be a potent toxicant, CYP1A1 inducer, and CYP1A1 
substrate in laboratory mammals. However, there have been many gaps in the information 
regarding TCB toxicity and TCB/CYPIA1 interactions in marine teleost species. Little has 
been known about the dose-response and time-course patterns of CYP1Al induction in 
extrahepatic organs and cells of fish, about the histopathology elicited by TCB in target 
organs and cells of fish, and about the involvement of cytochromes P450 in TCB 
metabolism in fish . Although suppression of CYP 1 A 1 protein content by planar PCB has 
been described or suggested in studies of fish, birds, and mammals, the specificity and 
mechanisms of this suppression have not been characterized in any species. The results 
presented within this thesis (chapters 2- 5) address these questions, utilizing the marine 
fish scup as a model species. Several questions remaining for future research are identified 
below. 
Exposure to TCB elicited effects at many levels in scup. On the most macroscopic 
level, a high dose of TCB (5.0 mg/kg) killed many individuals, and the rate of death 
increased with time following treatment. A small number of individuals apparently escaped 
the lethal effects of a high TCB dose, and seemed to return toward "normal" histology and 
biochemistry by day 16 after treatment (2 fish). It is unc1ear, however, whether these two 
individuals were truly in the process of recovery, or whether they too would have died if 
given the time. 
On a chemical level, the scup were able to metabolize administered TCB, and 
appeared to depurate the administered dose as both parent compound and as metabolites, 
largely through a biliary route. However, the circulation distributed TCB throughout the 
body before such elimination could clear it. The disposition differed at the two doses, with 
maximal TCB concentrations in liver on day 5 at 0.1 mg/kg TCB, and on day 12 and 5.0 
mglkg TCB. Pharmacokinetic studies have indicated that the time to reach peak 
concentration is dependent upon the depuration rate constant, and not upon the uptake rate 
constant. Thus the delayed hepatic peak concentration in fish treated with the high TCB 
dose suggests slower depuration. Consistent with this suggestion, bile residue data (White 
et al., in preparation) indicate that fish treated with the low dose had high concentrations of 
hydroxylated TCB metabolites in bile, whereas fish treated with the high dose had far 
lower concentrations of TCB metabolites in bile. Impaired metabolism at the high dose 
was likely related to the reduced hepatic CYPIAI content in fish treated with this dose, and 
apparently resulted in TCB accumulation in the livers of fish treated with 5.0 mglkg TCB. 
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On a tissue level, both TCB doses elicited necrosis of epithelial cells (kidney), 
altered proliferation of epithelial cells (gill), depletion of lymphoid tissue (kidney), and 
rearrangement of melanomacrophage cells (kidney, spleen). It is interesting to speculate 
that some of these tissue alterations may have been mediated by TCB binding to the 
cytosolic Ah receptor. Other alterations associated with TCB treatment included apparent 
edema in spleen and kidney, aneurysm of gill tissue, fin erosion, loss of lipid and glycogen 
stores in liver, and proliferation of endoplasmic reticulum in liver. Individuals treated with 
the low TCB dose and sampled on day 16 had relatively normal tissue morphology, 
resembling tissues of control fish. This apparent repair of tissue lesions occurred 
concomitantly with TCB depuration from tissues. Individuals treated with the high TCB 
dose exhibited severe tissue pathology until the end of the experiment, displaying no 
evidence of "recovery", despite the finding that much of the TCB dose had been depurated 
from these fish by day 16. At the high dose, it thus appeared that TCB treatment caused 
mortality before tissue repair and TCB depuration could take place. The proximal cause of 
death may have been a severe degeneration of kidney and gill tissue. Pathological 
alterations in liver were similar at the two doses, and included altered hepatocyte 
composition without necrosis. Thus liver damage cannot explain the apparent suppression 
of hepatic CYP1A1 protein content in fish treated with the high dose (see below). 
We speculate that these TCB-elicited tissue alterations may lead to systemic effects 
in teleost fish. Prolonged exposure, even to relatively low TCB doses, may compromise 
excretory and respiratory systems, as was seen in the present study during acute exposure 
to moderate and high doses. Liver function may also be compromised during long-term 
exposure, indicated here by an elevation in plasma AST in fish treated with 0.1 mg/kg TCB 
and sampled on day 12. Damage to other organs, including gonad, was less severe, 
although we cannot rule out the possibility of reproductive impairment due to TCB 
localization in gonad. 
On a molecular level, TCB strongly induced CYP1A1 in epithelial and endothelial 
cells of organs throughout the body. Weak to moderate induction was noted within 24 
hours of treatment in every cell type examined, and strong induction was noted at 24 hours 
in atrial endocardia. CYP1A1 content attenuated by day 16 in many epithelial cell types, 
but was persistent for several weeks after treatment in the endothelia of every organ 
examined. CYP1A1 induction in extrahepatic organs may be associated with TCB 
metabolism in these sites, possibly leading to the in situ production of aqueous-soluble 
TCB metabolites, reactive TCB metabolites, and reactive oxygen species (see below). As 
has been suggested in previous work, CYP1A1 induction in extrahepatic endothelia may 
play a role in binding and sequestration of blood-borne TCB, thus limiting the flow of TCB 
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into the organs. This hypothesis was supported by the moderate CYPlAl induction in 
capillary endothelia of spleen and bulbus arteriosus, which was seen in fish treated with the 
high dose but not in fish treated with the low dose. Future studies should define the role of 
endothelial CYPlAl in TCB sequestration. 
In some epithelial cells CYPlAl content was greater in fish treated with 0.1 mg/kg 
than in fish treated with 5.0 mg/kg, as determined by immunohistochemistry and as 
verified by immunoblotting: hepatocytes, kidney tubules and collecting ducts, and gill 
epithelia. In the case of kidney and gill epithelia, reduced CYP I A 1 content at the high dose 
was likely due to general pathology. In the kidneys of fish treated with the high dose, 
many tubules were characterized by necrotic epithelia, and many others by newly formed, 
regenerative epithelia. We speculate that the severely necrotic cells and the newly formed 
cells may have had a lower capacity to express CYPIAl than did the older, healthier renal 
tubule cells. Thus the reduced CYPlAl content at the high dose was related to the 
pathological alterations in kidney epithelia. In gills of fish treated with the high dose, there 
was a moderate to diffuse hyperplasia of epithelial cells between the secondary lamellae. 
The newly formed epithelia did not stain for CYP 1 A 1, and the older epithelia did. Thus the 
reduced CYPI A 1 content in gill epithelia at the high dose was due to the presence of 
populations of non-staining cells, which existed as a TCB-induced pathology. There was 
no evidence for marked pathology of liver epithelia at the high dose. We theorize that the 
reduced CYPJAI content in livers offish treated with the high dose was not due to general 
pathology, but rather resulted from specific TCB/CYPIAl interactions (see below). 
In liver microsomes, CYPlAl content was three-fold greater in fish treated with the 
low dose (0.1 mg/kg) than in fish treated with the high dose (5.0 mg/kg). Despite the 
strong difference in content of CYP 1 A 1 protein at the two doses, relative content of 
CYPIAI mRNA was the same in livers offish treated with the two doses. The contents of 
several other hepatic enzymes were statistically indistinguishable at the two TCB doses: 
cytochrome b5, NADPH cytochrome c (P450) reductase, UDP-glucuronosyl transferase, 
cytochrome P450B, and cytochrome P450A. Thus the reduced CYPlAl protein content 
was found to be post-transcriptionally controlled, and was found to be highly specific for 
CYPIAI. Both of these findings point toward the hypothesis that "suppressed" CYPlAI 
content at the high dose may be associated with specific TCB/CYP1A1 interactions. 
On a biochemical level, TCB was found to participate in a complex suite of 
interactions with CYPIAI. TCB bound to the active site of the enzyme, as demonstrated 
by binding spectra and by competitive inhibition of EROD activity. In binding, TCB was 
found to act as an apparent inhibitor of CYPIA1 catalytic activity in liver, kidney, and gill 
in vivo. TCB was also found to be a substrate of hepatic CYPIAI in vitro, although it was 
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converted to aqueous-soluble metabolites by the enzyme at an exceedingly slow rate. The 
production of reactive TCB metabolites, those that were capable of binding covalently to 
microsomal protein, proceeded at an almost negligible rate in vitro. However, we cannot 
exclude the possibility that reactive metabolite formation contributed to TCB disposition in 
vivo. It was thus found that TCB bound tightly and specifically to the CYPIAl active site 
but was a poor substrate for the enzyme, implying that it may be capable of uncoupling the 
CYPIAl catalytic cycle. 
The theorized uncoupling was indeed supported by in vitro results. It was found 
that CYPlAl was inactivated (a time-dependent loss of catalytic capacity) and denatured (a 
conversion of P450 to P420) by TCB, under complete reaction conditions. Inactivation 
and denaturation were not seen in the absence of TCB nor in the absence of cofactor, 
implying that substrate binding and electron transport are both required for the inactivation 
and denaturation. The processes of inactivation and denaturation were enhanced in the 
presence of sodium azide, suggesting the involvement of a reactive oxygen species such as 
hydrogen peroxide or hydroxyl radical. Thus TCB, in substrate binding to the CYPIAI 
active site, apparently elicited the oxidative inactivation of the enzyme in vitro. We 
speculate that such oxidative inactivation may contribute to the reduced hepatic CYPlAl 
content in fish exposed to a high TCB dose. Future work should further define the 
mechanisms of the oxidative inactivation, and the potential role of reactive oxygen species 
in both CYPIAI degradation and in histopathology in multiple organs. Further work 
should also focus on drawing a connection between CYPIAI inactivation by TCB in vitro 
and the apparent suppression of CYPI A 1 protein content by TCB in vivo. 
Because TCB exerts profound biochemical changes in teleost fish, interactive 
effects between TCB and other environmental contaminants are likely. Exposure to low 
TCB concentrations results in strong CYPlAl induction, which may lead to increased rates 
of metabolism of other CYPIAl substrates in the environment such as PAH and HAH. 
Increased rates of metabolism may enhance elimination of contaminants from tissues (for 
example PCBs), but may also result in contaminant activation to carcinogenic forms (for 
example P AHs such as BaP). Exposure to high TCB concentrations results in very weak 
apparent CYPlAl induction, manifest as relatively low hepatic CYPlAl protein content 
and activity. Such "suppression" of CYPIAl by TCB may hinder the metabolism, 
detoxification and elimination of both TCB and other PAH and HAH that are CYPlAl 
substrates, and to which the animal is simultaneously exposed. On the other hand, 
"suppressed" CYPlAl content would also lower the potential for metabolic activation of 
other contaminants, such as BaP, to carcinogenic forms. These hypotheses are further 
complicated by the possibility of competition for binding to the Ah receptor. If an animal is 
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exposed to high concentrations of a PAH as well as to TCB, a smaller fraction of the TCB 
may bind to the Ah receptor than would if the animal were exposed to TCB alone. Thus 
TCB effects may be minimized in the presence of other environmental Ah receptor 
agonists. 
Synergistic effects may be seen between TCB and environmental contaminants of 
similar structure. For example, 3,3',4,4',5-HCB may exert a similar CYPlAl 
"suppression" at relatively high doses. We thus speculate that CYPIAl suppression could 
occur in the presence of low TCB concentrations, in combination with low concentrations 
of HCB and other similarly acting chemicals. The hepatic TCB concentrations that were 
associated with CYP 1 A 1 suppression in the present study have been seen in feral fish from 
contaminated environments, implying that the effects reported here have physiological and 
environmental relevance. The possibility of synergistic effects with other chemicals 
increases the likelihood that CYPlAl suppression could occur in feral fish. 
Cetacean studies 
The cytochrome P450 system is known to play a central role in the disposition of 
toxic organic contaminants in laboratory mammals. However, very little has been 
determined about cytochrome P450 systems in marine mammals. Marine mammals are 
heavily exposed to organic contaminants in the environment, thus P450 may play an 
important role in chemical detoxification and activation in these species. P450 systems 
have previously been studied in only four cetacean species; the present work includes a 
catalytic and immunochemical description of P450 systems in two more cetacean species. 
Furthermore, no direct studies of HAH metabolism have previously been conducted in 
marine mammals. This thesis provides the first such data, with direct measurements of 
PCB metabolism in two cetacean species. 
Both beluga whale and pilot whale express a hepatic protein with immunochemical 
similarity to CYPlAl. Correlation analysis indicates that this protein is involved in EROD 
activity in both species. Content of the CYPIA enzyme is also correlated with PROD and 
AHH activities in beluga. In beluga, hepatic content of the CYPIA homologue is 
positively correlated with body burden of coplanar and mono-ortho substituted PCB, 
suggesting induction by environmental PCB. Thus the cetacean CYPIA appears to have 
catalytic and induction properties similar to CYPIA enzymes in laboratory mammals. 
Both cetacean species can convert 3,3',4,4'-TCB and 2,2',5,5'-TCB to aqueous-
soluble products in vitro, and rates of metabolism vary with sex, species, and congener. 
Inhibition studies and correlation analysis indicate that CYPlA is involved in the 
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metabolism of 3,3'4,4'-TCB in beluga. Both species express hepatic protein(s) with 
immunochemical similarity to rabbit and dog CYP2B-subfamily enzymes, but without 
immunochemical similarity to rat CYP2B-subfamily enzymes. The identity and function of 
these cetacean CYP2B-like proteins is not yet known, and should be the subject of future 
study. 
In summary, this thesis provides several original contributions to the body of work 
concerning polychlorinated biphenyl toxicity and cytochrome P450 action in marine fish 
and marine mammals. The thesis provides a time-course and dose-response study of TCB 
toxicity in multiple organs of scup, and a time-course and dose-response study of CYP 1 A 1 
induction by TCB in multiple organs and cell types of scup. The thesis identifies CYP1A1 
as a major catalyst for the metabolism of 3,3',4,4'-TCB in teleost fish, identifies a putative 
CYP2B form as a major catalyst for the metabolism of 2,2',5,5'-TCB in teleost fish, 
identifies a CYP1A form as a catalyst involved in the metabolism of 3,3',4,4'-TCB in 
marine mammals, and identifies the presence of a possible CYP2B homologue in marine 
mammals. The thesis provides evidence that TCB may act as an uncoupler of the CYP 1 A 1 
catalytic cycle in teleost liver in vitro, that such uncoupling is likely associated with 
CYP1Al enzyme inactivatiqn and denaturation in vitro, and that such inactivation and 
denaturation in vitro may be linked to suppressed hepatic CYPIAI protein content in TCB-
treated fish in vivo. Further elucidation of the mechanisms of inactivation and suppression 
by TCB remain for future work. 
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